IDEAS home Printed from https://ideas.repec.org/f/c/pgo681.html
   My authors  Follow this author

Dana P. Goldman

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Blog mentions

As found by EconAcademics.org, the blog aggregator for Economics research:
  1. P.-C. Michaud & D. Goldman & D. Lakdawalla & A. Gailey & Y. Zheng, 2009. "International Differences in Longevity and Health and their Economic Consequences," Social and Economic Dimensions of an Aging Population Research Papers 254, McMaster University.

    Mentioned in:

    1. Longevity and the cost of health
      by Economic Logician in Economic Logic on 2009-10-30 19:51:00

Working papers

  1. Vincenzo Atella & Federico Belotti & Kim Daejung & Dana Goldman & Tadeja Gracner & Andrea Piano Mortari & Bryan Tysinger, 2020. "The Future of the Elderly Population Health Status: Filling a Knowledge Gap," CEIS Research Paper 504, Tor Vergata University, CEIS, revised 22 Dec 2020.

    Cited by:

    1. Gastón A. Giordana & María Noel Pi Alperin, 2022. "Old age takes its toll: long-run projections of health-related public expenditure in Luxembourg," BCL working papers 158, Central Bank of Luxembourg.

  2. John A. Romley & Dana Goldman & Neeraj Sood & Abe C. Dunn, 2019. "Quantifying Productivity Growth in the Delivery of Important Episodes of Care Within the Medicare Program Using Insurance Claims and Administrative Data," BEA Papers 0111, Bureau of Economic Analysis.

    Cited by:

    1. Abe C. Dunn & Lasanthi Fernando & Eli Liebman, 2023. "A Direct Measure of Medical Innovation on Health Care Spending: A Condition-Specific Approach," BEA Papers 0121, Bureau of Economic Analysis.
    2. Dauda, Seidu & Dunn, Abe & Hall, Anne, 2022. "A systematic examination of quality-adjusted price index alternatives for medical care using claims data," Journal of Health Economics, Elsevier, vol. 85(C).

  3. Rebecca Myerson & Reginald Tucker-Seeley & Dana Goldman & Darius Lakdawalla, 2019. "Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes?," Working Papers 2019-054, Human Capital and Economic Opportunity Working Group.

    Cited by:

    1. Marianne P. Bitler & Christopher S. Carpenter & Danea Horn, 2021. "Effects of the Colorectal Cancer Control Program," Health Economics, John Wiley & Sons, Ltd., vol. 30(11), pages 2667-2685, November.
    2. Karinna Saxby & Joshua Byrnes & Sonja C. de New & Son Nghiem & Dennis Petrie, 2023. "Does affirmative action reduce disparities in healthcare use by Indigenous peoples? Evidence from Australia's Indigenous Practice Incentives Program," Health Economics, John Wiley & Sons, Ltd., vol. 32(4), pages 853-872, April.
    3. Guthmuller, Sophie & Carrieri, Vincenzo & Wübker, Ansgar, 2023. "Effects of organized screening programs on breast cancer screening, incidence, and mortality in Europe," Journal of Health Economics, Elsevier, vol. 92(C).

  4. Charles, Kerwin & Coile, Courtney & Gale, William & Goldman, Dana & Lucas, Charles & Orszag, Peter & Sheiner, Louise & Tysinger, Bryan & Weil, David & Wolfers, Justin & Wong, Rebeca & Auerbach, Alan &, 2017. "How The Growing Gap In Life Expectancy May Affect Retirement Benefits And Reforms," Department of Economics, Working Paper Series qt35g3339z, Department of Economics, Institute for Business and Economic Research, UC Berkeley.

    Cited by:

    1. Andras Simonovits, 2018. "The best indexation of public pensions: the point system," CERS-IE WORKING PAPERS 1815, Institute of Economics, Centre for Economic and Regional Studies.
    2. Mauro Caselli & Paolo Falco, 2020. "As long as they are cheap. Experimental evidence on the demand for migrant workers," Discussion Papers 20-06, University of Copenhagen. Department of Economics.
    3. Gordon, Robert J., 2018. "Declining American economic growth despite ongoing innovation," Explorations in Economic History, Elsevier, vol. 69(C), pages 1-12.
    4. Andras Simonovits, 2018. "Designing pension benefits when longevities increase with wages," CERS-IE WORKING PAPERS 1804, Institute of Economics, Centre for Economic and Regional Studies.
    5. Alan J. Auerbach & Laurence J. Kotlikoff & Darryl Koehler, 2016. "U.S. Inequality and Fiscal Progressivity -- An Intragenerational Accounting," Boston University - Department of Economics - Working Papers Series WP2020-004, Boston University - Department of Economics, revised Aug 2019.
    6. Kevin Milligan & Tammy Schirle, 2018. "The Evolution of Longevity: Evidence from Canada," NBER Working Papers 24929, National Bureau of Economic Research, Inc.
    7. Laun, Tobias & Markussen, Simen & Vigtel, Trond Christian & Wallenius, Johanna, 2018. "Health, Longevity and Pension Reform," Working Paper Series 2018:9, Uppsala University, Department of Economics.
    8. Peter Haan & Daniel Kemptner & Holger Lüthen, 2017. "The Rising Longevity Gap by Lifetime Earnings: Distributional Implications for the Pension System," Discussion Papers of DIW Berlin 1698, DIW Berlin, German Institute for Economic Research.
    9. Peter H. Lindert, 2017. "The Rise and Future of Progressive Redistribution," Commitment to Equity (CEQ) Working Paper Series 73, Tulane University, Department of Economics.
    10. Li Tan & Cory Koedel, 2017. "The Effects of Differential Income Replacement and Mortality on U.S. Social Security Redistribution," Working Papers 1701, Department of Economics, University of Missouri, revised Jun 2019.
    11. Culotta, Fabrizio & Alaimo, Leonardo Salvatore & Bravo, Jorge Miguel & di Bella, Enrico & Gandullia, Luca, 2022. "Total-employed longevity gap, pension fairness and public finance: Evidence from one of the oldest regions in EU," Socio-Economic Planning Sciences, Elsevier, vol. 82(PA).
    12. Eytan Sheshinski & Frank N. Caliendo, 2021. "Social Security and the increasing longevity gap," Journal of Public Economic Theory, Association for Public Economic Theory, vol. 23(1), pages 29-52, February.
    13. Fabrizio Culotta, 2021. "Life Expectancy Heterogeneity and Pension Fairness: An Italian North-South Divide," Risks, MDPI, vol. 9(3), pages 1-22, March.
    14. Svend E. Hougaard Jensen & Thorsteinn Sigurdur Sveinsson & Gylfi Zoega, 2021. "Longevity Adjustment of Retirement Age and Intragenerational Inequality," Economica, London School of Economics and Political Science, vol. 88(350), pages 339-363, April.
    15. Laun, Tobias & Markussen, Simen & Vigtel, Trond Christian & Wallenius, Johanna, 2019. "Health, longevity and retirement reform," Journal of Economic Dynamics and Control, Elsevier, vol. 103(C), pages 123-157.
    16. George Kudrna & Chung Tran & Alan Woodland, 2018. "Sustainable and Equitable Pensions with Means Testing in Aging Economies," ANU Working Papers in Economics and Econometrics 2018-666, Australian National University, College of Business and Economics, School of Economics.
    17. Péter Hudomiet & Michael D. Hurd & Susann Rohwedder, 2019. "Trends in Health and Mortality Inequalities in the United States," Working Papers wp401, University of Michigan, Michigan Retirement Research Center.
    18. Péter Hudomiet & Michael D. Hurd & Susann Rohwedder, 2020. "The Impact of Growing Health and Mortality Inequalities on Lifetime Social Security Payouts," Working Papers wp412, University of Michigan, Michigan Retirement Research Center.
    19. Hudomiet, Péter & Hurd, Michael D. & Rohwedder, Susann, 2021. "Forecasting mortality inequalities in the U.S. based on trends in midlife health," Journal of Health Economics, Elsevier, vol. 80(C).

  5. David Powell & Dana Goldman, 2016. "Disentangling Moral Hazard and Adverse Selection in Private Health Insurance," NBER Working Papers 21858, National Bureau of Economic Research, Inc.

    Cited by:

    1. Bedsworth, Fredrick & Neal, Daniel R. & Portillo, Javier E. & Willardsen, Kevin, 2021. "Asymmetric information and insurance: An experimental approach," Journal of Behavioral and Experimental Economics (formerly The Journal of Socio-Economics), Elsevier, vol. 92(C).
    2. Chenhao Yu & Huigang Liang & Zhiruo Zhang, 2022. "Does Health Insurance Reduce the Alcohol Consumption? Evidence from China Health and Nutrition Survey," Sustainability, MDPI, vol. 14(9), pages 1-10, May.
    3. Vincenzo Atella & Alberto Holly & Alessandro Mistretta, 2016. "Disentangling Adverse Selection, Moral Hazard and Supply Induced Demand: An Empirical Analysis of The Demand For Healthcare Services," CEIS Research Paper 389, Tor Vergata University, CEIS, revised 31 Oct 2018.
    4. Laurent Lamy & Manasa Patnam & Michael Visser, 2023. "Distinguishing Incentive from Selection Effects in Auction-Determined Contracts," Post-Print hal-03924664, HAL.
    5. Katarzyna Krot & Iga Rudawska, 2021. "How Public Trust in Health Care Can Shape Patient Overconsumption in Health Systems? The Missing Links," IJERPH, MDPI, vol. 18(8), pages 1-15, April.
    6. Hossein Kavand & Marcel-Cristian Voia, 2016. "Estimation of Health Care Demand and its Implication on Income Effects of Individuals," Carleton Economic Papers 16-01, Carleton University, Department of Economics, revised 26 Jun 2017.
    7. Valizadeh, Pourya & Smith, Travis A., 2018. "Distributional Impacts of WIC on Dietary Quality of Children: Evidence from a Regression Discontinuity Design," 2018 Annual Meeting, August 5-7, Washington, D.C. 273904, Agricultural and Applied Economics Association.
    8. Sengupta, Reshmi & Rooj, Debasis, 2019. "The effect of health insurance on hospitalization: Identification of adverse selection, moral hazard and the vulnerable population in the Indian healthcare market," World Development, Elsevier, vol. 122(C), pages 110-129.
    9. Laurent Lamy & Manasa Patnam & Michael Visser, 2023. "Distinguishing incentive from selection effects in auction-determined contracts," Post-Print hal-04382099, HAL.

  6. Alice Chen & Dana Goldman, 2015. "Health Care Spending: Historical Trends and New Directions," NBER Working Papers 21501, National Bureau of Economic Research, Inc.

    Cited by:

    1. Eunhae Shin, 2019. "Hospital responses to price shocks under the prospective payment system," Health Economics, John Wiley & Sons, Ltd., vol. 28(2), pages 245-260, February.
    2. Maryaline Catillon & David Cutler & Thomas Getzen, 2018. "Two Hundred Years of Health and Medical Care: The Importance of Medical Care for Life Expectancy Gains," NBER Working Papers 25330, National Bureau of Economic Research, Inc.
    3. Mark Elder & Magnus Bengtsson & Lewis Akenji, 2016. "An Optimistic Analysis of the Means of Implementation for Sustainable Development Goals: Thinking about Goals as Means," Sustainability, MDPI, vol. 8(9), pages 1-24, September.
    4. Joelle H Fong, 2019. "Out-of-pocket health spending among Medicare beneficiaries: Which chronic diseases are most costly?," PLOS ONE, Public Library of Science, vol. 14(9), pages 1-16, September.
    5. Richard Z. Xie & Erica deFur Malik & Mark T. Linthicum & Jennifer L. Bright, 2021. "Putting Stakeholder Engagement at the Center of Health Economic Modeling for Health Technology Assessment in the United States," PharmacoEconomics, Springer, vol. 39(6), pages 631-638, June.

  7. Mariana Carrera & Dana Goldman & Geoffrey Joyce, 2013. "Heterogeneity in Cost-Sharing and Cost-Sensitivity, and the Role of the Prescribing Physician," NBER Working Papers 19186, National Bureau of Economic Research, Inc.

    Cited by:

    1. Tianyan Hu & Sandra L. Decker & Shin-Yi Chou, 2014. "The Impact of Health Insurance Expansion on Physician Treatment Choice: Medicare Part D and Physician Prescribing," NBER Working Papers 20708, National Bureau of Economic Research, Inc.
    2. Vincenzo Atella & Federico Belotti & Domenico Depalo, 2017. "Drug therapy adherence and health outcomes in the presence of physician and patient unobserved heterogeneity," Health Economics, John Wiley & Sons, Ltd., vol. 26(S2), pages 106-126, September.
    3. Niels Skipper & Rune Vejlin, 2013. "Determinants of Generic vs. Brand Drug Choice: Evidence from Population-wide Danish Data," Economics Working Papers 2013-05, Department of Economics and Business Economics, Aarhus University.

  8. Pierre-Carl Michaud & Dana Goldman & Darius Lakdawalla & Yuhui Zhen & Adam H. Gailey, 2011. "The Value of Medican and Pharmaceutical Interventions for Reducing Obesity," Cahiers de recherche 1109, CIRPEE.

    Cited by:

    1. Bührer, Christian & Fetzer, Stefan & Hagist, Christian, 2020. "Adverse selection in the German Health Insurance System – the case of civil servants," Health Policy, Elsevier, vol. 124(8), pages 888-894.
    2. Duncan Ermini Leaf & Bryan Tysinger & Dana P. Goldman & Darius N. Lakdawalla, 2021. "Predicting quantity and quality of life with the Future Elderly Model," Health Economics, John Wiley & Sons, Ltd., vol. 30(S1), pages 52-79, November.
    3. Christian Bührer & Stefan Fetzer & Christian Hagist, 2018. "Adverse Selection in the German Health Insurance System – The Case of Civil Servants," WHU Working Paper Series - Economics Group 18-06, WHU - Otto Beisheim School of Management.
    4. David B Agus & Étienne Gaudette & Dana P Goldman & Andrew Messali, 2016. "The Long-Term Benefits of Increased Aspirin Use by At-Risk Americans Aged 50 and Older," PLOS ONE, Public Library of Science, vol. 11(11), pages 1-12, November.
    5. Kaixing Huang & Qianqian Hong, 2024. "The impact of global warming on obesity," Journal of Population Economics, Springer;European Society for Population Economics, vol. 37(3), pages 1-32, September.
    6. Daniel Bauer & Darius Lakdawalla & Julian Reif, 2018. "Mortality Risk, Insurance, and the Value of Life," NBER Working Papers 25055, National Bureau of Economic Research, Inc.
    7. Cawley, John, 2015. "An economy of scales: A selective review of obesity's economic causes, consequences, and solutions," Journal of Health Economics, Elsevier, vol. 43(C), pages 244-268.
    8. Julia Thornton Snider & Jeffrey Sullivan & Emma van Eijndhoven & Michael K Hansen & Nobel Bellosillo & Cheryl Neslusan & Ellen O’Brien & Ralph Riley & Seth Seabury & Bertram L Kasiske, 2019. "Lifetime benefits of early detection and treatment of diabetic kidney disease," PLOS ONE, Public Library of Science, vol. 14(5), pages 1-13, May.

  9. Lu, Yang & Goldman, Dana, 2010. "The Effects of Relative Food Prices on Obesity – Evidence from China: 1991-2006," Working Papers 58249, American Association of Wine Economists.

    Cited by:

    1. Loh, Chung-Ping A. & Li, Qiang, 2013. "Peer effects in adolescent bodyweight: Evidence from rural China," Social Science & Medicine, Elsevier, vol. 86(C), pages 35-44.
    2. Pierre Dubois & Rachel Griffith & Aviv Nevo, 2013. "Do Prices and Attributes Explain International Differences in Food Purchases?," NBER Working Papers 18750, National Bureau of Economic Research, Inc.
    3. Ren, Yanjun & Li, Hui & Wang, Xiaobing, 2019. "Family income and nutrition-related health: Evidence from food consumption in China," Social Science & Medicine, Elsevier, vol. 232(C), pages 58-76.
    4. Young Jo & Qing Wang, 2017. "The impact of maternal employment on children's adiposity: Evidence from China's labor policy reform," Health Economics, John Wiley & Sons, Ltd., vol. 26(12), pages 236-255, December.
    5. Tafreschi, Darjusch, 2015. "The income body weight gradients in the developing economy of China," Economics & Human Biology, Elsevier, vol. 16(C), pages 115-134.
    6. Rachel Griffith & Wenchao (Michelle) Jin & Valérie Lechene, 2022. "The decline of home‐cooked food," Fiscal Studies, John Wiley & Sons, vol. 43(2), pages 105-120, June.
    7. Römling, Cornelia & Qaim, Matin, 2011. "Direct and Indirect Determinants of Obesity: The Case of Indonesia," Proceedings of the German Development Economics Conference, Berlin 2011 70, Verein für Socialpolitik, Research Committee Development Economics.
    8. Clément, Matthieu, 2017. "The income-body-size gradient among Chinese urban adults: A semiparametric analysis," China Economic Review, Elsevier, vol. 44(C), pages 253-270.
    9. E. Van de Poel & O. O'Donnell & E. Van Doorslaer, 2012. "Is there a health penalty of China's rapid urbanization?," Health Economics, John Wiley & Sons, Ltd., vol. 21(4), pages 367-385, April.
    10. Romling, Cornelia & Qaim, Matin, 2011. "Direct and Indirect Determinants of Obesity: The Case of Indonesia," GlobalFood Discussion Papers 108350, Georg-August-Universitaet Goettingen, GlobalFood, Department of Agricultural Economics and Rural Development.
    11. Butzlaf, Iris & Minos, Dimitrios, 2016. "Understanding the Drivers of Overweight and Obesity in Developing Countries: The Case of South Africa," GlobalFood Discussion Papers 232025, Georg-August-Universitaet Goettingen, GlobalFood, Department of Agricultural Economics and Rural Development.

  10. Tomas J. Philipson & Gary Becker & Dana Goldman & Kevin M. Murphy, 2010. "Terminal Care and The Value of Life Near Its End," NBER Working Papers 15649, National Bureau of Economic Research, Inc.

    Cited by:

    1. Woojung Lee & William B. Wong & Stacey Kowal & Louis P. Garrison & David L. Veenstra & Meng Li, 2022. "Modeling the Ex Ante Clinical Real Option Value in an Innovative Therapeutic Area: ALK-Positive Non-Small-Cell Lung Cancer," PharmacoEconomics, Springer, vol. 40(6), pages 623-631, June.
    2. Thornton Snider Julia & Seabury Seth & Tebeka Mahlet Gizaw & Wu Yanyu & Batt Katharine, 2018. "The Option Value of Innovative Treatments for Metastatic Melanoma," Forum for Health Economics & Policy, De Gruyter, vol. 21(1), pages 1-10, June.
    3. Eric Budish & Benjamin Roin & Heidi Williams, 2013. "Do fixed patent terms distort innovation? Evidence from cancer clinical trials," Discussion Papers 13-001, Stanford Institute for Economic Policy Research.
    4. Dong Chen & Dennis Petrie & Kam Tang & Dongjie Wu, 2020. "Private Information and Misinformation in Subjective Life Expectancy," Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement, Springer, vol. 152(3), pages 1061-1083, December.
    5. Ariel Goldszmidt & John List & Robert Metcalfe & Ian Muir & Jenny Wang, 2020. "The Value of Time in the United States: Estimates from Nationwide Natural Field Experiments," Natural Field Experiments 00720, The Field Experiments Website.
    6. Michael Kuhn & Stefan Wrzaczek & Alexia Prskawetz & Gustav Feichtinger, 2010. "Externalities in a Life-Cycle Model with Endogenous Survival," VID Working Papers 1001, Vienna Institute of Demography (VID) of the Austrian Academy of Sciences in Vienna.
    7. Shafrin, Jason & Skornicki, Michelle & Brauer, Michelle & Villeneuve, Julie & Lees, Michael & Hertel, Nadine & Penrod, John R. & Jansen, Jeroen, 2018. "An exploratory case study of the impact of expanding cost-effectiveness analysis for second-line nivolumab for patients with squamous non-small cell lung cancer in Canada: Does it make a difference?," Health Policy, Elsevier, vol. 122(6), pages 607-613.
    8. Fischer, Barbara & Telser, Harry & Zweifel, Peter, 2018. "End-of-life healthcare expenditure: Testing economic explanations using a discrete choice experiment," Journal of Health Economics, Elsevier, vol. 60(C), pages 30-38.
    9. Joseph P Cook, 2014. "Real Option Value and Path Dependence in Oncology Innovation," Seminar Briefing 000077, Office of Health Economics.
    10. Eric Budish & Benjamin N. Roin & Heidi Williams, 2015. "Do Firms Underinvest in Long-Term Research? Evidence from Cancer Clinical Trials," American Economic Review, American Economic Association, vol. 105(7), pages 2044-2085, July.
    11. Joseph Cook & Joseph Golec & John Vernon & George Pink, 2011. "Real Option Value and Path Dependence in Oncology Innovation," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 18(2), pages 225-238.
    12. Kuhn, Michael & Wrzaczek, Stefan & Prskawetz, Alexia & Feichtinger, Gustav, 2015. "Optimal choice of health and retirement in a life-cycle model," Journal of Economic Theory, Elsevier, vol. 158(PA), pages 186-212.
    13. Thornton Snider Julia & Romley John A. & Vogt William B. & Philipson Tomas J., 2012. "The Option Value of Innovation," Forum for Health Economics & Policy, De Gruyter, vol. 15(1), pages 1-19, April.
    14. Alison Pearce & Marion Haas & Rosalie Viney, 2013. "Are the True Impacts of Adverse Events Considered in Economic Models of Antineoplastic Drugs? A Systematic Review," Applied Health Economics and Health Policy, Springer, vol. 11(6), pages 619-637, December.
    15. Meng Li & Anirban Basu & Caroline S. Bennette & David L. Veenstra & Louis P. Garrison, 2019. "Do cancer treatments have option value? Real‐world evidence from metastatic melanoma," Health Economics, John Wiley & Sons, Ltd., vol. 28(7), pages 855-867, July.
    16. Mark Pennington & Rachel Baker & Werner Brouwer & Helen Mason & Dorte Gyrd Hansen & Angela Robinson & Cam Donaldson & the EuroVaQ Team, 2015. "Comparing WTP Values of Different Types of QALY Gain Elicited from the General Public," Health Economics, John Wiley & Sons, Ltd., vol. 24(3), pages 280-293, March.
    17. Fink Simonsen, Nicolai & Kjær, Trine, 2021. "New Evidence of Health State Dependent Utility of Consumption: A combined survey and register study," DaCHE discussion papers 2021:2, University of Southern Denmark, Dache - Danish Centre for Health Economics.
    18. Hansen, Lise Desireé & Kjær, Trine, 2019. "Disentangling public preferences for health gains at end-of-life: Further evidence of no support of an end-of-life premium," Social Science & Medicine, Elsevier, vol. 236(C), pages 1-1.

  11. Eric C. Sun & Anupam B. Jena & Darius N. Lakdawalla & Carolina M. Reyes & Tomas J. Philipson & Dana P. Goldman, 2009. "An Economic Evaluation of the War on Cancer," NBER Working Papers 15574, National Bureau of Economic Research, Inc.

    Cited by:

    1. Frank R. Lichtenberg, 2014. "Has Medical Innovation Reduced Cancer Mortality?," CESifo Economic Studies, CESifo Group, vol. 60(1), pages 135-177.
    2. Kyle, Margaret & Dubois, Pierre, 2016. "The Effects of Pharmaceutical Innovation on Cancer Mortality," CEPR Discussion Papers 11487, C.E.P.R. Discussion Papers.
    3. Tomas J. Philipson & Sachin Kamal-Bahl & Anupam B. Jena, 2017. "Defining Value: The Need for a Longer, Broader View," PharmacoEconomics, Springer, vol. 35(7), pages 669-672, July.
    4. Rodrigo Camejo & Clare McGrath & Marisa Miraldo & Frans Rutten, 2014. "Distribution of health-related social surplus in pharmaceuticals: an estimation of consumer and producer surplus in the management of high blood lipids and COPD," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 15(4), pages 439-445, May.
    5. Eric Budish & Benjamin Roin & Heidi Williams, 2013. "Do fixed patent terms distort innovation? Evidence from cancer clinical trials," Discussion Papers 13-001, Stanford Institute for Economic Policy Research.
    6. Hintermann, Beat & Minke, Matthias, 2018. "The value of extending life at its end: Health care allocation in the presence of learning spillovers," Working papers 2018/15, Faculty of Business and Economics - University of Basel.
    7. Amitabh Chandra & Jonathan S. Skinner, 2011. "Technology Growth and Expenditure Growth in Health Care," NBER Working Papers 16953, National Bureau of Economic Research, Inc.
    8. Bloom, David E. & Chen, Simiao & Kuhn, Michael & McGovern, Mark E. & Oxley, Les & Prettner, Klaus, 2020. "The economic burden of chronic diseases: Estimates and projections for China, Japan, and South Korea," The Journal of the Economics of Ageing, Elsevier, vol. 17(C).
    9. Shafrin, Jason & Skornicki, Michelle & Brauer, Michelle & Villeneuve, Julie & Lees, Michael & Hertel, Nadine & Penrod, John R. & Jansen, Jeroen, 2018. "An exploratory case study of the impact of expanding cost-effectiveness analysis for second-line nivolumab for patients with squamous non-small cell lung cancer in Canada: Does it make a difference?," Health Policy, Elsevier, vol. 122(6), pages 607-613.
    10. Amitabh Chandra, 2011. "Comment on "The Value of Progress against Cancer in the Elderly"," NBER Chapters, in: Investigations in the Economics of Aging, pages 233-236, National Bureau of Economic Research, Inc.
    11. Rebecca M. Myerson & Reginald D. Tucker‐Seeley & Dana P. Goldman & Darius N. Lakdawalla, 2020. "Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes?," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 39(3), pages 577-604, June.
    12. Eric Budish & Benjamin N. Roin & Heidi Williams, 2015. "Do Firms Underinvest in Long-Term Research? Evidence from Cancer Clinical Trials," American Economic Review, American Economic Association, vol. 105(7), pages 2044-2085, July.
    13. Christoph M Rheinberger & Daniel Herrera-Araujo & James K. Hammitt, 2016. "The value of disease prevention vs treatment," Post-Print halshs-01626801, HAL.
    14. Kyle R. Myers, 2022. "Some Tradeoffs of Competition in Grant Contests," Papers 2207.02379, arXiv.org, revised Mar 2024.
    15. Adam Leive & Thomas Stratmann, 2015. "Do national cancer screening guidelines reduce mortality?," Journal of Population Economics, Springer;European Society for Population Economics, vol. 28(4), pages 1075-1095, October.
    16. Laura Grigolon & Laura Lasio, 2023. "Biased Beliefs and Stigma as Barriers to Treatment and Innovation Adoption," CRC TR 224 Discussion Paper Series crctr224_2023_277v2, University of Bonn and University of Mannheim, Germany.
    17. Hammitt, James K. & Herrera-Araujo, Daniel & Rheinberger, Christoph, 2016. "The Value of Cancer Prevention vs Treatment," TSE Working Papers 16-628, Toulouse School of Economics (TSE).
    18. Dubois, Pierre & Kyle, Margaret, 2016. "The Effects of Pharmaceutical Innovation on Cancer Mortality Rates," TSE Working Papers 16-688, Toulouse School of Economics (TSE).
    19. Engy Ziedan & Kosali I. Simon & Coady Wing, 2022. "Mortality Effects of Healthcare Supply Shocks: Evidence Using Linked Deaths and Electronic Health Records," NBER Working Papers 30553, National Bureau of Economic Research, Inc.

  12. Tomas J. Philipson & Eric C. Sun & Dana Goldman, 2009. "The Effects of Product Liability Exemption in the Presence of the FDA," NBER Working Papers 15603, National Bureau of Economic Research, Inc.

    Cited by:

    1. Giovanni Immordino & Marco Pagano & Michele Polo, 2009. "Incentives to Innovate and Social Harm: Laissez-Faire, Authorization or Penalties?," CSEF Working Papers 220, Centre for Studies in Economics and Finance (CSEF), University of Naples, Italy.
    2. Joshua Schwartzstein & Andrei Shleifer, 2013. "An Activity-Generating Theory of Regulation," Journal of Law and Economics, University of Chicago Press, vol. 56(1), pages 1-38.

  13. Michaud, Pierre-Carl & Goldman, Dana P. & Lakdawalla, Darius N. & Zheng, Yuhui & Gailey, Adam H., 2009. "International Differences in Longevity and Health and Their Economic Consequences," IZA Discussion Papers 4367, Institute of Labor Economics (IZA).

    Cited by:

    1. Samuel H. Preston & Jessica Y. Ho, 2009. "Low Life Expectancy in the United States: Is the Health Care System at Fault?," NBER Working Papers 15213, National Bureau of Economic Research, Inc.

  14. Dana Goldman & Darius Lakdawalla & Yuhui Zheng, 2009. "Food Prices and the Dynamics of Body Weight," NBER Working Papers 15096, National Bureau of Economic Research, Inc.

    Cited by:

    1. Georgia S. Papoutsi & Rodolfo M. Nayga & Panagiotis Lazaridis & Andreas C. Drichoutis, 2013. "Nudging parental health behavior with and without children's pestering power: Fat tax, subsidy or both?," Working Papers 2013-5, Agricultural University of Athens, Department Of Agricultural Economics.
    2. Wehby, George L. & Courtemanche, Charles J., 2012. "The heterogeneity of the cigarette price effect on body mass index," Journal of Health Economics, Elsevier, vol. 31(5), pages 719-729.
    3. Charles L. Baum & Shin-Yi Chou, 2011. "The Socio-Economic Causes of Obesity," NBER Working Papers 17423, National Bureau of Economic Research, Inc.
    4. Courtemanche, Charles & Pinkston, Joshua C. & Stewart, Jay, 2014. "Adjusting Body Mass for Measurement Error with Invalid Validation Data," IZA Discussion Papers 8009, Institute of Labor Economics (IZA).
    5. Shu Wen Ng & Edward C. Norton & David K. Guilkey & Barry M. Popkin, 2010. "Estimation of a Dynamic Model of Weight," NBER Working Papers 15864, National Bureau of Economic Research, Inc.
    6. Buttet, Sebastien & Dolar, Veronika, 2015. "Toward a quantitative theory of food consumption choices and body weight," Economics & Human Biology, Elsevier, vol. 17(C), pages 143-156.
    7. Paolo Nicola Barbieri, 2022. "Social distortion in weight perception: a decomposition of the obesity epidemic," Economia Politica: Journal of Analytical and Institutional Economics, Springer;Fondazione Edison, vol. 39(2), pages 685-713, July.
    8. Pierre Dubois & Rachel Griffith & Aviv Nevo, 2013. "Do Prices and Attributes Explain International Differences in Food Purchases?," NBER Working Papers 18750, National Bureau of Economic Research, Inc.
    9. McGeary, Kerry Anne, 2013. "The impact of state-level nutrition-education program funding on BMI: Evidence from the behavioral risk factor surveillance system," Social Science & Medicine, Elsevier, vol. 82(C), pages 67-78.
    10. Buttet, Sebastien & Dolar, Veronika, 2015. "The Price Of One Sweet Calorie," International Journal of Food and Agricultural Economics (IJFAEC), Alanya Alaaddin Keykubat University, Department of Economics and Finance, vol. 3(4), pages 1-14, October.
    11. Strulik, Holger, 2014. "A mass phenomenon: The social evolution of obesity," Journal of Health Economics, Elsevier, vol. 33(C), pages 113-125.
    12. Rafael Moreira Claro & Vargas Hernandez & Joel Alberto & Satoru Shimokawa & Euna Han & Sharada Keats & Steve Wiggins, 2015. "The Rising Cost of a Healthy Diet – Changing Relative prices of Foods in High- Income and Emerging Economies," Working Papers id:7250, eSocialSciences.
    13. Darius Lakdawalla & Tomas J. Philipson, 2006. "Economics of Obesity," Chapters, in: Andrew M. Jones (ed.), The Elgar Companion to Health Economics, chapter 7, Edward Elgar Publishing.
    14. Guy E.J. Faulkner & Paul Grootendorst & Van Hai Nguyen & Tatiana Andreyeva & Kelly Arbour-Nicitopoulos & Chris Auld & Sean B. Cash & John Cawley & Peter Donnelly & Adam Drewnowski & Laurette Dubé & R, 2011. "Economic Instruments for Obesity Prevention: Results of a Scoping Review and Modified Delphi Survey," Monash Economics Working Papers 31-11, Monash University, Department of Economics.
    15. J. Clark & O. Dittrich & Stephen Law & Qin Xu, 2014. "Nutrient Prices and Other Socio-Economic and Health Determinants of the Body Mass Index of Canadians," International Advances in Economic Research, Springer;International Atlantic Economic Society, vol. 20(3), pages 249-258, August.
    16. Charles J. Courtemanche & Joshua C. Pinkston & Christopher J. Ruhm & George L. Wehby, 2016. "Can Changing Economic Factors Explain the Rise in Obesity?," Southern Economic Journal, John Wiley & Sons, vol. 82(4), pages 1266-1310, April.
    17. Zhou, Song & Awokuse, Titus O., "undated". "Urbanization, Nutrition Transition, and Obesity: Evidence from China," 2014 Annual Meeting, July 27-29, 2014, Minneapolis, Minnesota 170458, Agricultural and Applied Economics Association.
    18. Cawley, John & Maclean, Johanna Catherine & Sikora Kessler, Asia, 2017. "Reporting error in weight and height among older adults: Implications for estimating healthcare costs," The Journal of the Economics of Ageing, Elsevier, vol. 9(C), pages 122-144.
    19. Courtemanche, Charles & Tchernis, Rusty & Ukert, Benjamin, 2018. "The effect of smoking on obesity: Evidence from a randomized trial," Journal of Health Economics, Elsevier, vol. 57(C), pages 31-44.
    20. Rachel Griffith & Wenchao (Michelle) Jin & Valérie Lechene, 2022. "The decline of home‐cooked food," Fiscal Studies, John Wiley & Sons, vol. 43(2), pages 105-120, June.
    21. Paul W. Dobson & Eitan Gerstner, 2010. "For a Few Cents More: Why Supersize Unhealthy Food?," Marketing Science, INFORMS, vol. 29(4), pages 770-778, 07-08.
    22. Ruhm, Christopher J., 2012. "Understanding overeating and obesity," Journal of Health Economics, Elsevier, vol. 31(6), pages 781-796.
    23. Lakdawalla, Darius & Philipson, Tomas, 2009. "The growth of obesity and technological change," Economics & Human Biology, Elsevier, vol. 7(3), pages 283-293, December.
    24. Charles Courtemanche & Garth Heutel & Patrick McAlvanah, 2015. "Impatience, Incentives and Obesity," Economic Journal, Royal Economic Society, vol. 125(582), pages 1-31, February.
    25. Xin Xu & Jayachandran N Variyam & Zhenxiang Zhao & Frank J Chaloupka, 2014. "Relative Food Prices and Obesity in U.S. Metropolitan Areas: 1976-2001," PLOS ONE, Public Library of Science, vol. 9(12), pages 1-22, December.
    26. Pinkston, Joshua C., 2017. "The dynamic effects of obesity on the wages of young workers," Economics & Human Biology, Elsevier, vol. 27(PA), pages 154-166.
    27. Bradbear, Catherine & Friel, Sharon, 2013. "Integrating climate change, food prices and population health," Food Policy, Elsevier, vol. 43(C), pages 56-66.
    28. Michelle Saksena & Norman Maldonado, 2017. "A Dynamic Estimation of Obesity Using Nhanes Data: A Pseudo‐Panel Approach," Health Economics, John Wiley & Sons, Ltd., vol. 26(12), pages 140-159, December.
    29. Banterle, Alessandro & Cavaliere, Alessia, 2014. "Is there a relationship between product attributes, nutrition labels and excess weight? Evidence from an Italian region," Food Policy, Elsevier, vol. 49(P1), pages 241-249.
    30. Gračner, Tadeja, 2021. "Bittersweet: How prices of sugar-rich foods contribute to the diet-related disease epidemic in Mexico," Journal of Health Economics, Elsevier, vol. 80(C).
    31. Scott A. Carson, 2013. "Statures, BMIs, and Weight: A Reassessment," CESifo Working Paper Series 4540, CESifo.

  15. Michaud, Pierre-Carl & Goldman, Dana P. & Lakdawalla, Darius N. & Zheng, Yuhui & Gailey, Adam H., 2009. "Understanding the Economic Consequences of Shifting Trends in Population Health," IZA Discussion Papers 4366, Institute of Labor Economics (IZA).

    Cited by:

    1. Anthony Webb & Natalia Zhivan, 2010. "How Much Is Enough? The Distribution of Lifetime Health Care Costs," Working Papers, Center for Retirement Research at Boston College wp2010-1, Center for Retirement Research, revised Feb 2010.
    2. Yang, Muzhe & Huang, Rui, 2010. "Exposure to Obesity and Weight Gain among Adolescents," Research Reports 149944, University of Connecticut, Food Marketing Policy Center.
    3. P.-C. Michaud & D. Goldman & D. Lakdawalla & A. Gailey & Y. Zheng, 2009. "International Differences in Longevity and Health and their Economic Consequences," Social and Economic Dimensions of an Aging Population Research Papers 254, McMaster University.
    4. Marc Carreras & Pere Ibern & José María Inoriza, 2018. "Ageing and healthcare expenditures: Exploring the role of individual health status," Health Economics, John Wiley & Sons, Ltd., vol. 27(5), pages 865-876, May.
    5. Jay Bhattacharya & Mikko Packalen, 2008. "The Other Ex-Ante Moral Hazard in Health," NBER Working Papers 13863, National Bureau of Economic Research, Inc.
    6. Bram Wouterse & Bert R. Meijboom & Johan J. Polder, 2011. "The relationship between baseline health and longitudinal costs of hospital use," Health Economics, John Wiley & Sons, Ltd., vol. 20(8), pages 985-1008, August.

  16. Nicole Maestas & Mathis Schroeder & Dana Goldman, 2009. "Price Variation in Markets with Homogeneous Goods: The Case of Medigap," NBER Working Papers 14679, National Bureau of Economic Research, Inc.

    Cited by:

    1. Martin Gaynor & Kate Ho & Robert Town, 2014. "The Industrial Organization of Health Care Markets," NBER Working Papers 19800, National Bureau of Economic Research, Inc.
    2. Amanda Starc, 2014. "Insurer pricing and consumer welfare: evidence from Medigap," RAND Journal of Economics, RAND Corporation, vol. 45(1), pages 198-220, March.
    3. Matthew N. White, 2016. "Competition Among Insurers and Consumer Welfare," Working Papers 16-02, University of Delaware, Department of Economics.
    4. Gaynor, Martin & Town, Robert J., 2011. "Competition in Health Care Markets," Handbook of Health Economics, in: Mark V. Pauly & Thomas G. Mcguire & Pedro P. Barros (ed.), Handbook of Health Economics, volume 2, chapter 0, pages 499-637, Elsevier.
    5. Keith M. Marzilli Ericson & Amanda Starc, 2012. "Pricing Regulation and Imperfect Competition on the Massachusetts Health Insurance Exchange," NBER Working Papers 18089, National Bureau of Economic Research, Inc.
    6. Jonneke Bolhaar & Bas van der Klaauw & Maarten Lindeboom, 2010. "Insurance Search and Switching Behavior," Tinbergen Institute Discussion Papers 10-072/3, Tinbergen Institute.
    7. Karine Lamiraud & Pierre Stadelmann, 2020. "Switching costs in competitive health insurance markets: The role of insurers' pricing strategies," Health Economics, John Wiley & Sons, Ltd., vol. 29(9), pages 992-1012, September.
    8. Haizhen Lin & Matthijs R. Wildenbeest, 2013. "Search and Prices in the Medigap Insurance Market," Working Papers 2013-15, Indiana University, Kelley School of Business, Department of Business Economics and Public Policy.
    9. Keane, M.P. & Thorp, S., 2016. "Complex Decision Making," Handbook of the Economics of Population Aging, in: Piggott, John & Woodland, Alan (ed.), Handbook of the Economics of Population Aging, edition 1, volume 1, chapter 0, pages 661-709, Elsevier.
    10. Wuppermann, Amelie & Bauhoff, Sebastian & Grabka, Markus, 2014. "The Price Sensitivity of Health Plan Choice among Retirees: Evidence from the German Social Health Insurance," VfS Annual Conference 2014 (Hamburg): Evidence-based Economic Policy 100352, Verein für Socialpolitik / German Economic Association.
    11. Wuppermann, Amelie C. & Bauhoff, Sebastian & Grabka, Markus M., 2014. "The Price Sensitivity of Health Plan Choice: Evidence from Retirees in the German Social Health Insurance," Discussion Papers in Economics 21080, University of Munich, Department of Economics.
    12. Michael P. Keane & Susan Thorp, 2016. "Complex Decision Making: The Roles of Cognitive Limitations, Cognitive Decline and Ageing," Economics Papers 2016-W10, Economics Group, Nuffield College, University of Oxford.

  17. John A. Romley & Dana Goldman, 2008. "How Costly Is Hospital Quality? A Revealed-Preference Approach," NBER Working Papers 13730, National Bureau of Economic Research, Inc.

    Cited by:

    1. Nils Gutacker & Chris Bojke & Silvio Daidone & Nancy Devlin & David Parkin & Andrew Street, 2011. "Truly inefficient or providing better quality of care? Analysing the relationship between riskadjusted hospital costs and patients’ health outcomes," Working Papers 068cherp, Centre for Health Economics, University of York.
    2. Zeynep Or & Thomas Renaud & Laure Com-Ruelle, 2009. "One price for all? Sources of cost variations between public and private hospitals," Working Papers DT25, IRDES institut for research and information in health economics, revised May 2009.
    3. Sajid Anwar & Sizhong Sun, 2023. "Foreign direct investment and product quality in host economies," The World Economy, Wiley Blackwell, vol. 46(5), pages 1290-1318, May.
    4. Dunn, Abe & Knepper, Matthew & Dauda, Seidu, 2021. "Insurance expansions and hospital utilization: Relabeling and reabling?," Journal of Health Economics, Elsevier, vol. 78(C).
    5. John A. Romley & Neeraj Sood, 2013. "Identifying the Health Production Function: The Case of Hospitals," NBER Working Papers 19490, National Bureau of Economic Research, Inc.
    6. Soroush Saghafian & Wallace J. Hopp, 2020. "Can Public Reporting Cure Healthcare? The Role of Quality Transparency in Improving Patient–Provider Alignment," Operations Research, INFORMS, vol. 68(1), pages 71-92, January.
    7. Baker, Laurence C. & Bundorf, M. Kate & Kessler, Daniel P., 2016. "The effect of hospital/physician integration on hospital choice," Journal of Health Economics, Elsevier, vol. 50(C), pages 1-8.
    8. Laurence C. Baker & M. Kate Bundorf & Daniel P. Kessler, 2015. "The Effect of Hospital/Physician Integration on Hospital Choice," NBER Working Papers 21497, National Bureau of Economic Research, Inc.
    9. Andrew Sfekas, 2019. "Quality Competition and Intra-System Substitution in the Hospital Industry," American Journal of Health Economics, MIT Press, vol. 5(1), pages 65-96, Winter.
    10. Howley, Peter, 2017. "Less money or better health? Evaluating individual’s willingness to make trade-offs using life satisfaction data," Journal of Economic Behavior & Organization, Elsevier, vol. 135(C), pages 53-65.
    11. Tito Nestor TIEHI, 2023. "Impact of HIV and Covid-19 pandemics on ivorian health system efficiency," Bulletin of Applied Economics, Risk Market Journals, vol. 10(1), pages 103-113.
    12. Dana Goldman & John A. Romley, 2008. "Hospitals As Hotels: The Role of Patient Amenities in Hospital Demand," NBER Working Papers 14619, National Bureau of Economic Research, Inc.
    13. Garthwaite, Craig & Ody, Christopher & Starc, Amanda, 2022. "Endogenous quality investments in the U.S. hospital market," Journal of Health Economics, Elsevier, vol. 84(C).
    14. K. John McConnell & Richard C. Lindrooth & Douglas R. Wholey & Thomas M. Maddox & Nick Bloom, 2016. "Modern Management Practices and Hospital Admissions," Health Economics, John Wiley & Sons, Ltd., vol. 25(4), pages 470-485, April.
    15. Calvin Ackley & Abe Dunn & Eli Liebman & Adam Hale Shapiro, 2024. "Are Medicaid and Medicare Patients Treated Equally?," Working Paper Series 2024-14, Federal Reserve Bank of San Francisco.
    16. Zeltzer, Dan & Einav, Liran & Chasid, Avichai & Balicer, Ran D., 2021. "Supply-side variation in the use of emergency departments," Journal of Health Economics, Elsevier, vol. 78(C).
    17. Devesh Raval & Ted Rosenbaum, 2021. "Why is Distance Important for Hospital Choice? Separating Home Bias From Transport Costs," Journal of Industrial Economics, Wiley Blackwell, vol. 69(2), pages 338-368, June.
    18. Saghafian, Soroush & Hopp, Wallace J., 2017. "Can Public Reporting Cure Healthcare? The Role of Quality Transparency in Improving Patient-Provider Alignment," Working Paper Series rwp17-044, Harvard University, John F. Kennedy School of Government.
    19. Keon-Hyung Lee & Seunghoo Lim & Jieun Moon, 2022. "The Link Between Hospital Competition and Hospital Behaviors in Korea: Competitive Interorganizational Relations," Global Journal of Flexible Systems Management, Springer;Global Institute of Flexible Systems Management, vol. 23(1), pages 1-14, December.
    20. Balia, Silvia & Brau, Rinaldo & Moro, Daniela, 2020. "Choice of hospital and long-distances: Evidence from Italy," Regional Science and Urban Economics, Elsevier, vol. 81(C).
    21. Sun, Sizhong & Anwar, Sajid, 2022. "Estimation of product quality in China's food processing and manufacturing industries," Economic Modelling, Elsevier, vol. 107(C).

  18. Dana Goldman & John A. Romley, 2008. "Hospitals As Hotels: The Role of Patient Amenities in Hospital Demand," NBER Working Papers 14619, National Bureau of Economic Research, Inc.

    Cited by:

    1. Walter Beckert & Kate Collyer, 2016. "Choice in the presence of experts: the role of general practitioners in patients' hospital choice," IFS Working Papers W16/21, Institute for Fiscal Studies.
    2. Peter Sivey, 2010. "The Effect of Waiting Time and Distance on Hospital Choice for English Cataract Patients," Melbourne Institute Working Paper Series wp2010n10, Melbourne Institute of Applied Economic and Social Research, The University of Melbourne.
    3. Honora Smith & Christine Currie & Pornpimol Chaiwuttisak & Andreas Kyprianou, 2018. "Patient choice modelling: how do patients choose their hospitals?," Health Care Management Science, Springer, vol. 21(2), pages 259-268, June.
    4. Moscone, Francesco & Tosetti, Elisa & Vittadini, Giorgio, 2009. "Social Interaction in Patients'�Hospital Choice: Evidences from Italy," MPRA Paper 17783, University Library of Munich, Germany.
    5. Paolo Berta & Gianmaria Martini & Francesco Moscone & Giorgio Vittadini, 2016. "The association between asymmetric information, hospital competition and quality of healthcare: evidence from Italy," Journal of the Royal Statistical Society Series A, Royal Statistical Society, vol. 179(4), pages 907-926, October.
    6. Kate Ho & Ariel Pakes, 2014. "Hospital Choices, Hospital Prices, and Financial Incentives to Physicians," American Economic Review, American Economic Association, vol. 104(12), pages 3841-3884, December.
    7. Pilny, Adam & Mennicken, Roman, 2014. "Does Hospital Reputation Influence the Choice of Hospital?," Ruhr Economic Papers 516, RWI - Leibniz-Institut für Wirtschaftsforschung, Ruhr-University Bochum, TU Dortmund University, University of Duisburg-Essen.
    8. Deepa Wani & Manoj Malhotra & Jonathan Clark, 2021. "Strategic Service Design Attributes, Customer Experience, and Co‐Created Service Choice: Evidence from Florida Hospitals," Production and Operations Management, Production and Operations Management Society, vol. 30(1), pages 210-234, January.
    9. Hendrik Schmitz & Magdalena A. Stroka‐Wetsch, 2020. "Determinants of nursing home choice: Does reported quality matter?," Health Economics, John Wiley & Sons, Ltd., vol. 29(7), pages 766-777, July.
    10. Brian Jacob & Brian McCall & Kevin Stange, 2018. "College as Country Club: Do Colleges Cater to Students’ Preferences for Consumption?," Journal of Labor Economics, University of Chicago Press, vol. 36(2), pages 309-348.
    11. Schmitz, Hendrik & Stroka, Magdalena A., 2014. "Do Elderly Choose Nursing Homes by Quality, Price or Location?," Ruhr Economic Papers 495, RWI - Leibniz-Institut für Wirtschaftsforschung, Ruhr-University Bochum, TU Dortmund University, University of Duisburg-Essen.
    12. Carrie Colla & Julie Bynum & Andrea Austin & Jonathan Skinner, 2016. "Hospital Competition, Quality, and Expenditures in the U.S. Medicare Population," NBER Working Papers 22826, National Bureau of Economic Research, Inc.
    13. Soheil Davari & Kemal Kilic & Gurdal Ertek, 2015. "Fuzzy bi-objective preventive health care network design," Health Care Management Science, Springer, vol. 18(3), pages 303-317, September.
    14. Varkevisser, Marco & van der Geest, Stéphanie A. & Schut, Frederik T., 2012. "Do patients choose hospitals with high quality ratings? Empirical evidence from the market for angioplasty in the Netherlands," Journal of Health Economics, Elsevier, vol. 31(2), pages 371-378.

  19. Dana Goldman & Tomas Philipson, 2007. "Integrated Insurance Design in the Presence of Multiple Medical Technologies," NBER Working Papers 12870, National Bureau of Economic Research, Inc.

    Cited by:

    1. Partha Deb & Pravin K. Trivedi & David M. Zimmer, 2014. "Cost‐Offsets Of Prescription Drug Expenditures: Data Analysis Via A Copula‐Based Bivariate Dynamic Hurdle Model," Health Economics, John Wiley & Sons, Ltd., vol. 23(10), pages 1242-1259, October.
    2. Joseph P. Newhouse, 2020. "An Ounce of Prevention," NBER Working Papers 27553, National Bureau of Economic Research, Inc.
    3. Rebecca Mary Myerson & Darius Lakdawalla & Lisandro D. Colantonio & Monika Safford & David Meltzer, 2018. "Effects of Expanding Health Screening on Treatment - What Should We Expect? What Can We Learn?," NBER Working Papers 24347, National Bureau of Economic Research, Inc.
    4. Anirban Basu & Tomas J. Philipson, 2010. "The Impact of Comparative Effectiveness Research on Health and Health Care Spending," NBER Working Papers 15633, National Bureau of Economic Research, Inc.
    5. Liran Einav & Amy Finkelstein & Maria Polyakova, 2016. "Private Provision of Social Insurance: Drug-specific Price Elasticities and Cost Sharing in Medicare Part D," NBER Working Papers 22277, National Bureau of Economic Research, Inc.
    6. Johannes G. Jaspersen, 2022. "When full insurance may not be optimal: The case of restricted substitution," Health Economics, John Wiley & Sons, Ltd., vol. 31(6), pages 1249-1257, June.
    7. Boone, J., 2014. "Basic Versus Supplementary Health Insurance : Moral Hazard and Adverse Selection," Discussion Paper 2014-059, Tilburg University, Center for Economic Research.
    8. Qian Li & Pravin K. Trivedi, 2016. "Adverse and Advantageous Selection in the Medicare Supplemental Market: A Bayesian Analysis of Prescription drug Expenditure," Health Economics, John Wiley & Sons, Ltd., vol. 25(2), pages 192-211, February.
    9. Murat K. Munkin & Pravin K. Trivedi, 2010. "Disentangling incentives effects of insurance coverage from adverse selection in the case of drug expenditure: a finite mixture approach," Health Economics, John Wiley & Sons, Ltd., vol. 19(9), pages 1093-1108, September.
    10. Florian Heiss & Daniel McFadden & Joachim Winter, 2010. "Mind the Gap! Consumer Perceptions and Choices of Medicare Part D Prescription Drug Plans," NBER Chapters, in: Research Findings in the Economics of Aging, pages 413-481, National Bureau of Economic Research, Inc.
    11. Boone, J., 2014. "Basic Versus Supplementary Health Insurance : Moral Hazard and Adverse Selection," Other publications TiSEM 8ad45428-2ab4-406f-bbd3-3, Tilburg University, School of Economics and Management.
    12. Marika Cabral & Mark R. Cullen, 2017. "The Effect Of Insurance Coverage On Preventive Care," Economic Inquiry, Western Economic Association International, vol. 55(3), pages 1452-1467, July.
    13. Timothy J. Halliday & Randall Q. Akee & Tetine Sentell & Megan Inada & Jill Miyamura, 2019. "The Impact of Medicaid on Medical Utilization in a Vulnerable Population: Evidence from COFA Migrants," NBER Working Papers 26030, National Bureau of Economic Research, Inc.
    14. Glazer, Jacob & McGuire, Thomas G., 2012. "A welfare measure of “offset effects” in health insurance," Journal of Public Economics, Elsevier, vol. 96(5), pages 520-523.
    15. Alex Hoagland & David M. Anderson & Ed Zhu, 2022. "Medical Bill Shock and Imperfect Moral Hazard," Papers 2211.01116, arXiv.org, revised Mar 2024.
    16. Melissa Boyle, 2008. "Costs and Benefits of Elderly Prescription Drug Coverage: Evidence from Veterans’ Health Care," Working Papers 0803, College of the Holy Cross, Department of Economics.
    17. Kurt Lavetti & Kosali Simon, 2016. "Strategic Formulary Design in Medicare Part D Plans," NBER Working Papers 22338, National Bureau of Economic Research, Inc.
    18. Katherine Baicker & Sendhil Mullainathan & Joshua Schwartzstein, 2012. "Behavioral Hazard in Health Insurance," NBER Working Papers 18468, National Bureau of Economic Research, Inc.
    19. Timothy J. Halliday & Randall Q. Akee & Tetine Sentell & Megan Inada & Jill Miyamura, 2019. "The Impact of Public Health Insurance on Medical Utilization in a Vulnerable Population: Evidence from COFA Migrants," Working Papers 2019-1, University of Hawaii Economic Research Organization, University of Hawaii at Manoa.
    20. Marika Cabral & Neale Mahoney, 2014. "Externalities and Taxation of Supplemental Insurance: A Study of Medicare and Medigap," NBER Working Papers 19787, National Bureau of Economic Research, Inc.
    21. Wang, Chao & Sweetman, Arthur, 2020. "Delisting eye examinations from public health insurance: Empirical evidence from Canada regarding impacts on patients and providers," Health Policy, Elsevier, vol. 124(5), pages 540-548.
    22. Ellis, Randall P. & Manning, Willard G., 2007. "Optimal health insurance for prevention and treatment," Journal of Health Economics, Elsevier, vol. 26(6), pages 1128-1150, December.
    23. Fiorio, Carlo V. & Siciliani, Luigi, 2010. "Co-payments and the demand for pharmaceuticals: Evidence from Italy," Economic Modelling, Elsevier, vol. 27(4), pages 835-841, July.
    24. Westerhout, Ed & Folmer, Kees, 2018. "The Effects of Capping Co-Insurance Payments," Discussion Paper 2018-050, Tilburg University, Center for Economic Research.
    25. Randall P. Ellis & Shenyi Jian & Willard G. Manning, 2015. "Optimal health insurance for multiple goods and time periods," Boston University - Department of Economics - Working Papers Series wp2015-019, Boston University - Department of Economics.
    26. Glazer Jacob & Huskamp Haiden A. & McGuire Thomas G., 2012. "A Prescription for Drug Formulary Evaluation: An Application of Price Indexes," Forum for Health Economics & Policy, De Gruyter, vol. 15(1), pages 1-26, March.
    27. Jacques Drèze & Erik Schokkaert, 2013. "Arrow’s theorem of the deductible: Moral hazard and stop-loss in health insurance," Journal of Risk and Uncertainty, Springer, vol. 47(2), pages 147-163, October.
    28. Rebecca Myerson & Darius Lakdawalla & Lisandro D. Colantonio & Monika Safford & David Meltzer, 2018. "Effects of expanding health screening on treatment – What should we expect? What can we learn?," Working Papers 2018-014, Human Capital and Economic Opportunity Working Group.
    29. Mark Egan & Tomas J. Philipson, 2014. "Health Care Adherence and Personalized Medicine," NBER Working Papers 20330, National Bureau of Economic Research, Inc.
    30. Patricia M. Danzon & Adrian K. Towse & Jorge Mestre-Ferrandiz, 2012. "Value-Based Differential Pricing: Efficient Prices for Drugs in a Global Context," NBER Working Papers 18593, National Bureau of Economic Research, Inc.
    31. Amitabh Chandra & Jonathan Gruber & Robin McKnight, 2012. "The Impact of Patient Cost-Sharing on the Poor: Evidence from Massachusetts," NBER Working Papers 18023, National Bureau of Economic Research, Inc.
    32. Berndt, Ernst R. & Newhouse, Joseph P., 2010. "Pricing and Reimbursement in U.S. Pharmaceutical Markets," Working Paper Series rwp10-039, Harvard University, John F. Kennedy School of Government.
    33. Amanda Starc & Robert J. Town, 2015. "Externalities and Benefit Design in Health Insurance," NBER Working Papers 21783, National Bureau of Economic Research, Inc.
    34. Chandra, Amitabh & Gruber, Jonathan & McKnight, Robin, 2009. "Patient Cost-Sharing and Hospitalization Offsets in the Elderly," Scholarly Articles 8058412, Harvard Kennedy School of Government.
    35. Jonathan D. Ketcham & Kosali Simon, 2008. "Medicare Part D's Effects on Elderly Drug Costs and Utilization," NBER Working Papers 14326, National Bureau of Economic Research, Inc.
    36. Boone, J., 2014. "Basic Versus Supplementary Health Insurance : Moral Hazard and Adverse Selection," Other publications TiSEM 6bf0e55c-e004-4c9e-8065-6, Tilburg University, School of Economics and Management.
    37. Deb P & Trivedi PK & Zimmer DM, 2009. "Dynamic Cost-offsets of Prescription Drug Expenditures: Panel Data Analysis Using a Copula-based Hurdle Model," Health, Econometrics and Data Group (HEDG) Working Papers 09/15, HEDG, c/o Department of Economics, University of York.
    38. Munkin M & Trivedi P. K, 2009. "Incentives and Selection Effects of Drug Coverage on Total Drug Expenditure: a Finite Mixture Approach," Health, Econometrics and Data Group (HEDG) Working Papers 09/22, HEDG, c/o Department of Economics, University of York.
    39. Mingming Xu & Benjamin Bittschi, 2022. "Does the abolition of copayment increase ambulatory care utilization?: a quasi-experimental study in Germany," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 23(8), pages 1319-1328, November.
    40. Ed Westerhout & Kees Folmer, 2013. "Why it may hurt to be insured: the effects of capping coinsurance payments," CPB Discussion Paper 239, CPB Netherlands Bureau for Economic Policy Analysis.
    41. Jakub P. Hlávka & Jeffrey C. Yu & Dana P. Goldman & Darius N. Lakdawalla, 2021. "The economics of alternative payment models for pharmaceuticals," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(4), pages 559-569, June.
    42. Amitabh Chandra & Jonathan Gruber & Robin McKnight, 2007. "Patient Cost-Sharing, Hospitalization Offsets, and the Design of Optimal Health Insurance for the Elderly," NBER Working Papers 12972, National Bureau of Economic Research, Inc.
    43. Jonathan D. Ketcham & Nicolai V. Kuminoff & Christopher A. Powers, 2016. "Choice Inconsistencies among the Elderly: Evidence from Plan Choice in the Medicare Part D Program: Comment," American Economic Review, American Economic Association, vol. 106(12), pages 3932-3961, December.
    44. Jonathan D. Ketcham & Nicolai V. Kuminoff & Christopher A. Powers, 2015. "Which Models Can We Trust to Evaluate Consumer Decision Making? Comment on “Choice Inconsistencies among the Elderly”," NBER Working Papers 21387, National Bureau of Economic Research, Inc.
    45. Florian Heiss & Daniel McFadden & Joachim Winter, 2008. "Mind the Gap! Consumer Perceptions and Choices," MEA discussion paper series 08156, Munich Center for the Economics of Aging (MEA) at the Max Planck Institute for Social Law and Social Policy.
    46. Brandon Pope & Abhijit Deshmukh & Andrew Johnson & James Rohack, 2014. "Multilateral Contracting And Prevention," Health Economics, John Wiley & Sons, Ltd., vol. 23(4), pages 397-409, April.
    47. Westerhout, Ed & Folmer, Kees, 2018. "The Effects of Capping Co-Insurance Payments," Other publications TiSEM 828746fb-4fb0-465b-bdff-3, Tilburg University, School of Economics and Management.

  20. Adeline Delavande & Dana Goldman & Neeraj Sood, 2007. "Criminal Prosecution and HIV-related Risky Behavior," NBER Working Papers 12903, National Bureau of Economic Research, Inc.

    Cited by:

    1. Raj Arunachalam & Manisha Shah, 2013. "Compensated for Life: Sex Work and Disease Risk," Journal of Human Resources, University of Wisconsin Press, vol. 48(2), pages 345-369.
    2. Delavande, Adeline & Sampaio, Mafalda & Sood, Neeraj, 2014. "HIV-related social intolerance and risky sexual behavior in a high HIV prevalence environment," Social Science & Medicine, Elsevier, vol. 111(C), pages 84-93.

  21. Baoping Shang & Dana P. Goldman, 2007. "Prescription Drug Coverage and Elderly Medicare Spending," NBER Working Papers 13358, National Bureau of Economic Research, Inc.

    Cited by:

    1. Joan Costa-i-Font & Cristina Vilaplana-Prieto, 2020. "'More than One Red Herring'? Heterogeneous Effects of Ageing on Healthcare Utilisation," CESifo Working Paper Series 8300, CESifo.
    2. Qian Li & Pravin K. Trivedi, 2016. "Adverse and Advantageous Selection in the Medicare Supplemental Market: A Bayesian Analysis of Prescription drug Expenditure," Health Economics, John Wiley & Sons, Ltd., vol. 25(2), pages 192-211, February.
    3. Murat K. Munkin & Pravin K. Trivedi, 2010. "Disentangling incentives effects of insurance coverage from adverse selection in the case of drug expenditure: a finite mixture approach," Health Economics, John Wiley & Sons, Ltd., vol. 19(9), pages 1093-1108, September.
    4. Florian Heiss & Daniel McFadden & Joachim Winter, 2010. "Mind the Gap! Consumer Perceptions and Choices of Medicare Part D Prescription Drug Plans," NBER Chapters, in: Research Findings in the Economics of Aging, pages 413-481, National Bureau of Economic Research, Inc.
    5. Glazer, Jacob & McGuire, Thomas G., 2012. "A welfare measure of “offset effects” in health insurance," Journal of Public Economics, Elsevier, vol. 96(5), pages 520-523.
    6. Melissa Boyle, 2008. "Costs and Benefits of Elderly Prescription Drug Coverage: Evidence from Veterans’ Health Care," Working Papers 0803, College of the Holy Cross, Department of Economics.
    7. Glazer Jacob & Huskamp Haiden A. & McGuire Thomas G., 2012. "A Prescription for Drug Formulary Evaluation: An Application of Price Indexes," Forum for Health Economics & Policy, De Gruyter, vol. 15(1), pages 1-26, March.
    8. Civan, Abdülkadir & Koksal, Bulent, 2007. "The Effect of Newer Drugs on Health Spending: Do They Really Increase the Costs?," MPRA Paper 6846, University Library of Munich, Germany.
    9. Lambrelli D & O’Donnell O, 2009. "Why Does the Utilization of Pharmaceuticals Vary So Much Across Europe? Evidence from Micro Data on Older Europeans," Health, Econometrics and Data Group (HEDG) Working Papers 09/06, HEDG, c/o Department of Economics, University of York.
    10. Deb P & Trivedi PK & Zimmer DM, 2009. "Dynamic Cost-offsets of Prescription Drug Expenditures: Panel Data Analysis Using a Copula-based Hurdle Model," Health, Econometrics and Data Group (HEDG) Working Papers 09/15, HEDG, c/o Department of Economics, University of York.
    11. Munkin M & Trivedi P. K, 2009. "Incentives and Selection Effects of Drug Coverage on Total Drug Expenditure: a Finite Mixture Approach," Health, Econometrics and Data Group (HEDG) Working Papers 09/22, HEDG, c/o Department of Economics, University of York.
    12. Claude Montmarquette & Stéphanie Boulenger & Joanne Castonguay, 2014. "Les risques liés à la création de PHARMA-QUEBEC," CIRANO Project Reports 2014rp-05, CIRANO.
    13. Sara Allin & Jeremiah Hurley, 2009. "Inequity in publicly funded physician care: what is the role of private prescription drug insurance?," Health Economics, John Wiley & Sons, Ltd., vol. 18(10), pages 1218-1232, October.
    14. William Encinosa & Didem Bernard & Avi Dor, 2010. "Does Prescription Drug Adherence Reduce Hospitalizations and Costs?," NBER Working Papers 15691, National Bureau of Economic Research, Inc.
    15. Florian Heiss & Daniel McFadden & Joachim Winter, 2008. "Mind the Gap! Consumer Perceptions and Choices," MEA discussion paper series 08156, Munich Center for the Economics of Aging (MEA) at the Max Planck Institute for Social Law and Social Policy.

  22. Dana Goldman & James P. Smith, 2005. "Socioeconomic Differences in the Adoption of New Medical Technologies," NBER Working Papers 11218, National Bureau of Economic Research, Inc.

    Cited by:

    1. Sansani, Shahar, 2009. "The Effects of School Quality on Long-Term Health," MPRA Paper 22189, University Library of Munich, Germany, revised Apr 2010.
    2. Anderberg, Dan & Chevalier, Arnaud & Wadsworth, Jonathan, 2008. "Anatomy of a Health Scare: Education, Income and the MMR Controversy in the UK," IZA Discussion Papers 3590, Institute of Labor Economics (IZA).
    3. María del Carmen Huerta & Francesca Borgonovi, 2010. "Education, Alcohol Use and Abuse Among Young Adults in Britain," OECD Education Working Papers 50, OECD Publishing.
    4. Vaalavuo, Maria, 2021. "The unequal impact of ill health: Earnings, employment, and mental health among breast cancer survivors in Finland," Labour Economics, Elsevier, vol. 69(C).
    5. Baris Alpaslan & Julide Yildirim, 2016. "The missing link: Are individuals with more social capital in better health? Evidence from India," CAMA Working Papers 2016-31, Centre for Applied Macroeconomic Analysis, Crawford School of Public Policy, The Australian National University.
    6. Schnittker, Jason & Karandinos, George, 2010. "Methuselah's medicine: Pharmaceutical innovation and mortality in the United States, 1960-2000," Social Science & Medicine, Elsevier, vol. 70(7), pages 961-968, April.
    7. Marisa E. Domino, 2012. "Does managed care affect the diffusion of psychotropic medications?," Health Economics, John Wiley & Sons, Ltd., vol. 21(4), pages 428-443, April.
    8. Francesca Borgonovi & Artur Pokropek, 2016. "Education and Self-Reported Health: Evidence from 23 Countries on the Role of Years of Schooling, Cognitive Skills and Social Capital," PLOS ONE, Public Library of Science, vol. 11(2), pages 1-16, February.
    9. Lenisa V. Chang, 2018. "Information, education, and health behaviors: Evidence from the MMR vaccine autism controversy," Health Economics, John Wiley & Sons, Ltd., vol. 27(7), pages 1043-1062, July.
    10. Binswanger, J. & Carman, K.G., 2011. "The Role of Desicion Making Processes in the Correlation between Wealth and Health," Other publications TiSEM deb8d0eb-7290-4a34-931b-d, Tilburg University, School of Economics and Management.
    11. Jürgen Maurer, 2007. "Assessing Horizontal Equity in Medication Treatment Among Elderly Mexicans: Which Socioeconomic Determinants Matter Most?," MEA discussion paper series 07143, Munich Center for the Economics of Aging (MEA) at the Max Planck Institute for Social Law and Social Policy.
    12. Frankovic, Ivan & Kuhn, Michael, 2019. "Access to health care, medical progress and the emergence of the longevity gap: A general equilibrium analysis," The Journal of the Economics of Ageing, Elsevier, vol. 14(C).
    13. Lambrelli D & O’Donnell O, 2009. "Why Does the Utilization of Pharmaceuticals Vary So Much Across Europe? Evidence from Micro Data on Older Europeans," Health, Econometrics and Data Group (HEDG) Working Papers 09/06, HEDG, c/o Department of Economics, University of York.
    14. James P. Smith, 2009. "Comment on "Is the US Population Behaving Healthier?"," NBER Chapters, in: Social Security Policy in a Changing Environment, pages 442-446, National Bureau of Economic Research, Inc.
    15. Jürgen Maurer, 2008. "Assessing horizontal equity in medication treatment among elderly Mexicans: which socioeconomic determinants matter most?," Health Economics, John Wiley & Sons, Ltd., vol. 17(10), pages 1153-1169, October.

  23. Dana Goldman & Nicole Maestas, 2005. "Medical Expenditure Risk and Household Portfolio Choice," NBER Working Papers 11818, National Bureau of Economic Research, Inc.

    Cited by:

    1. Angrisani, Marco & Atella, Vincenzo & Brunetti, Marianna, 2018. "Public health insurance and household portfolio Choices: Unravelling financial “Side Effects” of Medicare," Journal of Banking & Finance, Elsevier, vol. 93(C), pages 198-212.
    2. Dimitrios Christelis & Tullio Jappelli & Mario Padula, 2006. "Cognitive Abilities and Portfolio Choice," CSEF Working Papers 157, Centre for Studies in Economics and Finance (CSEF), University of Naples, Italy.
    3. Marianna Brunetti & Rocco Ciciretti & Ljubica Djordjevic, 2014. "The Determinants of Household's Bank Switching," CEIS Research Paper 322, Tor Vergata University, CEIS, revised 11 Nov 2015.
    4. Padmaja Ayyagari & Daifeng He, 2017. "The Role of Medical Expenditure Risk in Portfolio Allocation Decisions," Health Economics, John Wiley & Sons, Ltd., vol. 26(11), pages 1447-1458, November.
    5. Christophe Courbage & Guillem Montoliu-Montes & Béatrice Rey, 2018. "How vulnerable is risk aversion to wealth, health and other risks? An empirical analysis for Europe," Working Papers halshs-01935846, HAL.
    6. Saruultuya Tsendsuren & Chu-Shiu Li & Sheng-Chang Peng & Wing-Keung Wong, 2018. "The Effects of Health Status on Life Insurance Holdings in 16 European Countries," Sustainability, MDPI, vol. 10(10), pages 1-30, September.
    7. Dimitris Christelis & Dimitris Georgarakos & Anna Sanz-de-Galdeano, 2014. "The Impact of Health Insurance on Stockholding: A Regression Discontinuity Approach," CSEF Working Papers 382, Centre for Studies in Economics and Finance (CSEF), University of Naples, Italy.
    8. Christophe Courbage & Guillem Montoliu-Montes & Béatrice Rey, 2018. "How vulnerable is risk aversion to wealth, health and other risks? An empirical analysis for Europe," Working Papers 1827, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon.
    9. Dal Borgo, Mariela, 2021. "Do bankruptcy protection levels affect households' demand for stocks?," CAGE Online Working Paper Series 564, Competitive Advantage in the Global Economy (CAGE).
    10. David A. Love & Paul A. Smith, 2010. "Does health affect portfolio choice?," Health Economics, John Wiley & Sons, Ltd., vol. 19(12), pages 1441-1460, December.
    11. Strobl, Renate, 2022. "Background risk, insurance and investment behaviour: Experimental evidence from Kenya," Journal of Economic Behavior & Organization, Elsevier, vol. 202(C), pages 34-68.
    12. Itzhak Zilcha & Nancy Schneier, 2012. "Out‐of‐Pocket Health Expenditures: A Suggested Role for Social Security," Risk Management and Insurance Review, American Risk and Insurance Association, vol. 15(2), pages 153-164, September.
    13. Yinan Yang & Qian Wang, 2018. "Insurance Inclusion, Time Preference And Stock Investment Of The Chinese Households," The Singapore Economic Review (SER), World Scientific Publishing Co. Pte. Ltd., vol. 63(01), pages 27-44, March.
    14. Hugonnier, J. & Pelgrin, F. & St-Amour, P., 2016. "Closing Down the Shop: Optimal Health and Wealth Dynamics near the End of Life," Health, Econometrics and Data Group (HEDG) Working Papers 16/28, HEDG, c/o Department of Economics, University of York.
    15. Lee, Minjoon, 2023. "Portfolio allocation over the life cycle with multiple late-in-life saving motives," Journal of Empirical Finance, Elsevier, vol. 74(C).
    16. Du, You, 2023. "Health investment and medical risk: New explanations of the portfolio puzzle," Economic Modelling, Elsevier, vol. 127(C).
    17. Kronenberg, C. & van Kippersluis, H. & Rohde, K.I.M., 2014. "What drives the association between health and portfolio choice?," Health, Econometrics and Data Group (HEDG) Working Papers 14/27, HEDG, c/o Department of Economics, University of York.
    18. Lee, Daeyong, 2018. "Effects of health insurance coverage on household financial portfolio: Evidence from the Affordable Care Act," Economics Letters, Elsevier, vol. 171(C), pages 176-179.
    19. Huang, Bin & Wang, Bin & Chen, Zixuan, 2024. "Individual investment adaptations to COVID-19 lockdowns," The North American Journal of Economics and Finance, Elsevier, vol. 70(C).
    20. Guodong Chen & Minjoon Lee & Tong-yob Nam, 2018. "Forced Retirement Risk and Portfolio Choice," Carleton Economic Papers 18-06, Carleton University, Department of Economics.
    21. Nathan Blascak & Vyacheslav Mikhed, 2022. "Health Insurance and Young Adult Financial Distress," Working Papers 19-54, Federal Reserve Bank of Philadelphia.
    22. Nicole Maestas & Mathis Schroeder & Dana P. Goldman, 2007. "Price Variation in Markets with Homogeneous Goods The Case of Medigap," Working Papers WR-504, RAND Corporation.
    23. He, Zekai & Shi, Xiuzhen & Lu, Xiaomeng & Li, Feng, 2019. "Home equity and household portfolio choice: Evidence from China," International Review of Economics & Finance, Elsevier, vol. 60(C), pages 149-164.
    24. Zhongda Li & Lu Liu & Jiayu Shi & Yubing Sui, 2021. "Health insurance, risk attitudes, and household financial behavior," Health Economics, John Wiley & Sons, Ltd., vol. 30(5), pages 1239-1246, May.
    25. Yulin Liu & Min Zhang, 2020. "Is household registration system responsible for the limited participation of stock market in China?," Review of Behavioral Finance, Emerald Group Publishing Limited, vol. 13(3), pages 332-350, July.
    26. Niu, Geng & Wang, Qi & Li, Han & Zhou, Yang, 2020. "Number of brothers, risk sharing, and stock market participation," Journal of Banking & Finance, Elsevier, vol. 113(C).
    27. Eling, Martin & Ghavibazoo, Omid & Hanewald, Katja, 2021. "Willingness to take financial risks and insurance holdings: A European survey," Journal of Behavioral and Experimental Economics (formerly The Journal of Socio-Economics), Elsevier, vol. 95(C).
    28. Lei He & Shuyi Zhou, 2024. "Measuring household vulnerability to medical expenditure shock: method and its empirical application," International Journal of Health Economics and Management, Springer, vol. 24(3), pages 465-480, September.
    29. Jiapeng Liu & Rui Lu & Ronghua Yi & Ting Zhang, 2017. "Modelling optimal asset allocation when households experience health shocks," Review of Quantitative Finance and Accounting, Springer, vol. 49(1), pages 245-261, July.
    30. Gormley, Todd & Liu, Hong & Zhou, Guofu, 2010. "Limited participation and consumption-saving puzzles: A simple explanation and the role of insurance," Journal of Financial Economics, Elsevier, vol. 96(2), pages 331-344, May.
    31. Amitabh Chandra & Courtney Coile & Corina Mommaerts, 2020. "What Can Economics Say About Alzheimer's Disease?," NBER Working Papers 27760, National Bureau of Economic Research, Inc.
    32. Yujie Wang & Run Ge & Wenjing Gao & Dunzhe Tang, 2024. "How Does Fertility Policy Relaxation Affect Household Financial Asset Allocation? Evidence from the Universal Two-Child Policy in China," Sustainability, MDPI, vol. 16(3), pages 1-23, January.
    33. Eun Kim & Sherman Hanna & Swarn Chatterjee & Suzanne Lindamood, 2012. "Who Among the Elderly Owns Stocks? The Role of Cognitive Ability and Bequest Motive," Journal of Family and Economic Issues, Springer, vol. 33(3), pages 338-352, September.
    34. Tami Gurley-Calvez & Josephine Lugovskyy, 2019. "The role of entrepreneurial risk in financial portfolio allocation," Small Business Economics, Springer, vol. 53(4), pages 839-858, December.
    35. Fleck, Johannes & Monninger, Adrian, 2020. "Culture and portfolios: trust, precautionary savings and home ownership," Working Paper Series 2457, European Central Bank.
    36. Si Shi & Yawen Jiang, 2022. "Does supplemental private health insurance incentivize household risky financial asset investment? Evidence from the China Household Financial Survey," International Journal of Health Economics and Management, Springer, vol. 22(4), pages 369-421, December.

  24. Dana Goldman & Neeraj Sood & Arleen Leibowitz, 2005. "Wage and Benefit Changes in Response to Rising Health Insurance Costs," NBER Working Papers 11063, National Bureau of Economic Research, Inc.

    Cited by:

    1. Jessica Vistnes & Thomas Selden, 2011. "Premium growth and its effect on employer-sponsored insurance," International Journal of Health Economics and Management, Springer, vol. 11(1), pages 55-81, March.
    2. Daron Acemoglu & Andrea Manera & Pascual Restrepo, 2020. "Does the US Tax Code Favor Automation?," Brookings Papers on Economic Activity, Economic Studies Program, The Brookings Institution, vol. 51(1 (Spring), pages 231-300.
    3. Adams, Scott, 2007. "Health insurance market reform and employee compensation: The case of pure community rating in New York," Journal of Public Economics, Elsevier, vol. 91(5-6), pages 1119-1133, June.
    4. DeVaro, Jed & Maxwell, Nan L., 2014. "The elusive wage-benefit trade-off: The case of employer-provided health insurance," International Journal of Industrial Organization, Elsevier, vol. 37(C), pages 23-37.
    5. Nan L. Maxwell, 2008. "Labor Markets And Health Benefits: The Offer And Restrictions On It," Contemporary Economic Policy, Western Economic Association International, vol. 26(1), pages 73-88, January.
    6. Stéphanie Lluis, 2009. "The Structure of Wages by Firm Size: A Comparison of Canada and the USA," LABOUR, CEIS, vol. 23(2), pages 283-317, June.

  25. Dana P. Goldman & James P. Smith, 2004. "Can Patient Self-Management Help Explain the SES Health Gradient?," HEW 0403004, University Library of Munich, Germany.

    Cited by:

    1. David M. Cutler & Angus S. Deaton & Adriana Lleras-Muney, 2006. "The Determinants of Mortality," NBER Working Papers 11963, National Bureau of Economic Research, Inc.
    2. Titus Galama & Arie Kapteyn, 2009. "Grossman's Missing Health Threshold," Working Papers WR-684, RAND Corporation.
    3. Sansani, Shahar, 2009. "The Effects of School Quality on Long-Term Health," MPRA Paper 22189, University Library of Munich, Germany, revised Apr 2010.
    4. Kanika Kapur & Jeannette A. Rogowski & Vicki A. Freedman & Steven L. Wickstrom & John L. Adams & Jose J. Escarce, 2004. "Socioeconomic Status and Medical Care Expenditures in Medicare Managed Care," NBER Working Papers 10757, National Bureau of Economic Research, Inc.
    5. James Smith, 2003. "Consequences and predictors of new health events," IFS Working Papers W03/22, Institute for Fiscal Studies.
    6. Neil J Buckley & Frank T Denton & A Leslie Robb & Byron G Spencer, 2005. "Socioeconomic Influences on the Health of Older Canadians: Estimates Based on Two Longitudinal Surveys," Quantitative Studies in Economics and Population Research Reports 402, McMaster University.
    7. Wagstaff, Adam & Lindelow, Magnus, 2010. "Are health shocks different ? evidence from a multi-shock survey in Laos," Policy Research Working Paper Series 5335, The World Bank.
    8. James P. Smith, 2005. "Unraveling the SES-Health Connection," Labor and Demography 0505018, University Library of Munich, Germany.
    9. Donald Kenkel & Dean Lillard & Alan Mathios, 2006. "The Roles of High School Completion and GED Receipt in Smoking and Obesity," Journal of Labor Economics, University of Chicago Press, vol. 24(3), pages 635-660, July.
    10. Neil J. Buckley & Frank T. Denton & A. Leslie Robb & Byron G. Spencer, 2003. "The Transition from Good to Poor Health: An Econometric Study of the Older Population," Social and Economic Dimensions of an Aging Population Research Papers 94, McMaster University.
    11. Adriana Lleras-Muney, 2005. "The Relationship Between Education and Adult Mortality in the United States," The Review of Economic Studies, Review of Economic Studies Ltd, vol. 72(1), pages 189-221.
    12. Anne Case & Ingrid Le Roux & Alicia Menendez, 2004. "Medical Compliance and Income-Health Gradients," American Economic Review, American Economic Association, vol. 94(2), pages 331-335, May.
    13. Braakmann, Nils, 2011. "The causal relationship between education, health and health related behaviour: Evidence from a natural experiment in England," Journal of Health Economics, Elsevier, vol. 30(4), pages 753-763, July.
    14. Andreea Balan-Cohen, 2008. "Healthy, Wealthy, and Wise? The Impact of the Old Age Assistance Program on Elderly Mortality in the United States," Discussion Papers Series, Department of Economics, Tufts University 0719, Department of Economics, Tufts University.
    15. Michael Grossman, 2005. "Education and Nonmarket Outcomes," NBER Working Papers 11582, National Bureau of Economic Research, Inc.
    16. Dana Goldman & James P. Smith, 2005. "Socioeconomic Differences in the Adoption of New Medical Technologies," NBER Working Papers 11218, National Bureau of Economic Research, Inc.
    17. Jürgen Maurer, 2007. "Assessing Horizontal Equity in Medication Treatment Among Elderly Mexicans: Which Socioeconomic Determinants Matter Most?," MEA discussion paper series 07143, Munich Center for the Economics of Aging (MEA) at the Max Planck Institute for Social Law and Social Policy.
    18. David M. Cutler & Fabian Lange & Ellen Meara & Seth Richards & Christopher J. Ruhm, 2010. "Explaining the Rise in Educational Gradients in Mortality," NBER Working Papers 15678, National Bureau of Economic Research, Inc.
    19. David M. Cutler & Adriana Lleras-Muney, 2006. "Education and Health: Evaluating Theories and Evidence," NBER Working Papers 12352, National Bureau of Economic Research, Inc.
    20. Alan M. Garber & Jonathan Skinner, 2008. "Is American Health Care Uniquely Inefficient?," NBER Working Papers 14257, National Bureau of Economic Research, Inc.
    21. Douglas Almond & Bhashkar Mazumder, 2006. "How did schooling laws improve long-term health and lower mortality?," Working Paper Series WP-06-23, Federal Reserve Bank of Chicago.
    22. Strauss, John & Lei, Xiaoyan & Park, Albert & Shen, Yan & Smith, James P. & Yang, Zhe & Zhao, Yaohui, 2010. "Health Outcomes and Socio-Economic Status among the Elderly in China: Evidence from the CHARLS Pilot," IZA Discussion Papers 5152, Institute of Labor Economics (IZA).
    23. Bhashkar Mazumder, 2008. "Does education improve health? A reexamination of the evidence from compulsory schooling laws," Economic Perspectives, Federal Reserve Bank of Chicago, vol. 32(Q II), pages 2-16.
    24. Jürgen Maurer, 2007. "Socioeconomic and Health Determinants of Health Care Utilization Among Elderly Europeans: A Semiparametric Assessment of Equity, Intensity and Responsiveness for Ten European Countries," MEA discussion paper series 07144, Munich Center for the Economics of Aging (MEA) at the Max Planck Institute for Social Law and Social Policy.
    25. Jürgen Maurer, 2008. "Assessing horizontal equity in medication treatment among elderly Mexicans: which socioeconomic determinants matter most?," Health Economics, John Wiley & Sons, Ltd., vol. 17(10), pages 1153-1169, October.
    26. James Smith, 2007. "Diabetes and the Rise of the SES Health Gradient," NBER Working Papers 12905, National Bureau of Economic Research, Inc.

  26. Dana Goldman & Darius Lakdawalla & Neeraj Sood, 2004. "HIV Breakthroughs and Risk Sexual Behavior," NBER Working Papers 10516, National Bureau of Economic Research, Inc.

    Cited by:

    1. Jean-Claude Berthélemy & Victor Doubliez & Josselin Thuilliez, 2015. "Prevention or treatment? The introduction of a new antimalarial drug in Angola," Documents de travail du Centre d'Economie de la Sorbonne 15089, Université Panthéon-Sorbonne (Paris 1), Centre d'Economie de la Sorbonne.
    2. Kai Barron & Luis F. Gamboa & Paul Rodriguez-Lesmes, 2016. "Behavioural Response to a Sudden Health Risk: Dengue and Educational Outcomes in Colombia," Documentos de trabajo 17667, Escuela de Gobierno - Universidad de los Andes.
    3. Kai Barron & Charles D.H. Parry & Debbie Bradshaw & Rob Dorrington & Pam Groenewald & Ria Laubscher & Richard Matzopoulos, 2022. "Alcohol, Violence and Injury-Induced Mortality: Evidence from a Modern-Day Prohibition," CESifo Working Paper Series 9595, CESifo.
    4. Smart, Shanike J. & Polachek, Solomon, 2024. "COVID-19 Vaccine and Risk-Taking," IZA Discussion Papers 16707, Institute of Labor Economics (IZA).
    5. Jeremy Greenwood & Philipp Kircher & Cezar Santos & Michèle Tertilt, 2013. "An Equilibrium Model of the African HIV/AIDS Epidemic," NBER Working Papers 18953, National Bureau of Economic Research, Inc.
    6. Hussey, Andrew & Nikolsko-Rzhevskyy, Alex & Walker, Jay, 2010. "AIDing Contraception: HIV and Recent Trends in Abortion Rates," MPRA Paper 20895, University Library of Munich, Germany.
    7. Francis, Andrew M., 2008. "The economics of sexuality: The effect of HIV/AIDS on homosexual behavior in the United States," Journal of Health Economics, Elsevier, vol. 27(3), pages 675-689, May.
    8. Fichera, Eleonora & Banks, James & Siciliani, Luigi & Sutton, Matt, 2018. "Does patient health behaviour respond to doctor effort?," Journal of Economic Behavior & Organization, Elsevier, vol. 156(C), pages 225-251.
    9. Bryan Engelhardt & Mark R. Kurt & Philip M. Polgreen, 2013. "Sexually Transmitted Infections With Semi‐Anonymous Matching," Health Economics, John Wiley & Sons, Ltd., vol. 22(11), pages 1295-1317, November.
    10. Friedman, Willa Helterline, 2018. "Antiretroviral drug access and behavior change," Journal of Development Economics, Elsevier, vol. 135(C), pages 392-411.
    11. Mannberg, Andréa, 2012. "Risk and rationalization—The role of affect and cognitive dissonance for sexual risk taking," European Economic Review, Elsevier, vol. 56(6), pages 1325-1337.
    12. David Canning, 2006. "The Economics of HIV/AIDS in Low-Income Countries: The Case for Prevention," Journal of Economic Perspectives, American Economic Association, vol. 20(3), pages 121-142, Summer.
    13. Derksen, Laura & Muula, Adamson & van Oosterhout, Joep, 2022. "Love in the time of HIV: How beliefs about externalities impact health behavior," Journal of Development Economics, Elsevier, vol. 159(C).
    14. Adeline Delavande, 2012. "HIV/AIDS-related Expectations and Risky Sexual Behavior in Malawi," 2012 Meeting Papers 90, Society for Economic Dynamics.
    15. Nicholas Wilson, 2010. "Antiretroviral Therapy and Demand for HIV Testing: Evidence from Zambia," Department of Economics Working Papers 2010-23, Department of Economics, Williams College.
    16. Xue Qiao, 2012. "Unsafe sex, AIDS and development," Journal of Economics, Springer, vol. 105(3), pages 263-279, April.
    17. Rostislav Staněk & Ondřej Krčál & Katarína Čellárová, 2021. "Pull yourself up by your bootstraps: Identifying procedural preferences against helping others in the presence of moral hazard," MUNI ECON Working Papers 2021-11, Masaryk University, revised Feb 2023.
    18. Berry, James & Fischer, Gregory & Guiteras, Raymond, 2020. "Eliciting and utilizing willingness to pay: evidence from field trials in northern Ghana," LSE Research Online Documents on Economics 100236, London School of Economics and Political Science, LSE Library.
    19. Adeline Delavande & Dana Goldman & Neeraj Sood, 2007. "Criminal Prosecution and HIV-related Risky Behavior," NBER Working Papers 12903, National Bureau of Economic Research, Inc.
    20. Jay Bhattacharya & Kate Bundorf & Noemi Pace & Neeraj Sood, 2009. "Does Health Insurance Make You Fat?," NBER Working Papers 15163, National Bureau of Economic Research, Inc.
    21. Stevenson, Betsey & Wolfers, Justin, 2007. "Marriage and Divorce: Changes and their Driving Forces," IZA Discussion Papers 2602, Institute of Labor Economics (IZA).
    22. Yakubenko, Slava, 2021. "Home alone? Effect of weather-induced behaviour on spread of SARS-CoV-2 in Germany," Economics & Human Biology, Elsevier, vol. 42(C).
    23. Bennett, Daniel & Chiang, Chun-Fang & Malani, Anup, 2015. "Learning during a crisis: The SARS epidemic in Taiwan," Journal of Development Economics, Elsevier, vol. 112(C), pages 1-18.
    24. Spencer, Melissa K., 2024. "Safer sex? The effect of AIDS risk on birth rates," Journal of Health Economics, Elsevier, vol. 95(C).
    25. Doleac, Jennifer & Mukherjee, Anita, 2018. "The Moral Hazard of Lifesaving Innovations: Naloxone Access, Opioid Abuse, and Crime," IZA Discussion Papers 11489, Institute of Labor Economics (IZA).
    26. Andrew M. Jones, 2007. "Identification of treatment effects in Health Economics," Health Economics, John Wiley & Sons, Ltd., vol. 16(11), pages 1127-1131, November.
    27. Hugo M. Mialon & Erik T. Nesson & Michael C. Samuel, 2016. "Crystal Clear? The Relationship Between Methamphetamine Use and Sexually Transmitted Infections," Health Economics, John Wiley & Sons, Ltd., vol. 25(3), pages 292-313, March.
    28. Immordino, G. & Russo, F.F., 2015. "Regulating prostitution: A health risk approach," Journal of Public Economics, Elsevier, vol. 121(C), pages 14-31.
    29. Guimarães, Luís, 2021. "Antibody tests: They are more important than we thought," Journal of Mathematical Economics, Elsevier, vol. 93(C).
    30. Heinsalu, Sander, 2021. "Promotion of (interaction) abstinence increases infection prevalence," Journal of Economic Behavior & Organization, Elsevier, vol. 186(C), pages 94-112.
    31. Masahiro Shoji & Susumu Cato & Takashi Iida & Kenji Ishida & Asei Ito & Kenneth Mori McElwain, 2022. "Variations in Early-Stage Responses to Pandemics: Survey Evidence from the COVID-19 Pandemic in Japan," Economics of Disasters and Climate Change, Springer, vol. 6(2), pages 235-258, July.
    32. Hugo M. Mialon, & Erik Nesson & Michael C. Samuel, 2013. "Crystal Clear? The Relationship between Methamphetamine Use and Risky Sexual Behavior," Working Papers 201301, Ball State University, Department of Economics, revised Mar 2013.
    33. Neeraj Sood & Yanyu Wu, 2013. "The Impact of Insurance and HIV Treatment Technology on HIV Testing," NBER Working Papers 19397, National Bureau of Economic Research, Inc.
    34. Mendolia, Silvia & Stavrunova, Olena & Yerokhin, Oleg, 2021. "Determinants of the community mobility during the COVID-19 epidemic: The role of government regulations and information," Journal of Economic Behavior & Organization, Elsevier, vol. 184(C), pages 199-231.
    35. Malani, Anup & Philipson, Tomas J., 2011. "Can Medical Progress be Sustained? Implications of the Link Between Development and Output Markets," Working Papers 237, The University of Chicago Booth School of Business, George J. Stigler Center for the Study of the Economy and the State.
    36. Jackson, C. Kirabo & Owens, Emily Greene, 2011. "One for the road: Public transportation, alcohol consumption, and intoxicated driving," Journal of Public Economics, Elsevier, vol. 95(1), pages 106-121.
    37. Davide La Torre & Tufail Malik & Simone Marsiglio, 2019. "Optimal Control of Prevention and Treatment in a Basic Macroeconomic-Epidemiological Model," Papers 1910.03383, arXiv.org.
    38. Chen, Kong-Pin & Yang, Jui-Chung & Yang, Tzu-Ting, 2022. "JUE insight: Demand for transportation and spatial pattern of economic activity during the pandemic," Journal of Urban Economics, Elsevier, vol. 127(C).
    39. Noel Rapa, 2021. "Mitigation measures, prevalence response and public mobility during the COVID-19 emergency," CBM Working Papers WP/03/2021, Central Bank of Malta.
    40. Sander Heinsalu, 2019. "When abstinence increases prevalence," Papers 1905.02073, arXiv.org.
    41. Liang, Jian & Alexeev, Sergey, 2023. "Harm reduction or amplification? The adverse impact of a supervised injection room on housing prices," Regional Science and Urban Economics, Elsevier, vol. 98(C).
    42. Adeline Delavande & Dana Goldman & Neeraj Sood, 2010. "Criminal Prosecution and Human Immunodeficiency Virus-Related Risky Behavior," Journal of Law and Economics, University of Chicago Press, vol. 53(4), pages 741-782.
    43. Ibáñez, Ana María & Rozo, Sandra V. & Urbina, María J., 2021. "Forced Migration and the Spread of Infectious Diseases," Journal of Health Economics, Elsevier, vol. 79(C).
    44. Barron, Kai & Bradshaw, Debbie & Parry, Charles D. H. & Dorrington, Rob & Groenewald, Pam & Laubscher, Ria & Matzopoulos, Richard, 2021. "Alcohol and Short-Run Mortality: Evidence from a Modern-Day Prohibition," Rationality and Competition Discussion Paper Series 273, CRC TRR 190 Rationality and Competition.
    45. Wilson, Nicholas L. & Xiong, Wentao & Mattson, Christine L., 2014. "Is sex like driving? HIV prevention and risk compensation," Journal of Development Economics, Elsevier, vol. 106(C), pages 78-91.
    46. Francis, Andrew M. & Mialon, Hugo M. & Peng, Handie, 2012. "In sickness and in health: Same-sex marriage laws and sexually transmitted infections," Social Science & Medicine, Elsevier, vol. 75(8), pages 1329-1341.
    47. Sabine Liebenehm & Bernard Bett & Cristobal Verdugo & Mohamed Said, 2016. "Optimal Drug Control under Risk of Drug Resistance – The Case of African Animal Trypanosomosis," Journal of Agricultural Economics, Wiley Blackwell, vol. 67(2), pages 510-533, June.

  27. Goldman, Dana & Leibowitz, Arleen & Robalino, David, 2004. "Employee Responses to Health Insurance Premium Increases," MPRA Paper 12004, University Library of Munich, Germany.

    Cited by:

    1. Marcus C. Christiansen & Martin Eling & Jan-Philipp Schmidt & Lorenz Zirkelbach, 2016. "Who is Changing Health Insurance Coverage? Empirical Evidence on Policyholder Dynamics," Journal of Risk & Insurance, The American Risk and Insurance Association, vol. 83(2), pages 269-300, June.
    2. Chung Jen Yang & Ying Che Tsai & Joseph J. Tien, 2017. "The Impacts of Persistent Behaviour and Cost-Sharing Policy on Demand for Outpatient Visits by the Elderly: Evidence from Taiwan’s National Health Insurance," The Geneva Papers on Risk and Insurance - Issues and Practice, Palgrave Macmillan;The Geneva Association, vol. 42(1), pages 31-52, January.
    3. Dalit Daily-Amir & Hansjörg Albrecher & Martin Bladt & Joël Wagner, 2019. "On Market Share Drivers in the Swiss Mandatory Health Insurance Sector," Risks, MDPI, vol. 7(4), pages 1-25, November.
    4. Jonas Pendzialek & Dusan Simic & Stephanie Stock, 2016. "Differences in price elasticities of demand for health insurance: a systematic review," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(1), pages 5-21, January.

  28. Dana P. Goldman & Neeraj Sood & Arleen Leibowitz, 2003. "The Reallocation of Compensation in Response to Health Insurance Premium Increases," NBER Working Papers 9540, National Bureau of Economic Research, Inc.

    Cited by:

    1. Stéphanie Lluis & Jean Abraham, 2013. "The Wage–Health Insurance Trade-off and Worker Selection: Evidence From the Medical Expenditure Panel Survey 1997 to 2006," Industrial Relations: A Journal of Economy and Society, Wiley Blackwell, vol. 52(2), pages 541-581, April.
    2. Vikström, Johan, 2009. "The effect of employer incentives in social insurance on individual wages," Working Paper Series 2009:13, IFAU - Institute for Evaluation of Labour Market and Education Policy.
    3. Patricia Crifo & Marc-Arthur Diaye, 2011. "The Composition of Compensation Policy: From Cash to Fringe Benefits," Annals of Economics and Statistics, GENES, issue 101-102, pages 307-326.

  29. Jay Bhattacharya & Dana Goldman & Neeraj Sood, 2003. "Market Evidence of Misperceived Prices and Mistaken Mortality Risks," NBER Working Papers 9863, National Bureau of Economic Research, Inc.

    Cited by:

    1. Alma Cohen & Peter Siegelman, 2010. "Testing for Adverse Selection in Insurance Markets," Journal of Risk & Insurance, The American Risk and Insurance Association, vol. 77(1), pages 39-84, March.
    2. Milevsky, Moshe A. & Young, Virginia R., 2007. "Annuitization and asset allocation," Journal of Economic Dynamics and Control, Elsevier, vol. 31(9), pages 3138-3177, September.
    3. Yamamoto, Shinichi & 山本, 信一 & Yoneyama, Takau & 米山, 高生 & Kwon, W. Jean, 2012. "An Experimental Study On Adverse Selection And Moral Hazard," Hitotsubashi Journal of commerce and management, Hitotsubashi University, vol. 46(1), pages 51-64, October.
    4. Sandroni, Alvaro & Squintani, Francesco, 2013. "Overconfidence and asymmetric information: The case of insurance," Journal of Economic Behavior & Organization, Elsevier, vol. 93(C), pages 149-165.

  30. Jay Bhattacharya & Dana Goldman & Neeraj Sood, 2002. "The Link Between Public and Private Insurance and HIV-Related Mortality," NBER Working Papers 9346, National Bureau of Economic Research, Inc.

    Cited by:

    1. Lawrence P.O. Were & Joseph W Hogan & Omar Galárraga & Richard Wamai, 2020. "Predictors of Health Insurance Enrollment among HIV Positive Pregnant Women in Kenya: Potential for Adverse Selection and Implications for HIV Treatment and Prevention," IJERPH, MDPI, vol. 17(8), pages 1-14, April.
    2. Dana P. Goldman & Nicole Maestas, 2007. "Medical Expenditure Risk and Household Portfolio Choice," Working Papers WR-325-1, RAND Corporation.
    3. Tomas J. Philipson & Anupam B. Jena, 2005. "Who Benefits from New Medical Technologies? Estimates of Consumer and Producer Surpluses for HIV/AIDS Drugs," NBER Working Papers 11810, National Bureau of Economic Research, Inc.
    4. Meyerhoefer, Chad D. & Pylypchuk, Vuriy, 2008. "AJAE Appendix: Does Participation in the Food Stamp Program Increase the Prevalence of Obesity and Health Care Spending?," American Journal of Agricultural Economics APPENDICES, Agricultural and Applied Economics Association, vol. 90(2), pages 1-6.
    5. Xiao Hu & Zhengjie Wang & Jun Liu, 2022. "The impact of digital finance on household insurance purchases: evidence from micro data in China," The Geneva Papers on Risk and Insurance - Issues and Practice, Palgrave Macmillan;The Geneva Association, vol. 47(3), pages 538-568, July.
    6. Duggan Mark G & Evans William N, 2008. "Estimating the Impact of Medical Innovation: A Case Study of HIV Antiretroviral Treatments," Forum for Health Economics & Policy, De Gruyter, vol. 11(2), pages 1-39, January.
    7. Neeraj Sood & Zachary Wagner & Yanyu Wu, 2015. "The Impact of Insurance on HIV Testing," American Journal of Health Economics, MIT Press, vol. 1(4), pages 515-536, Fall.
    8. Jay Pan & Xiaoyan Lei & Gordon G. Liu, 2016. "Health Insurance and Health Status: Exploring the Causal Effect from a Policy Intervention," Health Economics, John Wiley & Sons, Ltd., vol. 25(11), pages 1389-1402, November.
    9. Glied, Sherry & Hong, Kai, 2018. "Health care in a multi-payer system: Spillovers of health care service demand among adults under 65 on utilization and outcomes in medicare," Journal of Health Economics, Elsevier, vol. 60(C), pages 165-176.
    10. Gabriel Picone & Arseniy Yashkin & Thomas Mroz & Frank Sloan, 2013. "Screening for a Chronic Disease: A Multiple Stage Duration Model with Partial Observability," Working Papers 0213, University of South Florida, Department of Economics.
    11. Dana P. Goldman & Benjamin G. Cohen & Jessica Y. Ho & Daniel L. McFadden & Martha S. Ryan & Bryan Tysinger, 2021. "Improved survival for individuals with common chronic conditions in the Medicare population," Health Economics, John Wiley & Sons, Ltd., vol. 30(S1), pages 80-91, November.
    12. Qin, Xuezheng & Pan, Jay & Liu, Gordon G., 2014. "Does participating in health insurance benefit the migrant workers in China? An empirical investigation," China Economic Review, Elsevier, vol. 30(C), pages 263-278.
    13. Yingying Meng & Junqiang Han & Siqi Qin, 2018. "The Impact of Health Insurance Policy on the Health of the Senior Floating Population—Evidence from China," IJERPH, MDPI, vol. 15(10), pages 1-17, October.
    14. Neeraj Sood & Yanyu Wu, 2013. "The Impact of Insurance and HIV Treatment Technology on HIV Testing," NBER Working Papers 19397, National Bureau of Economic Research, Inc.
    15. Nyman, John A. & Koc, Cagatay & Dowd, Bryan E. & McCreedy, Ellen & Trenz, Helen Markelova, 2018. "Decomposition of moral hazard," Journal of Health Economics, Elsevier, vol. 57(C), pages 168-178.
    16. Kelaher, Margaret & Jessop, Dorothy Jones, 2006. "The impact of loss of Medicaid on health service utilization among persons with HIV/AIDS in New York City," Health Policy, Elsevier, vol. 76(1), pages 80-92, March.
    17. PAN, Jay & QIN, Xuezheng & LIU, Gordon G., 2013. "The impact of body size on urban employment: Evidence from China," China Economic Review, Elsevier, vol. 27(C), pages 249-263.
    18. Adeline Delavande & Dana Goldman & Neeraj Sood, 2010. "Criminal Prosecution and Human Immunodeficiency Virus-Related Risky Behavior," Journal of Law and Economics, University of Chicago Press, vol. 53(4), pages 741-782.
    19. Huh, Jason & Reif, Julian, 2017. "Did Medicare Part D reduce mortality?," Journal of Health Economics, Elsevier, vol. 53(C), pages 17-37.
    20. Bryan Dowd & Matthew L. Maciejewski & Heidi O'Connor & Gerald Riley & Yisong Geng, 2011. "Health plan enrollment and mortality in the Medicare program," Health Economics, John Wiley & Sons, Ltd., vol. 20(6), pages 645-659, June.

  31. Dana Goldman & Darius Lakdawalla, 2001. "Understanding Health Disparities Across Education Groups," NBER Working Papers 8328, National Bureau of Economic Research, Inc.

    Cited by:

    1. Datta Gupta Nabanita & Lau Daniel & Pozzoli Dario, 2016. "The Impact of Education and Occupation on Temporary and Permanent Work Incapacity," The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 16(2), pages 577-617, April.
    2. Sansani, Shahar, 2009. "The Effects of School Quality on Long-Term Health," MPRA Paper 22189, University Library of Munich, Germany, revised Apr 2010.
    3. Leonardo Becchetti & Pierluigi Conzo & Fabio Pisani, 2018. "Education and health in Europe," Applied Economics, Taylor & Francis Journals, vol. 50(12), pages 1362-1377, March.
    4. Gregory, Christian & Rahkovsky, Ilya & Anekwe, Tobenna D., 2014. "Consumers’ Use of Nutrition Information When Eating Out," Economic Information Bulletin 174796, United States Department of Agriculture, Economic Research Service.
    5. Thomas C. Buchmueller & Léontine Goldzahl, 2018. "The effect of organized breast cancer screening on mammography use: Evidence from France," Health Economics, John Wiley & Sons, Ltd., vol. 27(12), pages 1963-1980, December.
    6. Donald Kenkel & Dean Lillard & Alan Mathios, 2006. "The Roles of High School Completion and GED Receipt in Smoking and Obesity," Journal of Labor Economics, University of Chicago Press, vol. 24(3), pages 635-660, July.
    7. Isaac Ehrlich & Yong Yin, 2004. "Explaining Diversities in Age-Specific Life Expectancies and Values of Life Saving: A Numerical Analysis," NBER Working Papers 10759, National Bureau of Economic Research, Inc.
    8. Christopher H. Wheeler, 2007. "Human capital externalities and adult mortality in the U.S," Working Papers 2007-045, Federal Reserve Bank of St. Louis.
    9. Adriana Lleras-Muney, 2005. "The Relationship Between Education and Adult Mortality in the United States," The Review of Economic Studies, Review of Economic Studies Ltd, vol. 72(1), pages 189-221.
    10. Lakhanpal, Manisha & Ram, Rati, 2008. "Educational attainment and HIV/AIDS prevalence: A cross-country study," Economics of Education Review, Elsevier, vol. 27(1), pages 14-21, February.
    11. William J. Collins & Melissa A. Thomasson, 2002. "Exploring the Racial Gap in Infant Mortality Rates, 1920-1970," NBER Working Papers 8836, National Bureau of Economic Research, Inc.
    12. M. Christopher Auld & Nirmal Sidhu, 2004. "Schooling, cognitive ability, and health," HEW 0405005, University Library of Munich, Germany.
    13. Adriana Lleras-Muney & Frank R. Lichtenberg, 2002. "The Effect of Education on Medical Technology Adoption: Are the More Educated More Likely to Use New Drugs," NBER Working Papers 9185, National Bureau of Economic Research, Inc.
    14. M. Kate Bundorf & Laurence Baker & Sara Singer & Todd Wagner, 2004. "Consumer Demand for Health Information on the Internet," NBER Working Papers 10386, National Bureau of Economic Research, Inc.
    15. William J. Collins & Melissa A. Thomasson, 2004. "The Declining Contribution of Socioeconomic Disparities to the Racial Gap in Infant Mortality Rates, 1920‐1970," Southern Economic Journal, John Wiley & Sons, vol. 70(4), pages 746-776, April.
    16. Variyam, Jayachandran N., 2005. "Nutrition Labeling in the Food-Away-From-Home Sector: An Economic Assessment," Economic Research Report 7235, United States Department of Agriculture, Economic Research Service.

  32. Darius Lakdawalla & Dana Goldman & Jay Bhattacharya, 2001. "Are the Young Becoming More Disabled?," NBER Working Papers 8247, National Bureau of Economic Research, Inc.

    Cited by:

    1. Richard V. Burkhauser & Mary C. Daly & Andrew J. Houtenville & Nigar Nargis, 2002. "Self-reported work limitation data: what they can and cannot tell us," Working Paper Series 2002-22, Federal Reserve Bank of San Francisco.
    2. Brunello, Giorgio & Michaud, Pierre-Carl & Sanz-de-Galdeano, Anna, 2008. "The Rise in Obesity across the Atlantic: An Economic Perspective," IZA Discussion Papers 3529, Institute of Labor Economics (IZA).
    3. Willaim G. Gale & Karen M. Pence, 2006. "Are Successive Generations Getting Wealthier, and If So, Why?," Brookings Papers on Economic Activity, Economic Studies Program, The Brookings Institution, vol. 37(1), pages 155-234.
    4. Brian Bell & James Smith, 2004. "Health, disability insurance and labour force participation," Bank of England working papers 218, Bank of England.
    5. Gale, William & Pence, Karen, 2006. "Are Successive Generations Getting Wealthier, and If So, Why?Evidence from the 1990s," MPRA Paper 55502, University Library of Munich, Germany.
    6. Xavier Pautrel, 2009. "Health-enhancing Activities and the Environment: How Competition for Resources Makes the Environmental Policy Beneficial," Working Papers 2009.111, Fondazione Eni Enrico Mattei.
    7. Richard Burkhauser & John Cawley, 2006. "The Importance of Objective Health Measures in Predicting Early Receipt of Social Security Benefits: The Case of Fatness," Working Papers wp148, University of Michigan, Michigan Retirement Research Center.
    8. K. Bolin & B. Lindgren & P. Lundborg, 2008. "Informal and formal care among single‐living elderly in Europe," Health Economics, John Wiley & Sons, Ltd., vol. 17(3), pages 393-409, March.
    9. Jay Bhattacharya & Alan M. Garber & Thomas MaCurdy, 2010. "The Narrowing Dispersion of Medicare Expenditures 1997 to 2005," NBER Chapters, in: Research Findings in the Economics of Aging, pages 387-407, National Bureau of Economic Research, Inc.
    10. Nathalie Mathieu-Bolh & Xavier Pautrel, 2014. "Environmental taxation, health and the life-cycle," Working Papers hal-00990256, HAL.
    11. Roger Wilkins, 2003. "Labour Market Outcomes and Welfare Dependence of Persons with Disabilities in Australia," Melbourne Institute Working Paper Series wp2003n02, Melbourne Institute of Applied Economic and Social Research, The University of Melbourne.
    12. Pilar García-Gómez & Hans-Martin Gaudecker & Maarten Lindeboom, 2011. "Health, disability and work: patterns for the working age population," International Tax and Public Finance, Springer;International Institute of Public Finance, vol. 18(2), pages 146-165, April.
    13. Rashwan, Wael & Abo-Hamad, Waleed & Arisha, Amr, 2015. "A system dynamics view of the acute bed blockage problem in the Irish healthcare system," European Journal of Operational Research, Elsevier, vol. 247(1), pages 276-293.
    14. Xiaoyan Li & Nicole Maestas, 2008. "Does the Rise in the Full Retirement Age Encourage Disability Benefits Applications? Evidence from the Health and Retirement Study," Working Papers wp198, University of Michigan, Michigan Retirement Research Center.
    15. Ana Isabel Gil & Jose Alberto Molina, 2007. "Human development and alcohol abuse in adolescence," Applied Economics, Taylor & Francis Journals, vol. 39(10), pages 1315-1323.
    16. Brown, Jeffrey R. & Finkelstein, Amy, 2007. "Why is the market for long-term care insurance so small?," Journal of Public Economics, Elsevier, vol. 91(10), pages 1967-1991, November.
    17. Hansen, Helena & Bourgois, Philippe & Drucker, Ernest, 2014. "Pathologizing poverty: New forms of diagnosis, disability, and structural stigma under welfare reform," Social Science & Medicine, Elsevier, vol. 103(C), pages 76-83.
    18. David H. Autor & Mark G. Duggan, 2001. "The Rise in Disability Recipiency and the Decline in Unemployment," NBER Working Papers 8336, National Bureau of Economic Research, Inc.
    19. Cawley, John & Han, Euna & Norton, Edward C., 2009. "Obesity and labor market outcomes among legal immigrants to the United States from developing countries," Economics & Human Biology, Elsevier, vol. 7(2), pages 153-164, July.
    20. Amitabh Chandra & Andrew A. Samwick, 2005. "Disability Risk and the Value of Disability Insurance," NBER Working Papers 11605, National Bureau of Economic Research, Inc.
    21. Jeffrey R. Brown & Amy Finkelstein, 2004. "The Interaction of Public and Private Insurance: Medicaid and the Long-Term Care Insurance Market," NBER Working Papers 10989, National Bureau of Economic Research, Inc.
    22. Mary Beth Landrum & Kate A. Stewart & David M. Cutler, 2009. "Clinical Pathways to Disability," NBER Chapters, in: Health at Older Ages: The Causes and Consequences of Declining Disability among the Elderly, pages 151-187, National Bureau of Economic Research, Inc.
    23. John Cawley & Richard V. Burkhauser, 2006. "Beyond BMI: The Value of More Accurate Measures of Fatness and Obesity in Social Science Research," NBER Working Papers 12291, National Bureau of Economic Research, Inc.
    24. Jeffrey R. Brown & Amy Finkelstein, 2004. "Supply or Demand: Why is the Market for Long-Term Care Insurance So Small?," NBER Working Papers 10782, National Bureau of Economic Research, Inc.
    25. Plisson, Manuel, 2009. "Assurabilité et développement de l'assurance dépendance," Economics Thesis from University Paris Dauphine, Paris Dauphine University, number 123456789/5064 edited by Lorenzi, Jean-Hervé.
    26. Lucie Schmidt, 2013. "The New Safety Net? Supplemental Security Income after Welfare Reform," Department of Economics Working Papers 2013-07, Department of Economics, Williams College.

Articles

  1. Wändi Bruine de Bruin & Aulona Ulqinaku & Dana P. Goldman, 2022. "Effect of COVID-19 vaccine allocation strategies on vaccination refusal: a national survey," Journal of Risk Research, Taylor & Francis Journals, vol. 25(9), pages 1047-1054, October.

    Cited by:

    1. Elena Fumagalli & Candelaria Belén Krick & Marina Belén Dolmatzian & Julieta Edith Del Negro & Joaquin Navajas, 2023. "Partisanship predicts COVID-19 vaccine brand preference: the case of Argentina," Palgrave Communications, Palgrave Macmillan, vol. 10(1), pages 1-10, December.

  2. Vincenzo Atella & Federico Belotti & Daejung Kim & Dana Goldman & Tadeja Gracner & Andrea Piano Mortari & Bryan Tysinger, 2021. "The future of the elderly population health status: Filling a knowledge gap," Health Economics, John Wiley & Sons, Ltd., vol. 30(S1), pages 11-29, November.
    See citations under working paper version above.
  3. Jakub P. Hlávka & Jeffrey C. Yu & Dana P. Goldman & Darius N. Lakdawalla, 2021. "The economics of alternative payment models for pharmaceuticals," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(4), pages 559-569, June.

    Cited by:

    1. Wettstein, Dominik J. & Boes, Stefan, 2022. "How value-based policy interventions influence price negotiations for new medicines: An experimental approach and initial evidence," Health Policy, Elsevier, vol. 126(2), pages 112-121.
    2. Levaggi, Laura & Levaggi, Rosella, 2024. "Competition, value-based prices and incentives to research personalised drugs," Socio-Economic Planning Sciences, Elsevier, vol. 93(C).

  4. Dana P. Goldman & Benjamin G. Cohen & Jessica Y. Ho & Daniel L. McFadden & Martha S. Ryan & Bryan Tysinger, 2021. "Improved survival for individuals with common chronic conditions in the Medicare population," Health Economics, John Wiley & Sons, Ltd., vol. 30(S1), pages 80-91, November.

    Cited by:

    1. Vincenzo Atella & Dana Goldman & Daniel McFadden, 2021. "Disparate ageing: The role of education and socioeconomic gradients in future health and disability in an international context," Health Economics, John Wiley & Sons, Ltd., vol. 30(S1), pages 3-10, November.

  5. Powell, David & Goldman, Dana, 2021. "Disentangling moral hazard and adverse selection in private health insurance," Journal of Econometrics, Elsevier, vol. 222(1), pages 141-160.
    See citations under working paper version above.
  6. Duncan Ermini Leaf & Bryan Tysinger & Dana P. Goldman & Darius N. Lakdawalla, 2021. "Predicting quantity and quality of life with the Future Elderly Model," Health Economics, John Wiley & Sons, Ltd., vol. 30(S1), pages 52-79, November.

    Cited by:

    1. Jorge Luis Garcia & Frederik Bennhoff & Duncan Ermini Leaf & James J. Heckman, 2021. "The Dynastic Benefits of Early Childhood Education," Working Papers 2021-033, Human Capital and Economic Opportunity Working Group.

  7. Wändi Bruine de Bruin & Htay-Wah Saw & Dana P. Goldman, 2020. "Political polarization in US residents’ COVID-19 risk perceptions, policy preferences, and protective behaviors," Journal of Risk and Uncertainty, Springer, vol. 61(2), pages 177-194, October.

    Cited by:

    1. Powdthavee, Nattavudh & Riyanto, Yohanes E. & Wong, Erwin & Yeo, Jonathan & Chan, Qi Yu, 2021. "When Face Masks Signal Social Identity: Explaining the Deep Face-Mask Divide during the COVID-19 Pandemic," IZA Discussion Papers 14715, Institute of Labor Economics (IZA).
    2. Smart, Shanike J. & Polachek, Solomon, 2024. "COVID-19 Vaccine and Risk-Taking," IZA Discussion Papers 16707, Institute of Labor Economics (IZA).
    3. Liesel Ritchie & Duane Gill, 2021. "Considering COVID-19 through the Lens of Hazard and Disaster Research," Social Sciences, MDPI, vol. 10(7), pages 1-20, June.
    4. Dan Goldhaber & Scott A. Imberman & Katharine O. Strunk & Bryant Hopkins & Nate Brown & Erica Harbatkin & Tara Kilbride, 2021. "To What Extent Does In-Person Schooling Contribute to the Spread of COVID-19? Evidence from Michigan and Washington," NBER Working Papers 28455, National Bureau of Economic Research, Inc.
    5. Jack P Hughes & Alexandros Efstratiou & Sara R Komer & Lilli A Baxter & Milica Vasiljevic & Ana C Leite, 2022. "The impact of risk perceptions and belief in conspiracy theories on COVID-19 pandemic-related behaviours," PLOS ONE, Public Library of Science, vol. 17(2), pages 1-20, February.
    6. Sabrina Cipolletta & Gabriela Rios Andreghetti & Giovanna Mioni, 2022. "Risk Perception towards COVID-19: A Systematic Review and Qualitative Synthesis," IJERPH, MDPI, vol. 19(8), pages 1-25, April.
    7. Jesper Akesson & Sam Ashworth-Hayes & Robert Hahn & Robert D. Metcalfe & Itzhak Rasooly, 2020. "Fatalism, Beliefs, and Behaviors During the COVID-19 Pandemic," NBER Working Papers 27245, National Bureau of Economic Research, Inc.
    8. W. Kip Viscusi, 2020. "Pricing the global health risks of the COVID-19 pandemic," Journal of Risk and Uncertainty, Springer, vol. 61(2), pages 101-128, October.
    9. Hyun Kyung Park & Ji Hye Ham & Deok Hyun Jang & Jin Yong Lee & Won Mo Jang, 2021. "Political Ideologies, Government Trust, and COVID-19 Vaccine Hesitancy in South Korea: A Cross-Sectional Survey," IJERPH, MDPI, vol. 18(20), pages 1-9, October.
    10. Li, Ying & Luan, Shenghua & Li, Yugang & Hertwig, Ralph, 2021. "Changing emotions in the COVID-19 pandemic: A four-wave longitudinal study in the United States and China," Social Science & Medicine, Elsevier, vol. 285(C).
    11. Lueck, Jennifer A. & Callaghan, Timothy, 2022. "Inside the ‘black box’ of COVID-19 vaccination beliefs: Revealing the relative importance of public confidence and news consumption habits," Social Science & Medicine, Elsevier, vol. 298(C).
    12. Grimalda, Gianluca & Murtin, Fabrice & Pipke, David & Putterman, Louis & Sutter, Matthias, 2022. "The Politicized Pandemic: Ideological Polarization and the Behavioral Response to COVID-19," IZA Discussion Papers 15032, Institute of Labor Economics (IZA).
    13. Laura K. Globig & Bastien Blain & Tali Sharot, 2022. "Perceptions of personal and public risk: Dissociable effects on behavior and well-being," Journal of Risk and Uncertainty, Springer, vol. 64(2), pages 213-234, April.
    14. Cinthya G. Caamal-Olvera & Julio César Arteaga García, 2021. "Initial Management of COVID-19 Outbreak in Mexico," Remef - Revista Mexicana de Economía y Finanzas Nueva Época REMEF (The Mexican Journal of Economics and Finance), Instituto Mexicano de Ejecutivos de Finanzas, IMEF, vol. 16(3), pages 1-22, Julio - S.
    15. Zhong, Wei & Broniatowski, David A., 2023. "Economic risk framing increases intention to vaccinate among Republican COVID-19 vaccine refusers," Social Science & Medicine, Elsevier, vol. 317(C).
    16. Thierry Blayac & Dimitri Dubois & Sébastien Duchêne & Phu Nguyen-Van & Bruno Ventelou & Marc Willinger, 2022. "What drives the acceptability of restrictive health policies: An experimental assessment of individual preferences for anti-COVID 19 strategies," Post-Print hal-03866196, HAL.
    17. Sacco, Pier Luigi & Gallotti, Riccardo & Pilati, Federico & Castaldo, Nicola & De Domenico, Manlio, 2021. "Emergence of knowledge communities and information centralization during the COVID-19 pandemic," Social Science & Medicine, Elsevier, vol. 285(C).
    18. François, Abel & Gergaud, Olivier & Noury, Abdul, 2023. "Can health passport overcome political hurdles to COVID-19 vaccination?," European Journal of Political Economy, Elsevier, vol. 80(C).
    19. David Rozado & Eric Kaufmann, 2022. "The Increasing Frequency of Terms Denoting Political Extremism in U.S. and U.K. News Media," Social Sciences, MDPI, vol. 11(4), pages 1-16, April.
    20. Wirpsa, M.J. & Galchutt, P. & Price, C.S. & Schaefer, B. & Szilagyi, C. & Palmer, P.K., 2023. "Mandatory COVID-19 vaccination for healthcare workers: The experience of chaplains evaluating religious accommodation requests from coworkers," Social Science & Medicine, Elsevier, vol. 332(C).
    21. Ori Heffetz & Guy Ishai, 2021. "Which Beliefs? Behavior-Predictive Beliefs are Inconsistent with Information-Based Beliefs: Evidence from COVID-19," NBER Working Papers 29452, National Bureau of Economic Research, Inc.
    22. Dhaval Dave & Joseph J. Sabia & Samuel Safford, 2022. "The limits of reopening policy to alter economic behavior: New evidence from Texas," Journal of Risk and Uncertainty, Springer, vol. 64(2), pages 109-145, April.
    23. Habicher, Daria & Windegger, Felix & von der Gracht, Heiko A. & Pechlaner, Harald, 2022. "Beyond the COVID-19 crisis: A research note on post-pandemic scenarios for South Tyrol 2030+," Technological Forecasting and Social Change, Elsevier, vol. 180(C).
    24. Rachel Leonard & Sean R. O'Connor & Jennifer Hanratty & Ciara Keenan & Yuan Chi & Jenny Ferguson & Ariana Axiaq & Anna Volz & Ceri Welsh & Kerry Campbell & Victoria Hawkins & Sarah Miller & Declan Bra, 2024. "Psychological and psychosocial determinants of COVID‐related handwashing behaviours: A systematic review," Campbell Systematic Reviews, John Wiley & Sons, vol. 20(3), September.
    25. Yi Yang & Ru-De Liu & Yi Ding & Jia Wang & Wei Hong & Ying Wu, 2021. "The Influence of Communication on College Students’ Self–Other Risk Perceptions of COVID-19: A Comparative Study of China and the United States," IJERPH, MDPI, vol. 18(23), pages 1-16, November.
    26. Jessecae K. Marsh & Nick D. Ungson & Dominic J. Packer, 2021. "Of Pandemics and Zombies: The Influence of Prior Concepts on COVID-19 Pandemic-Related Behaviors," IJERPH, MDPI, vol. 18(10), pages 1-17, May.
    27. Qin, Hua & Sanders, Christine & Prasetyo, Yanu & Syukron, Muh. & Prentice, Elizabeth, 2021. "Exploring the dynamic relationships between risk perception and behavior in response to the Coronavirus Disease 2019 (COVID-19) outbreak," Social Science & Medicine, Elsevier, vol. 285(C).

  8. Rebecca M. Myerson & Reginald D. Tucker‐Seeley & Dana P. Goldman & Darius N. Lakdawalla, 2020. "Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes?," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 39(3), pages 577-604, June.
    See citations under working paper version above.
  9. John Romley & Erin Trish & Dana Goldman & Melinda Beeuwkes Buntin & Yulei He & Paul Ginsburg, 2019. "Geographic variation in the delivery of high-value inpatient care," PLOS ONE, Public Library of Science, vol. 14(3), pages 1-11, March.

    Cited by:

    1. John A. Romley & Dana Goldman & Neeraj Sood & Abe C. Dunn, 2019. "Quantifying Productivity Growth in the Delivery of Important Episodes of Care Within the Medicare Program Using Insurance Claims and Administrative Data," BEA Papers 0111, Bureau of Economic Analysis.

  10. Dana P. Goldman & Kip Hagopian, 2018. "It Is Time For Universal Coverage Without Breaking The Bank," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 37(1), pages 182-188, January.

    Cited by:

    1. Naomi Zewde, 2021. "Did Marketplace coverage really offer financial protection? Financial gains from the Affordable Care Act's private insurance policies among the previously uninsured," Journal of Risk & Insurance, The American Risk and Insurance Association, vol. 88(2), pages 413-427, June.

  11. Mintu P Turakhia & Jason Shafrin & Katalin Bognar & Jeffrey Trocio & Younos Abdulsattar & Daniel Wiederkehr & Dana P Goldman, 2018. "Estimated prevalence of undiagnosed atrial fibrillation in the United States," PLOS ONE, Public Library of Science, vol. 13(4), pages 1-11, April.

    Cited by:

    1. Ali Bahrami Rad & Conner Galloway & Daniel Treiman & Joel Xue & Qiao Li & Reza Sameni & Dave Albert & Gari D Clifford, 2021. "Atrial fibrillation detection in outpatient electrocardiogram monitoring: An algorithmic crowdsourcing approach," PLOS ONE, Public Library of Science, vol. 16(11), pages 1-15, November.

  12. Mariana Carrera & Dana P. Goldman & Geoffrey Joyce & Neeraj Sood, 2018. "Do Physicians Respond to the Costs and Cost-Sensitivity of Their Patients?," American Economic Journal: Economic Policy, American Economic Association, vol. 10(1), pages 113-152, February.

    Cited by:

    1. Villas-Boas, Sofia B & Carrera, Mariana, 2016. "Generic aversion and observational learning in the over-the-counter drug market," Department of Agricultural & Resource Economics, UC Berkeley, Working Paper Series qt0q03b5f2, Department of Agricultural & Resource Economics, UC Berkeley.
    2. Christian Posso & Jorge Tamayo & Arlen Guarin & Estefania Saravia, 2024. "Luck of the Draw: The Causal Effect of Physicians on Birth Outcomes," Borradores de Economia 1269, Banco de la Republica de Colombia.
    3. Newham, Melissa & Valente, Marica, 2024. "The cost of influence: How gifts to physicians shape prescriptions and drug costs," Journal of Health Economics, Elsevier, vol. 95(C).
    4. Laura V Minard & Amber Corkum & Ingrid Sketris & Judith Fisher & Ying Zhang & Ahmed Saleh, 2016. "Trends in Statin Use in Seniors 1999 to 2013: Time Series Analysis," PLOS ONE, Public Library of Science, vol. 11(7), pages 1-15, July.
    5. Rabideau, Brendan & Eisenberg, Matthew D. & Reid, Rachel & Sood, Neeraj, 2021. "Effects of employer-offered high-deductible plans on low-value spending in the privately insured population," Journal of Health Economics, Elsevier, vol. 76(C).
    6. Magno, Cielo & Guzman, Ricardo Rafael S., 2019. "Drug price sensitivity among physicians in a developing healthcare system: Evidence from the Philippine market for statins and beta blockers," Economic Analysis and Policy, Elsevier, vol. 62(C), pages 268-279.
    7. Fiorentini, Gianluca & Bruni, Matteo Lippi & Mammi, Irene, 2022. "The same old medicine but cheaper: The impact of patent expiry on physicians’ prescribing behaviour," Journal of Economic Behavior & Organization, Elsevier, vol. 204(C), pages 37-68.
    8. Sebastian Linde & Brandon Norton & Ralph Siebert, 2019. "The Effect of Bargaining Power Determinants on Pharmaceutical Prices," CESifo Working Paper Series 7988, CESifo.
    9. Kurt R. Brekke & Dag Morten Dalen & Odd Rune Straume, 2021. "Paying for pharmaceuticals: uniform pricing versus two-part tariffs," NIPE Working Papers 01/2021, NIPE - Universidade do Minho.
    10. Ghosh, Ausmita & Simon, Kosali & Sommers, Benjamin D., 2019. "The Effect of Health Insurance on Prescription Drug Use Among Low-Income Adults:Evidence from Recent Medicaid Expansions," Journal of Health Economics, Elsevier, vol. 63(C), pages 64-80.
    11. Suppliet, Moritz, 2017. "Umbrella Branding in Pharmaceutical Markets," Other publications TiSEM be3f3c38-5e39-4a67-af57-8, Tilburg University, School of Economics and Management.
    12. Wu, Bingxiao, 2019. "Physician agency in China: Evidence from a drug-percentage incentive scheme," Journal of Development Economics, Elsevier, vol. 140(C), pages 72-89.
    13. Lee, Chung-Ying, 2020. "Pricing strategy and moral hazard: Copay coupons in pharmaceuticals," International Journal of Industrial Organization, Elsevier, vol. 70(C).
    14. Christopher Bates & Susan J. Méndez, 2024. "Therapeutic Substitution in Response to Patent Expiry? Statins in Australia," Economic Papers, The Economic Society of Australia, vol. 43(2), pages 112-123, June.
    15. Meng-Chi Tang & Yi-Nong Wu, 2020. "Medical providers as double agents in a universal health care system: evidence from generic pharmaceutical adoption in Taiwan," Empirical Economics, Springer, vol. 59(1), pages 169-203, July.
    16. Kyle, Margaret K., 2022. "Incentives for pharmaceutical innovation: What’s working, what’s lacking," International Journal of Industrial Organization, Elsevier, vol. 84(C).

  13. Jason Shafrin & Jeff Sullivan & Dana P Goldman & Thomas M Gill, 2017. "The association between observed mobility and quality of life in the near elderly," PLOS ONE, Public Library of Science, vol. 12(8), pages 1-13, August.

    Cited by:

    1. Yousif Elsamani & Yuya Kajikawa, 2024. "Envisioning the Future of Mobility: A Well-Being-Oriented Approach," Sustainability, MDPI, vol. 16(18), pages 1-22, September.
    2. Elke Warmerdam & Clint Hansen & Robbin Romijnders & Markus A. Hobert & Julius Welzel & Walter Maetzler, 2022. "Full-Body Mobility Data to Validate Inertial Measurement Unit Algorithms in Healthy and Neurological Cohorts," Data, MDPI, vol. 7(10), pages 1-8, September.

  14. Alan J. Auerbach & Kerwin K. Charles & Courtney C. Coile & William Gale & Dana Goldman & Ronald Lee & Charles M. Lucas & Peter R. Orszag & Louise M. Sheiner & Bryan Tysinger & David N. Weil & Justin W, 2017. "How the Growing Gap in Life Expectancy May Affect Retirement Benefits and Reforms," The Geneva Papers on Risk and Insurance - Issues and Practice, Palgrave Macmillan;The Geneva Association, vol. 42(3), pages 475-499, July.
    See citations under working paper version above.
  15. David B Agus & Étienne Gaudette & Dana P Goldman & Andrew Messali, 2016. "The Long-Term Benefits of Increased Aspirin Use by At-Risk Americans Aged 50 and Older," PLOS ONE, Public Library of Science, vol. 11(11), pages 1-12, November.

    Cited by:

    1. Daniel Bauer & Darius Lakdawalla & Julian Reif, 2018. "Mortality Risk, Insurance, and the Value of Life," NBER Working Papers 25055, National Bureau of Economic Research, Inc.

  16. Alice Chen & Dana Goldman, 2016. "Health Care Spending: Historical Trends and New Directions," Annual Review of Economics, Annual Reviews, vol. 8(1), pages 291-319, October.
    See citations under working paper version above.
  17. Gaudette Étienne & Tysinger Bryan & Cassil Alwyn & Goldman Dana P., 2015. "Health and Health Care of Medicare Beneficiaries in 2030," Forum for Health Economics & Policy, De Gruyter, vol. 18(2), pages 75-96, December.

    Cited by:

    1. Duncan Ermini Leaf & Bryan Tysinger & Dana P. Goldman & Darius N. Lakdawalla, 2021. "Predicting quantity and quality of life with the Future Elderly Model," Health Economics, John Wiley & Sons, Ltd., vol. 30(S1), pages 52-79, November.
    2. David B Agus & Étienne Gaudette & Dana P Goldman & Andrew Messali, 2016. "The Long-Term Benefits of Increased Aspirin Use by At-Risk Americans Aged 50 and Older," PLOS ONE, Public Library of Science, vol. 11(11), pages 1-12, November.

  18. Étienne Gaudette & Dana Goldman & Andrew Messali & Neeraj Sood, 2015. "Do Statins Reduce the Health and Health Care Costs of Obesity?," PharmacoEconomics, Springer, vol. 33(7), pages 723-734, July.

    Cited by:

    1. Afschin Gandjour, 2016. "Comment on: “The Role of Chronic Disease, Obesity, and Improved Treatment and Detection in Accounting for the Rise in Healthcare Spending Between 1987 and 2011”," Applied Health Economics and Health Policy, Springer, vol. 14(2), pages 241-241, April.
    2. David B Agus & Étienne Gaudette & Dana P Goldman & Andrew Messali, 2016. "The Long-Term Benefits of Increased Aspirin Use by At-Risk Americans Aged 50 and Older," PLOS ONE, Public Library of Science, vol. 11(11), pages 1-12, November.
    3. Christian Frois & Pierre-Yves Cremieux, 2015. "For a Step Change to Curb the Obesity Epidemic," PharmacoEconomics, Springer, vol. 33(7), pages 613-617, July.
    4. Étienne Gaudette & Gwyn C. Pauley & Julie Zissimopoulos, 2016. "Long-term Individual and Population Consequences of Early-life Access to Health Insurance," Working Papers wp355, University of Michigan, Michigan Retirement Research Center.

  19. Seabury Seth A. & Lakdawalla Darius N. & Walter Deborah & Hayes John & Gustafson Thomas & Shrestha Anshu & Goldman Dana P., 2014. "Patient Outcomes and Cost Effects of Medicaid Formulary Restrictions on Antidepressants," Forum for Health Economics & Policy, De Gruyter, vol. 17(2), pages 153-168, September.

    Cited by:

    1. Dillender, Marcus, 2018. "What happens when the insurer can say no? Assessing prior authorization as a tool to prevent high-risk prescriptions and to lower costs," Journal of Public Economics, Elsevier, vol. 165(C), pages 170-200.

  20. Anirban Basu & Anupam B. Jena & Dana P. Goldman & Tomas J. Philipson & Robert Dubois, 2014. "Heterogeneity In Action: The Role Of Passive Personalization In Comparative Effectiveness Research," Health Economics, John Wiley & Sons, Ltd., vol. 23(3), pages 359-373, March.

    Cited by:

    1. Jason Abaluck & Leila Agha & David C. Chan Jr & Daniel Singer & Diana Zhu, 2020. "Fixing Misallocation with Guidelines: Awareness vs. Adherence," NBER Working Papers 27467, National Bureau of Economic Research, Inc.
    2. Sasaki, Yuya & Ura, Takuya, 2023. "Estimation and inference for policy relevant treatment effects," Journal of Econometrics, Elsevier, vol. 234(2), pages 394-450.
    3. David D. Kim & Anirban Basu, 2017. "New Metrics for Economic Evaluation in the Presence of Heterogeneity: Focusing on Evaluating Policy Alternatives Rather than Treatment Alternatives," Medical Decision Making, , vol. 37(8), pages 930-941, November.
    4. Anirban Basu, 2018. "Comment: Manski's views on patient care under uncertainty," Health Economics, John Wiley & Sons, Ltd., vol. 27(10), pages 1422-1424, October.
    5. Kristopher J. Hult, 2017. "Measuring the Potential Health Impact of Personalized Medicine: Evidence from MS Treatments," NBER Working Papers 23900, National Bureau of Economic Research, Inc.
    6. Kristopher J. Hult, 2018. "Measuring the Potential Health Impact of Personalized Medicine: Evidence from Multiple Sclerosis Treatments," NBER Chapters, in: Economic Dimensions of Personalized and Precision Medicine, pages 185-216, National Bureau of Economic Research, Inc.

  21. Dana P. Goldman & Peter R. Orszag, 2014. "The Growing Gap in Life Expectancy: Using the Future Elderly Model to Estimate Implications for Social Security and Medicare," American Economic Review, American Economic Association, vol. 104(5), pages 230-233, May.

    Cited by:

    1. Teresa Ghilarducci & Siavash Radpour & Jessica Forden, 2023. "No Rest for The Weary: Measuring the Changing Distribution of Wealth in The US," SCEPA working paper series. 2023-02, Schwartz Center for Economic Policy Analysis (SCEPA), The New School.
    2. David McCarthy, 2021. "80 will be the new 70: Old‐age mortality postponement in the United States and its likely effect on the finances of the OASI program," Journal of Risk & Insurance, The American Risk and Insurance Association, vol. 88(2), pages 381-412, June.
    3. McCarthy, David G. & Wang, Po-Lin, 2021. "Pooling mortality risk in Eurozone state pension liabilities: An application of a Bayesian coherent multi-population cohort-based mortality model," Insurance: Mathematics and Economics, Elsevier, vol. 99(C), pages 459-485.
    4. Gaudette Étienne & Tysinger Bryan & Cassil Alwyn & Goldman Dana P., 2015. "Health and Health Care of Medicare Beneficiaries in 2030," Forum for Health Economics & Policy, De Gruyter, vol. 18(2), pages 75-96, December.
    5. Li Tan & Cory Koedel, 2017. "The Effects of Differential Income Replacement and Mortality on U.S. Social Security Redistribution," Working Papers 1701, Department of Economics, University of Missouri, revised Jun 2019.
    6. Milevsky, Moshe A., 2020. "Swimming with wealthy sharks: longevity, volatility and the value of risk pooling," Journal of Pension Economics and Finance, Cambridge University Press, vol. 19(2), pages 217-246, April.
    7. Weidong Tian & Zimu Zhu, 2020. "A Portfolio Choice Problem Under Risk Capacity Constraint," Papers 2005.13741, arXiv.org, revised Dec 2021.
    8. James M. Poterba, 2014. "Retirement Security in an Aging Population," American Economic Review, American Economic Association, vol. 104(5), pages 1-30, May.
    9. James M. Poterba, 2014. "Retirement Security in an Aging Society," NBER Working Papers 19930, National Bureau of Economic Research, Inc.
    10. Jiaxin Shi & Christian Dudel & Christiaan Monden & Alyson A. van Raalte, 2022. "Inequalities in retirement lifespan in the United States," MPIDR Working Papers WP-2022-015, Max Planck Institute for Demographic Research, Rostock, Germany.
    11. Jing Guo & Marilyn Moon, 2018. "Lifetime Taxpayer Contributions And Benefits Of Medicare And Social Security," Contemporary Economic Policy, Western Economic Association International, vol. 36(3), pages 483-492, July.
    12. Bram Wouterse & Arjen Hussem & Albert Wong, 2022. "The risk protection and redistribution effects of long‐term care co‐payments," Journal of Risk & Insurance, The American Risk and Insurance Association, vol. 89(1), pages 161-186, March.
    13. Daniel Bauer & Darius Lakdawalla & Julian Reif, 2018. "Mortality Risk, Insurance, and the Value of Life," NBER Working Papers 25055, National Bureau of Economic Research, Inc.
    14. Dianna M. Smith & Alison Heppenstall & Monique Campbell, 2021. "Estimating Health over Space and Time: A Review of Spatial Microsimulation Applied to Public Health," J, MDPI, vol. 4(2), pages 1-11, June.

  22. Joyce, Geoffrey F. & Zissimopoulos, Julie & Goldman, Dana P., 2013. "Digesting the doughnut hole," Journal of Health Economics, Elsevier, vol. 32(6), pages 1345-1355.

    Cited by:

    1. Liran Einav & Amy Finkelstein & Raymond Kluender & Paul Schrimpf, 2015. "Beyond Statistics: The Economic Content of Risk Scores," NBER Working Papers 21304, National Bureau of Economic Research, Inc.
    2. Judith Liu & Yuting Zhang & Cameron M. Kaplan, 2023. "Effects of Medicare Part D coverage gap closure on utilization of branded and generic drugs," Health Economics, John Wiley & Sons, Ltd., vol. 32(3), pages 639-653, March.
    3. Naomi C. Sacks & James F. Burgess & Howard J. Cabral & Steven D. Pizer, 2017. "Myopic and Forward Looking Behavior in Branded Oral Anti‐Diabetic Medication Consumption: An Example from Medicare Part D," Health Economics, John Wiley & Sons, Ltd., vol. 26(6), pages 753-764, June.

  23. Goldman Dana P. & Gupta Charu & Vasudeva Eshan & Trakas Kostas & Riley Ralph & Lakdawalla Darius & Agus David & Sood Neeraj & Jena Anupam B. & Philipson Tomas J., 2013. "The Value of Diagnostic Testing in Personalized Medicine," Forum for Health Economics & Policy, De Gruyter, vol. 16(2), pages 87-99, September.

    Cited by:

    1. Ernst R. Berndt & Dana P. Goldman & John W. Rowe, 2018. "Introduction to "Economic Dimensions of Personalized and Precision Medicine"," NBER Chapters, in: Economic Dimensions of Personalized and Precision Medicine, pages 1-7, National Bureau of Economic Research, Inc.
    2. Manuel I. Hermosilla & Jorge A. Lemus, 2017. "Therapeutic Translation of Genomic Science: Opportunities and limitations of GWAS," NBER Working Papers 23989, National Bureau of Economic Research, Inc.

  24. Dana Goldman & Nicole Maestas, 2013. "Medical Expenditure Risk And Household Portfolio Choice," Journal of Applied Econometrics, John Wiley & Sons, Ltd., vol. 28(4), pages 527-550, June.
    See citations under working paper version above.
  25. Michaud, Pierre-Carl & Goldman, Dana P. & Lakdawalla, Darius N. & Zheng, Yuhui & Gailey, Adam H., 2012. "The value of medical and pharmaceutical interventions for reducing obesity," Journal of Health Economics, Elsevier, vol. 31(4), pages 630-643.
    See citations under working paper version above.
  26. Philipson Tomas J. & Sun Eric & Goldman Dana & Jena Anupam B., 2012. "A Reexamination of the Costs of Medical R&D Regulation," Forum for Health Economics & Policy, De Gruyter, vol. 15(1), pages 1-28, October.

    Cited by:

    1. Stevens Warren & Philipson Tomas & Wu Yanyu & Chen Connie & Lakdawalla Darius, 2014. "A Cost-Benefit Analysis of Using Evidence of Effectiveness in Terms of Progression Free Survival in Making Reimbursement Decisions on New Cancer Therapies," Forum for Health Economics & Policy, De Gruyter, vol. 17(1), pages 21-52, January.

  27. Hackbarth, Andrew D. & Romley, John A. & Goldman, Dana P., 2011. "Racial and ethnic disparities in hospital care resulting from air pollution in excess of federal standards," Social Science & Medicine, Elsevier, vol. 73(8), pages 1163-1168.

    Cited by:

    1. Collins, Timothy W. & Grineski, Sara E. & Morales, Danielle X., 2017. "Environmental injustice and sexual minority health disparities: A national study of inequitable health risks from air pollution among same-sex partners," Social Science & Medicine, Elsevier, vol. 191(C), pages 38-47.
    2. McDonald, Yolanda J. & Grineski, Sara E. & Collins, Timothy W. & Kim, Young-An, 2015. "A scalable climate health justice assessment model," Social Science & Medicine, Elsevier, vol. 133(C), pages 242-252.

  28. Michaud, Pierre-Carl & Goldman, Dana & Lakdawalla, Darius & Gailey, Adam & Zheng, Yuhui, 2011. "Differences in health between Americans and Western Europeans: Effects on longevity and public finance," Social Science & Medicine, Elsevier, vol. 73(2), pages 254-263, July.

    Cited by:

    1. Raquel Fonseca & Yuhui Zheng, 2013. "The Effect of Education on Health: Cross-Country Evidence," Cahiers de recherche 1325, CIRPEE.
    2. Vincenzo Atella & Federico Belotti & Daejung Kim & Dana Goldman & Tadeja Gracner & Andrea Piano Mortari & Bryan Tysinger, 2021. "The future of the elderly population health status: Filling a knowledge gap," Health Economics, John Wiley & Sons, Ltd., vol. 30(S1), pages 11-29, November.
    3. Raquel Fonseca & Pierre-Carl Michaud & Yuhui Zheng, 2018. "The Effect of Education on Health: Evidence from National Compulsory Schooling Reforms," CIRANO Working Papers 2018s-10, CIRANO.
    4. Datta Gupta, Nabanita & Kleinjans, Kristin J. & Larsen, Mona, 2015. "The effect of a severe health shock on work behavior: Evidence from different health care regimes," Social Science & Medicine, Elsevier, vol. 136, pages 44-51.
    5. Goldman Dana P. & Lakdawalla Darius N. & Baumgardner James R. & Linthicum Mark T., 2016. "Are Biopharmaceutical Budget Caps Good Public Policy?," The Economists' Voice, De Gruyter, vol. 13(1), pages 27-42, December.
    6. Côté-Sergent, Aurelie & Fonseca, Raquel & Strumpf, Erin, 2020. "Comparing the education gradient in health deterioration among the elderly in six OECD countries," Health Policy, Elsevier, vol. 124(3), pages 326-335.
    7. Duncan Ermini Leaf & Bryan Tysinger & Dana P. Goldman & Darius N. Lakdawalla, 2021. "Predicting quantity and quality of life with the Future Elderly Model," Health Economics, John Wiley & Sons, Ltd., vol. 30(S1), pages 52-79, November.
    8. Silvia Balia, 2014. "Survival expectations, subjective health and smoking: evidence from SHARE," Empirical Economics, Springer, vol. 47(2), pages 753-780, September.
    9. Chen, Cynthia & Lim, Jue Tao & Chia, Ngee Choon & Wang, Lijia & Tysinger, Bryan & Zissimopoulos, Julie & Chong, Ming Zhe & Wang, Zhe & Koh, Gerald Choon Huat & Yuan, Jian-Min & Tan, Kelvin Bryan & Chi, 2019. "The long-term impact of functional disability on hospitalization spending in Singapore," The Journal of the Economics of Ageing, Elsevier, vol. 14(C).
    10. Daniel Bauer & Darius Lakdawalla & Julian Reif, 2018. "Mortality Risk, Insurance, and the Value of Life," NBER Working Papers 25055, National Bureau of Economic Research, Inc.

  29. Goldman, Dana & Smith, James P., 2011. "The increasing value of education to health," Social Science & Medicine, Elsevier, vol. 72(10), pages 1728-1737, May.

    Cited by:

    1. Guy Lacroix & Francois Lalibertée-Auger & Pierre-Carl Michaud & Daniel Parent, 2018. "The Effect of College Education on Health and Mortality: Evidence from Canada," Cahiers de recherche 1820, Centre de recherche sur les risques, les enjeux économiques, et les politiques publiques.
    2. Farrukh Shahzad & Fahad Saleem & Qaiser Iqbal & Naheed Haque & Sajjad Haider & Muhammad Salman & Imran Masood & Mohamed Azmi Hassali & Shehla Iftikhar & Mohammad Bashaar & Tafseera Hashemi, 2018. "A Cross-Sectional Assessment of Health Literacy among Hypertensive Community of Quetta City, Pakistan," Biomedical Journal of Scientific & Technical Research, Biomedical Research Network+, LLC, vol. 11(4), pages 8685-8693, December.
    3. Dana P. Goldman & Peter R. Orszag, 2014. "The Growing Gap in Life Expectancy: Using the Future Elderly Model to Estimate Implications for Social Security and Medicare," American Economic Review, American Economic Association, vol. 104(5), pages 230-233, May.
    4. Mazzonna, Fabrizio, 2014. "The long lasting effects of education on old age health: Evidence of gender differences," Social Science & Medicine, Elsevier, vol. 101(C), pages 129-138.
    5. Perelman, Julian, 2014. "Are chronic diseases related to height? Results from the Portuguese National Health Interview Survey," Economics & Human Biology, Elsevier, vol. 15(C), pages 56-66.
    6. Setti Rais Ali & Paul Dourgnon & Lise Rochaix, 2018. "Social Capital or Education: What Matters Most to Cut Time to Diagnosis?," PSE Working Papers halshs-01703170, HAL.
    7. Sanders, Jane E. & Fallon, Barbara, 2018. "Child welfare involvement and academic difficulties: Characteristics of children, families, and households involved with child welfare and experiencing academic difficulties," Children and Youth Services Review, Elsevier, vol. 86(C), pages 98-109.
    8. Vincenzo Atella & Dana Goldman & Daniel McFadden, 2021. "Disparate ageing: The role of education and socioeconomic gradients in future health and disability in an international context," Health Economics, John Wiley & Sons, Ltd., vol. 30(S1), pages 3-10, November.
    9. Aidan R. Vining & David L. Weimer, 2019. "The Value of High School Graduation in the United States: Per-Person Shadow Price Estimates for Use in Cost–Benefit Analysis," Administrative Sciences, MDPI, vol. 9(4), pages 1-15, October.
    10. Ameed Saabneh, 2015. "Ethnic Health Inequalities in Unequal Societies: Morbidity Gaps Between Palestinians and Jews in Israel," European Journal of Population, Springer;European Association for Population Studies, vol. 31(4), pages 445-466, October.
    11. Guy Lacroix & François Laliberté-Auger & Pierre-Carl Michaud & Daniel Parent, 2018. "The Effect of College Education on Health and Mortality: Evidence from Canada," CIRANO Working Papers 2018s-41, CIRANO.
    12. Ma, Yuanyuan & Nolan, Anne & Smith, James P., 2018. "The value of education to health: Evidence from Ireland," Economics & Human Biology, Elsevier, vol. 31(C), pages 14-25.
    13. Clifford, Brendan & Wilson, Andrew & Harris, Patrick, 2019. "Homelessness, health and the policy process: A literature review," Health Policy, Elsevier, vol. 123(11), pages 1125-1132.

  30. Goldman Dana P & Zissimopoulos Julie & Lu Yang, 2011. "Medical Expenditure Measures in the Health and Retirement Study," Forum for Health Economics & Policy, De Gruyter, vol. 14(2), pages 1-33, April.

    Cited by:

    1. Zissimopoulos Julie & Crimmins Eileen & St.Clair Patricia, 2015. "The Value of Delaying Alzheimer’s Disease Onset," Forum for Health Economics & Policy, De Gruyter, vol. 18(1), pages 25-39, January.
    2. Joelle H Fong, 2019. "Out-of-pocket health spending among Medicare beneficiaries: Which chronic diseases are most costly?," PLOS ONE, Public Library of Science, vol. 14(9), pages 1-16, September.

  31. John A. Romley & Dana P. Goldman, 2011. "How Costly is Hospital Quality? A Revealed‐Preference Approach," Journal of Industrial Economics, Wiley Blackwell, vol. 59(4), pages 578-608, December.
    See citations under working paper version above.
  32. Katherine Baicker & Dana Goldman, 2011. "Patient Cost-Sharing and Healthcare Spending Growth," Journal of Economic Perspectives, American Economic Association, vol. 25(2), pages 47-68, Spring.

    Cited by:

    1. Jesse Bump & Susan Sparkes & Mehtap Tatar & Yusuf Celik & Meltem Aran & Claudia Rokx, 2014. "Turkey On The Way Of Universal Health Coverage Through The Health Transformation Program (2003-13)," Health, Nutrition and Population (HNP) Discussion Paper Series 93172, The World Bank.
    2. Mark Stabile & Sarah Thomson, 2014. "The Changing Role of Government in Financing Health Care: An International Perspective," Journal of Economic Literature, American Economic Association, vol. 52(2), pages 480-518, June.
    3. Minke Remmerswaal & Jan Boone & Michiel Bijlsma & Rudy Douven, 2017. "Cost-Sharing Design Matters: A Comparison of the Rebate and Deductible in Healthcare," CPB Discussion Paper 367, CPB Netherlands Bureau for Economic Policy Analysis.
    4. Gruber, Jonathan & Maclean, J. Catherine & Wright, Bill & Wilkinson, Eric & Volpp, Kevin G., 2017. "The Impact of Increased Cost-Sharing on Utilization of Low Value Services: Evidence from the State of Oregon," IZA Discussion Papers 10477, Institute of Labor Economics (IZA).
    5. Kuhn, Michael & Prettner, Klaus, 2013. "Growth and Welfare Effects of Health Care in Knowledge Based Economies," VfS Annual Conference 2013 (Duesseldorf): Competition Policy and Regulation in a Global Economic Order 79970, Verein für Socialpolitik / German Economic Association.
    6. Hossein, Zare & Gerard, Anderson, 2013. "Trends in cost sharing among selected high income countries—2000–2010," Health Policy, Elsevier, vol. 112(1), pages 35-44.
    7. Nicolas Ziebarth, 2014. "Assessing the effectiveness of health care cost containment measures: evidence from the market for rehabilitation care," International Journal of Health Economics and Management, Springer, vol. 14(1), pages 41-67, March.
    8. Paula González, 2020. "On the design of equity-oriented pharmaceutical copayments," SERIEs: Journal of the Spanish Economic Association, Springer;Spanish Economic Association, vol. 11(2), pages 179-202, June.
    9. Chung Jen Yang & Ying Che Tsai & Joseph J. Tien, 2017. "The Impacts of Persistent Behaviour and Cost-Sharing Policy on Demand for Outpatient Visits by the Elderly: Evidence from Taiwan’s National Health Insurance," The Geneva Papers on Risk and Insurance - Issues and Practice, Palgrave Macmillan;The Geneva Association, vol. 42(1), pages 31-52, January.
    10. Baird, Katherine Elizabeth, 2016. "The incidence of high medical expenses by health status in seven developed countries," Health Policy, Elsevier, vol. 120(1), pages 26-34.
    11. Brosig-Koch , Jeannette & Hennig-Schmidt , Heike & Kairies-Schwarz, Nadja & Wiesen, Daniel, 2014. "Using artefactual field and lab experiments to investigate how fee-for-service and capitation affect medical service provision," HERO Online Working Paper Series 2014:3, University of Oslo, Health Economics Research Programme.
    12. Remmerswaal, Minke & Boone, Jan & Bijlsma, Michiel & Douven, Rudy, 2019. "Cost-sharing design matters: A comparison of the rebate and deductible in healthcare," Journal of Public Economics, Elsevier, vol. 170(C), pages 83-97.
    13. Boone, Jan & Remmerswaal, Minke & Bijlsma, Michiel & Douven, Rudy, 2017. "Cost-Sharing Design Matters: A Comparison of the Rebate and Deductible in Healthcare," CEPR Discussion Papers 12507, C.E.P.R. Discussion Papers.
    14. Marika Cabral & Mark R. Cullen, 2017. "The Effect Of Insurance Coverage On Preventive Care," Economic Inquiry, Western Economic Association International, vol. 55(3), pages 1452-1467, July.
    15. Remmerswaal, Minke & Boone, Jan & Bijlsma, Michiel & Douven, R.C.M.H., 2017. "Cost-Sharing Design Matters : A Comparison of the Rebate and Deductible in Healthcare," Other publications TiSEM 67163c04-3d3b-499c-882c-d, Tilburg University, School of Economics and Management.
    16. Takaku, Reo, 2017. "The Effect Of Patient Cost Sharing On Health Care Utilization Among Low-Income Children," Hitotsubashi Journal of Economics, Hitotsubashi University, vol. 58(1), pages 69-88, June.
    17. Suppliet, Moritz & Herr, Annika, 2016. "Cost-Sharing and Drug Pricing Strategies : Introducing Tiered Co-Payments in Reference Price Markets," Other publications TiSEM 6430293b-fde9-4f91-ab35-3, Tilburg University, School of Economics and Management.
    18. Remmerswaal, Minke & Boone, Jan & Bijlsma, Michiel & Douven, R.C.M.H., 2017. "Cost-Sharing Design Matters : A Comparison of the Rebate and Deductible in Healthcare," Other publications TiSEM 624251d4-89fb-4c0b-8dd1-f, Tilburg University, School of Economics and Management.
    19. Ana Aizcorbe & Tina Highfill, 2015. "Medical Care Expenditure Indexes for the US, 1980-2006," BEA Working Papers 0121, Bureau of Economic Analysis.
    20. Takaku, Reo, 2016. "Effects of reduced cost-sharing on children's health: Evidence from Japan," Social Science & Medicine, Elsevier, vol. 151(C), pages 46-55.
    21. Ma, Yuanyuan & Nolan, Anne & Smith, James P., 2020. "Free GP care and psychological health: Quasi-experimental evidence from Ireland," Journal of Health Economics, Elsevier, vol. 72(C).
    22. Helmchen Lorens A. & Encinosa William E. & Chernew Michael E. & Hirth Richard A., 2013. "Integrating Patient Incentives with Episode-Based Payment," Forum for Health Economics & Policy, De Gruyter, vol. 16(1), pages 123-136, May.
    23. Brosig-Koch, Jeannette & Hennig-Schmidt, Heike & Kairies-Schwarz, Nadja & Wiesen, Daniel, 2015. "The Effects of Introducing Mixed Payment Systems for Physicians – Experimental Evidence," Ruhr Economic Papers 543, RWI - Leibniz-Institut für Wirtschaftsforschung, Ruhr-University Bochum, TU Dortmund University, University of Duisburg-Essen.
    24. Maurizio Bussolo & Johannes Koettl & Emily Sinnott, 2015. "Golden Aging," World Bank Publications - Books, The World Bank Group, number 22018.
    25. David Powell & Dana Goldman, 2016. "Disentangling Moral Hazard and Adverse Selection in Private Health Insurance," NBER Working Papers 21858, National Bureau of Economic Research, Inc.
    26. Hirotaka Kato & Rei Goto & Taishi Tsuji & Katsunori Kondo, 2022. "The effects of patient cost-sharing on health expenditure and health among older people: Heterogeneity across income groups," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 23(5), pages 847-861, July.
    27. Toshiaki Iizuka & Hitoshi Shigeoka, 2018. "Free for Children? Patient Cost-sharing and Healthcare Utilization," NBER Working Papers 25306, National Bureau of Economic Research, Inc.
    28. Remmerswaal, Minke & Boone, Jan & Bijlsma, Michiel & Douven, R.C.M.H., 2017. "Cost-Sharing Design Matters : A Comparison of the Rebate and Deductible in Healthcare," Discussion Paper 2017-039, Tilburg University, Tilburg Law and Economic Center.
    29. Lütkemeyer, Daniel & Heese, H. Sebastian & Wuttke, David A., 2021. "Overcoming inefficiencies in the development of personalized medicine," European Journal of Operational Research, Elsevier, vol. 290(1), pages 278-296.
    30. Jeffrey Clemens, 2012. "The Effect of U.S. Health Insurance Expansions on Medical Innovation," Discussion Papers 11-016, Stanford Institute for Economic Policy Research.
    31. Meltem Aran & Claudia Rokx, 2014. "Turkey on the Way of Universal Health Coverage Through the Health Transformation Program (2003-2013)," Health, Nutrition and Population (HNP) Discussion Paper Series 91326, The World Bank.
    32. Katherine Baicker & Amitabh Chandra, 2011. "Aspirin, angioplasty and proton beam therapy: the economics of smarter health-care spending," Proceedings - Economic Policy Symposium - Jackson Hole, Federal Reserve Bank of Kansas City, pages 197-235.
    33. Chandra, Amitabh & Gruber, Jonathan & McKnight, Robin, 2014. "The impact of patient cost-sharing on low-income populations: Evidence from Massachusetts," Journal of Health Economics, Elsevier, vol. 33(C), pages 57-66.
    34. D. Cattel & R. C. Kleef & R. C. J. A. Vliet, 2017. "A method to simulate incentives for cost containment under various cost sharing designs: an application to a first-euro deductible and a doughnut hole," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 18(8), pages 987-1000, November.
    35. Amitabh Chandra & Jonathan Holmes & Jonathan Skinner, 2013. "Is This Time Different? The Slowdown in Healthcare Spending," Brookings Papers on Economic Activity, Economic Studies Program, The Brookings Institution, vol. 44(2 (Fall)), pages 261-323.
    36. Nilsson, Anton & Paul, Alexander, 2018. "Patient cost-sharing, socioeconomic status, and children's health care utilization," Journal of Health Economics, Elsevier, vol. 59(C), pages 109-124.
    37. Herr, Annika & Suppliet, Moritz, 2012. "Pharmaceutical prices under regulation: Tiered co-payments and reference pricing in Germany," DICE Discussion Papers 48, Heinrich Heine University Düsseldorf, Düsseldorf Institute for Competition Economics (DICE).
    38. Feng Huang & Li Gan`, 2017. "The Impacts of China's Urban Employee Basic Medical Insurance on Healthcare Expenditures and Health Outcomes," Health Economics, John Wiley & Sons, Ltd., vol. 26(2), pages 149-163, February.
    39. Laurence Seidman, 2014. "Medicare For All: A Public Finance Analysis," Working Papers 14-02, University of Delaware, Department of Economics.
    40. Claudio Lucifora & Antonio Russo & Daria Vigani, 2021. "Does prescribing appropriateness reduce health expenditures? Main effects and unintended outcomes," DISCE - Working Papers del Dipartimento di Economia e Finanza def103, Università Cattolica del Sacro Cuore, Dipartimenti e Istituti di Scienze Economiche (DISCE).
    41. Brosig-Koch, Jeannette & Hennig-Schmidt, Heike & Kairies-Schwarz, Nadja & Wiesen, Daniel, 2016. "Physician performance pay: Evidence from a laboratory experiment," Ruhr Economic Papers 658, RWI - Leibniz-Institut für Wirtschaftsforschung, Ruhr-University Bochum, TU Dortmund University, University of Duisburg-Essen.
    42. Paul, Alexander & Nilsson, Anton, 2014. "The Effect of Copayments on Children's and Adolescents' Demand for Medical Care," VfS Annual Conference 2014 (Hamburg): Evidence-based Economic Policy 100403, Verein für Socialpolitik / German Economic Association.
    43. SeungHoon Han & Hosung Sohn, 2023. "The short-term effects of fixed copayment policy on elderly health spending and service utilization: evidence from South Korea’s age-based policy using exact date of birth," International Journal of Health Economics and Management, Springer, vol. 23(2), pages 255-279, June.
    44. Brosig-Koch, Jeannette & Groß, Mona & Hennig-Schmidt, Heike & Kairies-Schwarz, Nadja & Wiesen, Daniel, 2021. "Physicians' incentives, patients' characteristics, and quality of care: A systematic experimental comparison of fee-for-service, capitation, and pay for performance," Ruhr Economic Papers 923, RWI - Leibniz-Institut für Wirtschaftsforschung, Ruhr-University Bochum, TU Dortmund University, University of Duisburg-Essen.
    45. Lopes, Francisca Vargas & Riumallo Herl, Carlos J. & Mackenbach, Johan P. & Van Ourti, Tom, 2022. "Patient cost-sharing, mental health care and inequalities: A population-based natural experiment at the transition to adulthood," Social Science & Medicine, Elsevier, vol. 296(C).
    46. Remmerswaal, Minke & Boone, Jan & Douven, Rudy, 2023. "Minimum generosity levels in a competitive health insurance market," Journal of Health Economics, Elsevier, vol. 90(C).
    47. Jaume Puig-Junoy & Pilar Garcia-Gomez & David Casado-Marin, 2011. "Free Medicines thanks to Retirement: Moral Hazard and Hospitalization Offsets in an NHS," Tinbergen Institute Discussion Papers 11-108/3, Tinbergen Institute.
    48. Simona Gamba & Niklas Jakobsson & Mikael Svensson, 2022. "The impact of cost-sharing on prescription drug demand: evidence from a double-difference regression kink design," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 23(9), pages 1591-1599, December.
    49. Laurence Seidman, 2013. "Medicare for All," Challenge, Taylor & Francis Journals, vol. 56(1), pages 88-115.
    50. Cheolmin Kang & Akira Kawamura & Haruko Noguchi, 2019. "Does Free Healthcare Affect Children's Healthcare Use and Outcomes?," Working Papers 1914, Waseda University, Faculty of Political Science and Economics.
    51. Fukushima, Kazuya & Mizuoka, Sou & Yamamoto, Shunsuke & Iizuka, Toshiaki, 2016. "Patient cost sharing and medical expenditures for the Elderly," Journal of Health Economics, Elsevier, vol. 45(C), pages 115-130.
    52. Kang, Cheolmin & Kawamura, Akira & Noguchi, Haruko, 2022. "Does free healthcare improve children's healthcare use and outcomes? Evidence from Japan's healthcare subsidy for young children," Journal of Economic Behavior & Organization, Elsevier, vol. 202(C), pages 372-406.
    53. Naimi Johansson & Niklas Jakobsson & Mikael Svensson, 2019. "Effects of primary care cost-sharing among young adults: varying impact across income groups and gender," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(8), pages 1271-1280, November.
    54. Brosig-Koch, Jeannette & Hennig-Schmidt, Heike & Kairies-Schwarz, Nadja & Kokot, Johanna & Wiesen, Daniel, 2020. "Physician performance pay: Experimental evidence," HERO Online Working Paper Series 2020:3, University of Oslo, Health Economics Research Programme.
    55. Marco A. Castaneda & Meryem Saygili, 2021. "The effects of health insurance on the choice of medical procedures: Evidence from heart attacks and childbirths," International Journal of Health Planning and Management, Wiley Blackwell, vol. 36(5), pages 1626-1652, September.
    56. Kyle, Margaret K., 2022. "Incentives for pharmaceutical innovation: What’s working, what’s lacking," International Journal of Industrial Organization, Elsevier, vol. 84(C).
    57. Brenna, Elenka & Giammanco, Maria Daniela, 2024. "The use of voluntary health insurance in the access to specialist care: Evidence from the Italian NHS," Socio-Economic Planning Sciences, Elsevier, vol. 93(C).

  33. Dana P. Goldman & Geoffrey F. Joyce & William B. Vogt, 2011. "Part D Formulary and Benefit Design as a Risk-Steering Mechanism," American Economic Review, American Economic Association, vol. 101(3), pages 382-386, May.

    Cited by:

    1. Jeffrey R. Kling & Sendhil Mullainathan & Eldar Shafir & Lee Vermeulen & Marian Wrobel, 2011. "Comparison Friction: Experimental Evidence from Medicare Drug Plans," NBER Working Papers 17410, National Bureau of Economic Research, Inc.

  34. Tomas J. Philipson & Seth A. Seabury & Lee M. Lockwood & Dana P. Goldman & Darius N. Lakdawalla, 2010. "Geographic Variation in Health Care: The Role of Private Markets," Brookings Papers on Economic Activity, Economic Studies Program, The Brookings Institution, vol. 41(1 (Spring), pages 325-361.

    Cited by:

    1. Thomas M. Selden & Zeynal Karaca & Sandra Decker, 2018. "Has inpatient hospital treatment before and after age 65 changed as the difference between private and Medicare payment rates has widened?," International Journal of Health Economics and Management, Springer, vol. 18(4), pages 409-423, December.
    2. Vilsa Curto & Liran Einav & Amy Finkelstein & Jonathan D. Levin & Jay Bhattacharya, 2017. "Healthcare Spending and Utilization in Public and Private Medicare," NBER Working Papers 23090, National Bureau of Economic Research, Inc.
    3. Nathan E. Wilson, 2016. "For-profit status and industry evolution in health care markets: evidence from the dialysis industry," International Journal of Health Economics and Management, Springer, vol. 16(4), pages 297-319, December.
    4. Dizioli, Allan & Pinheiro, Roberto B., 2012. "Health insurance as a productive factor," MPRA Paper 39743, University Library of Munich, Germany.
    5. Zach Y. Brown, 2019. "Equilibrium Effects of Health Care Price Information," The Review of Economics and Statistics, MIT Press, vol. 101(4), pages 699-712, October.
    6. David Molitor, 2018. "The Evolution of Physician Practice Styles: Evidence from Cardiologist Migration," American Economic Journal: Economic Policy, American Economic Association, vol. 10(1), pages 326-356, February.
    7. Amy Finkelstein & Matthew Gentzkow & Heidi Williams, 2016. "Sources of Geographic Variation in Health Care: Evidence From PatientMigration," The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 131(4), pages 1681-1726.
    8. Deborah Peikes & Stacy Dale & Eric Lundquist & Janice Genevro & David Meyers, 2011. "Building the Evidence Base for the Medical Home: What Sample and Sample Size Do Studies Need?," Mathematica Policy Research Reports 5814eb8219b24982af7f7536c, Mathematica Policy Research.
    9. Lakomaa, Erik & Sanandaji, Tino, 2017. "Integrating community driven care service in European welfare states – nonprofit institutional entrepreneurship as driver for expanding access," SSE Working Paper Series in Economic History 2017:5, Stockholm School of Economics.
    10. Zack Cooper & Stuart Craig & Martin Gaynor & John Van Reenen, 2015. "The Price Ain't Right? Hospital Prices and Health Spending on the Privately Insured," CEP Discussion Papers dp1395, Centre for Economic Performance, LSE.
    11. Anna A. Levine Taub & Anton Kolotilin & Robert S. Gibbons & Ernst R. Berndt, 2011. "The Diversity of Concentrated Prescribing Behavior: An Application to Antipsychotics," NBER Working Papers 16823, National Bureau of Economic Research, Inc.
    12. Priyanka Anand, 2017. "Health Insurance Costs and Employee Compensation: Evidence from the National Compensation Survey," Health Economics, John Wiley & Sons, Ltd., vol. 26(12), pages 1601-1616, December.
    13. Thierry Nianogo & Albert Okunade & Demba Fofana & Weiwei Chen, 2016. "Determinants of US Prescription Drug Utilization using County Level Data," Health Economics, John Wiley & Sons, Ltd., vol. 25(5), pages 606-619, May.

  35. Daniella Perlroth & Dana Goldman & Alan Garber, 2010. "The potential impact of comparative effectiveness research on U.S. Health Care expenditures," Demography, Springer;Population Association of America (PAA), vol. 47(1), pages 173-190, March.

    Cited by:

    1. David M. Cutler, 2011. "Where Are the Health Care Entrepreneurs? The Failure of Organizational Innovation in Health Care," NBER Chapters, in: Innovation Policy and the Economy, Volume 11, pages 1-28, National Bureau of Economic Research, Inc.
    2. Titus J. Galama & Patrick Hullegie & Erik Meijer & Sarah Outcault, 2012. "Is There Empirical Evidence For Decreasing Returns To Scale In A Health Capital Model?," Health Economics, John Wiley & Sons, Ltd., vol. 21(9), pages 1080-1100, September.
    3. Mousnad, Mohamed Awad & Shafie, Asrul Akmal & Ibrahim, Mohamed Izham, 2014. "Systematic review of factors affecting pharmaceutical expenditures," Health Policy, Elsevier, vol. 116(2), pages 137-146.
    4. Hullegie, P.G.J., 2012. "Essays on health and labor economics," Other publications TiSEM dcc68fc9-7af1-4ba9-8f90-6, Tilburg University, School of Economics and Management.
    5. Katherine Baicker & Sendhil Mullainathan & Joshua Schwartzstein, 2012. "Behavioral Hazard in Health Insurance," NBER Working Papers 18468, National Bureau of Economic Research, Inc.
    6. Helmchen Lorens A. & Encinosa William E. & Chernew Michael E. & Hirth Richard A., 2013. "Integrating Patient Incentives with Episode-Based Payment," Forum for Health Economics & Policy, De Gruyter, vol. 16(1), pages 123-136, May.
    7. Amitabh Chandra & Anupam B. Jena & Jonathan S. Skinner, 2011. "The Pragmatist's Guide to Comparative Effectiveness Research," Journal of Economic Perspectives, American Economic Association, vol. 25(2), pages 27-46, Spring.
    8. David M. Cutler, 2011. "Where Are the Health Care Entrepreneurs? The Failure of Organizational Innovation in Health Care," Innovation Policy and the Economy, University of Chicago Press, vol. 11(1), pages 1-28.
    9. Titus Galama & Patrick Hullegie & Erik Meijer & Sarah Outcault, 2012. "Empirical Evidence for Decreasing Returns to Scale in a Health Capital Model," Working Papers WR-928, RAND Corporation.
    10. Cutler, David M., 2010. "Where Are the Health Care Entrepreneurs? The Failure of Organizational Innovation in Health Care," Scholarly Articles 5345877, Harvard University Department of Economics.
    11. Mortimer, Duncan & Peacock, Stuart, 2012. "Social welfare and the Affordable Care Act: Is it ever optimal to set aside comparative cost?," Social Science & Medicine, Elsevier, vol. 75(7), pages 1156-1162.

  36. Baoping Shang & Dana Goldman, 2010. "Prescription Drug Coverage and Medicare Spending among U.S. Elderly*," The Geneva Papers on Risk and Insurance - Issues and Practice, Palgrave Macmillan;The Geneva Association, vol. 35(4), pages 539-567, October.

    Cited by:

    1. Allin, Sara & Law, Michael R. & Laporte, Audrey, 2013. "How does complementary private prescription drug insurance coverage affect seniors’ use of publicly funded medications?," Health Policy, Elsevier, vol. 110(2), pages 147-155.

  37. Lakdawalla, Darius N. & Sun, Eric C. & Jena, Anupam B. & Reyes, Carolina M. & Goldman, Dana P. & Philipson, Tomas J., 2010. "An economic evaluation of the war on cancer," Journal of Health Economics, Elsevier, vol. 29(3), pages 333-346, May.
    See citations under working paper version above.
  38. Adeline Delavande & Dana Goldman & Neeraj Sood, 2010. "Criminal Prosecution and Human Immunodeficiency Virus-Related Risky Behavior," Journal of Law and Economics, University of Chicago Press, vol. 53(4), pages 741-782.

    Cited by:

    1. Francis, Andrew M. & Mialon, Hugo M. & Peng, Handie, 2012. "In sickness and in health: Same-sex marriage laws and sexually transmitted infections," Social Science & Medicine, Elsevier, vol. 75(8), pages 1329-1341.
    2. M. V. Lee Badgett & Christopher S. Carpenter & Maxine J. Lee & Dario Sansone, 2024. "A Review of the Economics of Sexual Orientation and Gender Identity," Journal of Economic Literature, American Economic Association, vol. 62(3), pages 948-994, September.

  39. Sun Eric & Jena Anupam B & Lakdawalla Darius & Reyes Carolina & Philipson Tomas J & Goldman Dana, 2010. "The Contributions of Improved Therapy and Earlier Detection to Cancer Survival Gains, 1988-2000," Forum for Health Economics & Policy, De Gruyter, vol. 13(2), pages 1-22, February.

    Cited by:

    1. Eric C. Sun & Anupam B. Jena & Darius N. Lakdawalla & Carolina M. Reyes & Tomas J. Philipson & Dana P. Goldman, 2009. "An Economic Evaluation of the War on Cancer," NBER Working Papers 15574, National Bureau of Economic Research, Inc.
    2. Fatih Safa Erenay & Oguzhan Alagoz & Ritesh Banerjee & Robert R. Cima, 2011. "Estimating the Unknown Parameters of the Natural History of Metachronous Colorectal Cancer Using Discrete-Event Simulation," Medical Decision Making, , vol. 31(4), pages 611-624, July.
    3. Adam Leive & Thomas Stratmann, 2015. "Do national cancer screening guidelines reduce mortality?," Journal of Population Economics, Springer;European Society for Population Economics, vol. 28(4), pages 1075-1095, October.
    4. David H. Howard & Peter B. Bach & Ernst R. Berndt & Rena M. Conti, 2015. "Pricing in the Market for Anticancer Drugs," NBER Working Papers 20867, National Bureau of Economic Research, Inc.
    5. Seabury Seth A. & Goldman Dana P. & Gupta Charu N. & Khan Zeba M. & Chandra Amitabh & Philipson Tomas J. & Lakdawalla Darius N., 2016. "Quantifying Gains in the War on Cancer Due to Improved Treatment and Earlier Detection," Forum for Health Economics & Policy, De Gruyter, vol. 19(1), pages 141-156, June.

  40. Dana Goldman & Darius Lakdawalla & Tomas J. Philipson & Wesley Yin, 2010. "Erratum: Valuing health technologies at NICE: recommendations for improved incorporation of treatment value in HTA," Health Economics, John Wiley & Sons, Ltd., vol. 19(12), pages 1510-1510, December.

    Cited by:

    1. Ake Blomqvist & Colin Busby & Don Husereau, 2013. "Capturing Value from Health Technologies in Lean Times," C.D. Howe Institute Commentary, C.D. Howe Institute, issue 396, December.
    2. Goldman Dana P. & Lakdawalla Darius N. & Baumgardner James R. & Linthicum Mark T., 2016. "Are Biopharmaceutical Budget Caps Good Public Policy?," The Economists' Voice, De Gruyter, vol. 13(1), pages 27-42, December.
    3. Andrew Briggs, 2016. "A View from the Bridge: Health Economic Evaluation — A Value‐Based Framework?," Health Economics, John Wiley & Sons, Ltd., vol. 25(12), pages 1499-1502, December.
    4. Ulucanlar, S. & Faulkner, A. & Peirce, S. & Elwyn, G., 2013. "Technology identity: The role of sociotechnical representations in the adoption of medical devices," Social Science & Medicine, Elsevier, vol. 98(C), pages 95-105.
    5. Aris Angelis & Ansgar Lange & Panos Kanavos, 2018. "Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(1), pages 123-152, January.

  41. Goldman, Dana & Michaud, Pierre-Carl & Lakdawalla, Darius & Zheng, Yuhui & Gailey, Adam & Vaynman, Igor, 2010. "The Fiscal Consequences of Trends in Population Health," National Tax Journal, National Tax Association;National Tax Journal, vol. 63(2), pages 307-330, June.

    Cited by:

    1. Vincenzo Atella & Federico Belotti & Daejung Kim & Dana Goldman & Tadeja Gracner & Andrea Piano Mortari & Bryan Tysinger, 2021. "The future of the elderly population health status: Filling a knowledge gap," Health Economics, John Wiley & Sons, Ltd., vol. 30(S1), pages 11-29, November.
    2. Joachim Winter & Amelie C. Wuppermann, 2012. "Do they Know what's at Risk? Health Risk Perception among the Obese," CESifo Working Paper Series 3864, CESifo.
    3. Pierre-Carl Michaud & Dana Goldman & Darius Lakdawalla & Yuhui Zhen & Adam H. Gailey, 2011. "The Value of Medican and Pharmaceutical Interventions for Reducing Obesity," Cahiers de recherche 1109, CIRPEE.
    4. Michaud, Pierre-Carl & Goldman, Dana & Lakdawalla, Darius & Gailey, Adam & Zheng, Yuhui, 2011. "Differences in health between Americans and Western Europeans: Effects on longevity and public finance," Social Science & Medicine, Elsevier, vol. 73(2), pages 254-263, July.
    5. Pi Alperin, María Noel & Perquin, Magali & Giordana, Gastón A., 2024. "Population ageing and public finance burden of dementia: Micro-simulations evaluating risk factors, treatments and comorbidities in Luxembourg," The Journal of the Economics of Ageing, Elsevier, vol. 28(C).
    6. Mark P. Connolly & Nikolaos Kotsopoulos & Aomesh Bhatt & Maarten J. Postma, 2019. "Sustainability of public finances: inclusion of unrelated medical cost only part of the story," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(8), pages 1281-1282, November.
    7. Daniel Bauer & Darius Lakdawalla & Julian Reif, 2018. "Mortality Risk, Insurance, and the Value of Life," NBER Working Papers 25055, National Bureau of Economic Research, Inc.

  42. Dana Goldman & Darius Lakdawalla & Tomas J. Philipson & Wesley Yin, 2010. "Valuing health technologies at nice: recommendations for improved incorporation of treatment value in HTA," Health Economics, John Wiley & Sons, Ltd., vol. 19(10), pages 1109-1116, October.

    Cited by:

    1. Ake Blomqvist & Colin Busby & Don Husereau, 2013. "Capturing Value from Health Technologies in Lean Times," C.D. Howe Institute Commentary, C.D. Howe Institute, issue 396, December.
    2. Goldman Dana P. & Lakdawalla Darius N. & Baumgardner James R. & Linthicum Mark T., 2016. "Are Biopharmaceutical Budget Caps Good Public Policy?," The Economists' Voice, De Gruyter, vol. 13(1), pages 27-42, December.
    3. Andrew Briggs, 2016. "A View from the Bridge: Health Economic Evaluation — A Value‐Based Framework?," Health Economics, John Wiley & Sons, Ltd., vol. 25(12), pages 1499-1502, December.
    4. Ulucanlar, S. & Faulkner, A. & Peirce, S. & Elwyn, G., 2013. "Technology identity: The role of sociotechnical representations in the adoption of medical devices," Social Science & Medicine, Elsevier, vol. 98(C), pages 95-105.
    5. Nord, Erik & Johansen, Rune, 2014. "Concerns for severity in priority setting in health care: A review of trade-off data in preference studies and implications for societal willingness to pay for a QALY," Health Policy, Elsevier, vol. 116(2), pages 281-288.
    6. Aris Angelis & Ansgar Lange & Panos Kanavos, 2018. "Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(1), pages 123-152, January.

  43. Goldman, D.P. & Zheng, Y. & Girosi, F. & Michaud, P.-C. & Olshansky, S.J. & Cutler, D. & Rowe, J.W., 2009. "The benefits of risk factor prevention in Americans aged 51 years and older," American Journal of Public Health, American Public Health Association, vol. 99(11), pages 2096-2101.

    Cited by:

    1. Vincenzo Atella & Federico Belotti & Daejung Kim & Dana Goldman & Tadeja Gracner & Andrea Piano Mortari & Bryan Tysinger, 2021. "The future of the elderly population health status: Filling a knowledge gap," Health Economics, John Wiley & Sons, Ltd., vol. 30(S1), pages 11-29, November.
    2. Datta Gupta, Nabanita & Kleinjans, Kristin J. & Larsen, Mona, 2011. "The Effect of an Acute Health Shock on Work Behavior: Evidence from Different Health Care Regimes," IZA Discussion Papers 5843, Institute of Labor Economics (IZA).
    3. Abbygail Jaccard & Lise Retat & Martin Brown & Laura Webber & Zaid Chalabi, 2018. "Global Sensitivity Analysis of a Model Simulating an Individual’s Health State through Their Lifetime," International Journal of Microsimulation, International Microsimulation Association, vol. 11(3), pages 100-121.
    4. Pierre-Carl Michaud & Dana Goldman & Darius Lakdawalla & Yuhui Zhen & Adam H. Gailey, 2011. "The Value of Medican and Pharmaceutical Interventions for Reducing Obesity," Cahiers de recherche 1109, CIRPEE.
    5. Jinjing Li & Cathal O'Donoghue, 2013. "A survey of dynamic microsimulation models: uses, model structure and methodology," International Journal of Microsimulation, International Microsimulation Association, vol. 6(2), pages 3-55.
    6. Michaud, Pierre-Carl & Goldman, Dana & Lakdawalla, Darius & Gailey, Adam & Zheng, Yuhui, 2011. "Differences in health between Americans and Western Europeans: Effects on longevity and public finance," Social Science & Medicine, Elsevier, vol. 73(2), pages 254-263, July.
    7. Daniel Bauer & Darius Lakdawalla & Julian Reif, 2018. "Mortality Risk, Insurance, and the Value of Life," NBER Working Papers 25055, National Bureau of Economic Research, Inc.
    8. Julia Thornton Snider & Jeffrey Sullivan & Emma van Eijndhoven & Michael K Hansen & Nobel Bellosillo & Cheryl Neslusan & Ellen O’Brien & Ralph Riley & Seth Seabury & Bertram L Kasiske, 2019. "Lifetime benefits of early detection and treatment of diabetic kidney disease," PLOS ONE, Public Library of Science, vol. 14(5), pages 1-13, May.

  44. Bhattacharya, Jay & Goldman, Dana & Sood, Neeraj, 2009. "Market evidence of misperceived mortality risk," Journal of Economic Behavior & Organization, Elsevier, vol. 72(1), pages 451-462, October.

    Cited by:

    1. Carmelo Giaccotto & Joseph Golec & Bryan P. Schmutz, 2017. "Measuring the Performance of the Secondary Market for Life Insurance Policies," Journal of Risk & Insurance, The American Risk and Insurance Association, vol. 84(1), pages 127-151, March.
    2. Bago d'Uva, Teresa & O'Donnell, Owen & van Doorslaer, Eddy, 2020. "Who can predict their own demise? Heterogeneity in the accuracy and value of longevity expectations☆," The Journal of the Economics of Ageing, Elsevier, vol. 17(C).
    3. Innocenti, Stefania & Clark, Gordon L. & McGill, Sarah & Cuñado, Juncal, 2019. "The effect of past health events on intentions to purchase insurance: Evidence from 11 countries," Journal of Economic Psychology, Elsevier, vol. 74(C).
    4. Post, Thomas & Hanewald, Katja, 2010. "Stochastic mortality, subjective survival expectations, and individual saving behavior," SFB 649 Discussion Papers 2010-040, Humboldt University Berlin, Collaborative Research Center 649: Economic Risk.

  45. Goldman Dana P & McFadden Daniel L, 2008. "Want to Monitor Medicare's New Drug Benefit Program? Start by Sending a Check for $120,000," The Economists' Voice, De Gruyter, vol. 5(4), pages 1-4, July.

    Cited by:

    1. Jonathan D. Ketcham & Claudio Lucarelli & Eugenio J. Miravete & M. Christopher Roebuck, 2012. "Sinking, Swimming, or Learning to Swim in Medicare Part D," American Economic Review, American Economic Association, vol. 102(6), pages 2639-2673, October.
    2. Yeo, Jungwon & Miller, Daniel P., 2018. "Estimating switching costs with market share data: an application to Medicare Part D," International Journal of Industrial Organization, Elsevier, vol. 61(C), pages 459-501.

  46. Baoping Shang & Dana Goldman, 2008. "Does age or life expectancy better predict health care expenditures?," Health Economics, John Wiley & Sons, Ltd., vol. 17(4), pages 487-501, April.

    Cited by:

    1. Philippe Mossé, 2015. "Caring an ageing population : challenges, facts, artifacts and policies [Cuidado en el contexto de envejecimiento : desafios, hechos, artefactos e politica]," Post-Print hal-01306562, HAL.
    2. Frankovic, Ivan & Kuhn, Michael & Wrzaczek, Stefan, 2017. "Medical progress, demand for health care, and economic performance," ECON WPS - Working Papers in Economic Theory and Policy 08/2017, TU Wien, Institute of Statistics and Mathematical Methods in Economics, Economics Research Unit.
    3. Louise Sheiner, 2009. "Intergenerational aspects of health care," Finance and Economics Discussion Series 2009-38, Board of Governors of the Federal Reserve System (U.S.).
    4. Yu, Tiffany Hui-Kuang & Wang, David Han-Min & Wu, Kuo-Lun, 2015. "Reexamining the red herring effect on healthcare expenditures," Journal of Business Research, Elsevier, vol. 68(4), pages 783-787.
    5. Anthony Webb & Natalia Zhivan, 2010. "How Much Is Enough? The Distribution of Lifetime Health Care Costs," Working Papers, Center for Retirement Research at Boston College wp2010-1, Center for Retirement Research, revised Feb 2010.
    6. S. P. Thi颡ut & T. Barnay & B. Ventelou, 2013. "Ageing, chronic conditions and the evolution of future drugs expenditure: a five-year micro-simulation from 2004 to 2029," Applied Economics, Taylor & Francis Journals, vol. 45(13), pages 1663-1672, May.
    7. Friedrich Breyer & Normann Lorenz & Thomas Niebel, 2012. "Health Care Expenditures and Longevity: Is There a Eubie Blake Effect?," Discussion Papers of DIW Berlin 1226, DIW Berlin, German Institute for Economic Research.
    8. Friedrich Breyer & Normann Lorenz, 2021. "The “red herring” after 20 years: ageing and health care expenditures," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(5), pages 661-667, July.
    9. Stefan Felder, 2013. "The Impact of Demographic Change on Healthcare Expenditure," ifo DICE Report, ifo Institute - Leibniz Institute for Economic Research at the University of Munich, vol. 11(01), pages 03-06, April.
    10. Lindgren, Björn, 2016. "The Rise in Life Expectancy, Health Trends among the Elderly, and the Demand for Health and Social Care," Working Papers 142, National Institute of Economic Research.
    11. Kim Peijnenburg & Theo Nijman & Bas J.M. Werker, 2017. "Health Cost Risk: A Potential Solution to the Annuity Puzzle," Economic Journal, Royal Economic Society, vol. 127(603), pages 1598-1625, August.
    12. Vrhovec, Jure & Tajnikar, Maks, 2016. "Population ageing and healthcare demand: The case of Slovenia," Health Policy, Elsevier, vol. 120(11), pages 1329-1336.
    13. Nisha C. Hazra & Caroline Rudisill & Martin C. Gulliford, 2018. "Determinants of health care costs in the senior elderly: age, comorbidity, impairment, or proximity to death?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(6), pages 831-842, July.
    14. Karlsson, Martin & Klohn, Florian, 2011. "Some notes on how to catch a red herring: Ageing, time-to-death & care costs for older people in Sweden," Darmstadt Discussion Papers in Economics 207, Darmstadt University of Technology, Department of Law and Economics.
    15. Peijnenburg, J.M.J. & Nijman, T.E. & Werker, B.J.M., 2010. "Health Cost Risk and Optimal Retirement Provision : A Simple Rule for Annuity Demand," Other publications TiSEM f178a33d-4386-4036-861f-6, Tilburg University, School of Economics and Management.
    16. Murphy, Michael & Martikainen, Pekka, 2013. "Use of hospital and long-term institutional care services in relation to proximity to death among older people in Finland," Social Science & Medicine, Elsevier, vol. 88(C), pages 39-47.
    17. Santos, João Vasco & Martins, Filipa Santos & Pestana, Joana & Souza, Júlio & Freitas, Alberto & Cylus, Jonathan, 2023. "Should we adjust health expenditure for age structure on health systems efficiency? A worldwide analysis," LSE Research Online Documents on Economics 118298, London School of Economics and Political Science, LSE Library.
    18. Julie Shi & Yi Yao & Gordon Liu, 2018. "Modeling individual health care expenditures in China: Evidence to assist payment reform in public insurance," Health Economics, John Wiley & Sons, Ltd., vol. 27(12), pages 1945-1962, December.
    19. Elena Demuru & Viviana Egidi, 2016. "Adjusting prospective old-age thresholds by health status: empirical findings and implications. A case study of Italy," Vienna Yearbook of Population Research, Vienna Institute of Demography (VID) of the Austrian Academy of Sciences in Vienna, vol. 14(1), pages 131-154.
    20. Caravaggio, Nicola & Resce, Giuliano, 2023. "Enhancing Healthcare Cost Forecasting: A Machine Learning Model for Resource Allocation in Heterogeneous Regions," Economics & Statistics Discussion Papers esdp23090, University of Molise, Department of Economics.
    21. Bjorn Lindgren, 2016. "The Rise in Life Expectancy, Health Trends among the Elderly, and the Demand for Care - A Selected Literature Review," NBER Working Papers 22521, National Bureau of Economic Research, Inc.
    22. Ross Stolzenberg, 2011. "Do Not Go Gentle Into That Good Night: The Effect of Retirement on Subsequent Mortality of U.S. Supreme Court Justices, 1801–2006," Demography, Springer;Population Association of America (PAA), vol. 48(4), pages 1317-1346, November.
    23. Thomas Barnay & Sophie Thiébaut & Bruno Ventelou, 2010. "Ageing, chronic conditions and the evolution of future drugs expenditures," TEPP Working Paper 2010-08, TEPP.
    24. Gielen, Birgit & Remacle, Anne & Mertens, Raf, 2010. "Patterns of health care use and expenditure during the last 6 months of life in Belgium: Differences between age categories in cancer and non-cancer patients," Health Policy, Elsevier, vol. 97(1), pages 53-61, September.
    25. Anne Mason & Idaira Rodriguez Santana & María José Aragón & Nigel Rice & Martin Chalkley & Raphael Wittenberg & Jose-Luis Fernandez, 2019. "Drivers of health care expenditure: Final report," Working Papers 169cherp, Centre for Health Economics, University of York.
    26. Fengping Tian & Jiti Gao & Ke Yang, 2018. "A quantile regression approach to panel data analysis of health‐care expenditure in Organisation for Economic Co‐operation and Development countries," Health Economics, John Wiley & Sons, Ltd., vol. 27(12), pages 1921-1944, December.
    27. Frankovic, Ivan & Kuhn, Michael & Wrzaczek, Stefan, 2016. "Medical care within an OLG economy with realistic demography," ECON WPS - Working Papers in Economic Theory and Policy 02/2016, TU Wien, Institute of Statistics and Mathematical Methods in Economics, Economics Research Unit.
    28. Norton, E.C., 2016. "Health and Long-Term Care," Handbook of the Economics of Population Aging, in: Piggott, John & Woodland, Alan (ed.), Handbook of the Economics of Population Aging, edition 1, volume 1, chapter 0, pages 951-989, Elsevier.
    29. Karlsson, Martin & Klohn, Florian, 2011. "Some notes on how to catch a red herring - Ageing, time-to-death and care costs for older people in Sweden," HERO Online Working Paper Series 2011:6, University of Oslo, Health Economics Research Programme.
    30. Breyer Friedrich, 2015. "Demographischer Wandel und Gesundheitsausgaben: Theorie, Empirie und Politikimplikationen," Perspektiven der Wirtschaftspolitik, De Gruyter, vol. 16(3), pages 215-230, October.
    31. Wildman, John & McMeekin, Peter, 2014. "Health care and social care: complements, substitutes and attributes," MPRA Paper 54425, University Library of Munich, Germany.
    32. Edouard Augustin Ribes, 2023. "Transforming personal finance thanks to artificial intelligence: myth or reality?," Financial Economics Letters, Anser Press, vol. 2(1), pages 11-12, April.
    33. Peijnenburg, J.M.J., 2011. "Consumption, savings, and investments over the life cycle," Other publications TiSEM 53507526-8619-428d-865f-d, Tilburg University, School of Economics and Management.
    34. Weiwei Chen & Albert Okunade & Gregory G. Lubiani, 2014. "Quality–Quantity Decomposition Of Income Elasticity Of U.S. Hospital Care Expenditure Using State‐Level Panel Data," Health Economics, John Wiley & Sons, Ltd., vol. 23(11), pages 1340-1352, November.
    35. Laudicella, Mauro & Di Donni, Paolo & Rose Olsen, Kim & Gyrd-Hansen, Dorte, 2020. "Age, morbidity, or something else? A residual approach using microdata to measure the impact of technological progress on health care expenditure," DaCHE discussion papers 2020:4, University of Southern Denmark, Dache - Danish Centre for Health Economics.
    36. van Baal, Pieter H. & Wong, Albert, 2012. "Time to death and the forecasting of macro-level health care expenditures: Some further considerations," Journal of Health Economics, Elsevier, vol. 31(6), pages 876-887.
    37. Edouard Ribes, 2022. "Financial planning & optimal retirement timing for physically intensive occupations," Working Papers hal-03219182, HAL.
    38. Edouard Ribes, 2022. "Transforming personal finance thanks to artificial intelligence: myth or reality?," Working Papers hal-03862261, HAL.
    39. Edouard A. Ribes, 2022. "Financial planning and optimal retirement timing for physically intensive occupations," SN Business & Economics, Springer, vol. 2(8), pages 1-28, August.
    40. Atella, Vincenzo & Conti, Valentina, 2014. "The effect of age and time to death on primary care costs: The Italian experience," Social Science & Medicine, Elsevier, vol. 114(C), pages 10-17.
    41. Blanco-Moreno, Ángela & Urbanos-Garrido, Rosa M. & Thuissard-Vasallo, Israel John, 2013. "Public healthcare expenditure in Spain: Measuring the impact of driving factors," Health Policy, Elsevier, vol. 111(1), pages 34-42.

  47. Tomas J. Philipson & Dana Goldman, 2007. "Integrated Insurance Design in the Presence of Multiple Medical Technologies," American Economic Review, American Economic Association, vol. 97(2), pages 427-432, May.
    See citations under working paper version above.
  48. Goldman Dana P & Joyce Geoffrey & Karaca-Mandic Pinar & Sood Neeraj, 2006. "Adverse Selection in Retiree Prescription Drug Plans," Forum for Health Economics & Policy, De Gruyter, vol. 9(1), pages 1-25, December.

    Cited by:

    1. Carey, Colleen, 2021. "Sharing the burden of subsidization: Evidence on pass-through from a subsidy revision in Medicare Part D," Journal of Public Economics, Elsevier, vol. 198(C).
    2. Colleen Carey, 2017. "Technological Change and Risk Adjustment: Benefit Design Incentives in Medicare Part D," American Economic Journal: Economic Policy, American Economic Association, vol. 9(1), pages 38-73, February.
    3. Murat K. Munkin & Pravin K. Trivedi, 2010. "Disentangling incentives effects of insurance coverage from adverse selection in the case of drug expenditure: a finite mixture approach," Health Economics, John Wiley & Sons, Ltd., vol. 19(9), pages 1093-1108, September.
    4. Munkin M & Trivedi P. K, 2009. "Incentives and Selection Effects of Drug Coverage on Total Drug Expenditure: a Finite Mixture Approach," Health, Econometrics and Data Group (HEDG) Working Papers 09/22, HEDG, c/o Department of Economics, University of York.

  49. Goldman Dana P & Cutler David M & Shang Baoping & Joyce Geoffrey F, 2006. "The Value of Elderly Disease Prevention," Forum for Health Economics & Policy, De Gruyter, vol. 9(2), pages 1-29, January.

    Cited by:

    1. Vincenzo Atella & Federico Belotti & Daejung Kim & Dana Goldman & Tadeja Gracner & Andrea Piano Mortari & Bryan Tysinger, 2021. "The future of the elderly population health status: Filling a knowledge gap," Health Economics, John Wiley & Sons, Ltd., vol. 30(S1), pages 11-29, November.
    2. P.-C. Michaud & D. Goldman & D. Lakdawalla & A. Gailey & Y. Zheng, 2009. "International Differences in Longevity and Health and their Economic Consequences," Social and Economic Dimensions of an Aging Population Research Papers 254, McMaster University.
    3. Knai, Cecile & Suhrcke, Marc & Lobstein, Tim, 2007. "Obesity in Eastern Europe: An overview of its health and economic implications," Economics & Human Biology, Elsevier, vol. 5(3), pages 392-408, December.
    4. Jinjing Li & Cathal O'Donoghue, 2013. "A survey of dynamic microsimulation models: uses, model structure and methodology," International Journal of Microsimulation, International Microsimulation Association, vol. 6(2), pages 3-55.
    5. Suhrcke, Marc & Urban, Dieter M. & Moesgaard Iburg, Kim & Schwappach, David & Boluarte, Till & McKee, Martin, 2007. "The economic benefits of health and prevention in a high-income country: the example of Germany," Discussion Papers, Research Group Public Health SP I 2007-302, WZB Berlin Social Science Center.
    6. Julia Thornton Snider & Jeffrey Sullivan & Emma van Eijndhoven & Michael K Hansen & Nobel Bellosillo & Cheryl Neslusan & Ellen O’Brien & Ralph Riley & Seth Seabury & Bertram L Kasiske, 2019. "Lifetime benefits of early detection and treatment of diabetic kidney disease," PLOS ONE, Public Library of Science, vol. 14(5), pages 1-13, May.

  50. Darius Lakdawalla & Neeraj Sood & Dana Goldman, 2006. "HIV Breakthroughs and Risky Sexual Behavior," The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 121(3), pages 1063-1102.
    See citations under working paper version above.
  51. Goldman Dana P & Sood Neeraj & Leibowitz Arleen, 2005. "Wage and Benefit Changes in Response to Rising Health Insurance," Forum for Health Economics & Policy, De Gruyter, vol. 8(1), pages 1-17, January.

    Cited by:

    1. Jessica Vistnes & Thomas Selden, 2011. "Premium growth and its effect on employer-sponsored insurance," International Journal of Health Economics and Management, Springer, vol. 11(1), pages 55-81, March.
    2. Daron Acemoglu & Andrea Manera & Pascual Restrepo, 2020. "Does the US Tax Code Favor Automation?," Brookings Papers on Economic Activity, Economic Studies Program, The Brookings Institution, vol. 51(1 (Spring), pages 231-300.
    3. Adams, Scott, 2007. "Health insurance market reform and employee compensation: The case of pure community rating in New York," Journal of Public Economics, Elsevier, vol. 91(5-6), pages 1119-1133, June.
    4. DeVaro, Jed & Maxwell, Nan L., 2014. "The elusive wage-benefit trade-off: The case of employer-provided health insurance," International Journal of Industrial Organization, Elsevier, vol. 37(C), pages 23-37.
    5. Nan L. Maxwell, 2008. "Labor Markets And Health Benefits: The Offer And Restrictions On It," Contemporary Economic Policy, Western Economic Association International, vol. 26(1), pages 73-88, January.
    6. Stéphanie Lluis, 2009. "The Structure of Wages by Firm Size: A Comparison of Canada and the USA," LABOUR, CEIS, vol. 23(2), pages 283-317, June.

  52. Goldman, Dana P. & Sood, Neeraj & Leibowitz, Arleen, 2005. "The reallocation of compensation in response to health insurance premium increases," Economics Letters, Elsevier, vol. 88(2), pages 147-151, August.
    See citations under working paper version above.
  53. Goldman Dana P & Lakdawalla Darius N., 2005. "A Theory of Health Disparities and Medical Technology," The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 4(1), pages 1-30, September.

    Cited by:

    1. Marisa Hidalgo-Hidalgo & Pedro Albarrán & Iñigo Iturbe-Ormaetxe, 2019. "Education and adult health: Is there a causal effect?," Working Papers 19.11, Universidad Pablo de Olavide, Department of Economics.
    2. Anderberg, Dan & Chevalier, Arnaud & Wadsworth, Jonathan, 2008. "Anatomy of a Health Scare: Education, Income and the MMR Controversy in the UK," IZA Discussion Papers 3590, Institute of Labor Economics (IZA).
    3. David P. Baker & William C. Smith & Ismael G. Muñoz & Haram Jeon & Tian Fu & Juan Leon & Daniel Salinas & Renata Horvatek, 2017. "The Population Education Transition Curve: Education Gradients Across Population Exposure to New Health Risks," Demography, Springer;Population Association of America (PAA), vol. 54(5), pages 1873-1895, October.
    4. Dora L. Costa, 2015. "Health and the Economy in the United States from 1750 to the Present," Journal of Economic Literature, American Economic Association, vol. 53(3), pages 503-570, September.
    5. Cutler, David M. & Lleras-Muney, Adriana, 2010. "Understanding Differences in Health Behaviors by Education," Scholarly Articles 5344195, Harvard University Department of Economics.
    6. Bijwaard, G. & van Kippersluis, H., 2015. "Efficiency of health investment: education or intelligence?," Health, Econometrics and Data Group (HEDG) Working Papers 15/12, HEDG, c/o Department of Economics, University of York.
    7. Volker Grossmann, 2021. "Medical Innovations and Ageing: A Health Economics Perspective," CESifo Working Paper Series 9387, CESifo.
    8. Hernandez, Elaine M., 2013. "Provider and patient influences on the formation of socioeconomic health behavior disparities among pregnant women," Social Science & Medicine, Elsevier, vol. 82(C), pages 35-42.
    9. Stefan Boes, 2011. "On the causal effect of schooling on smoking: evidence without exogeneity conditions," Diskussionsschriften dp1102, Universitaet Bern, Departement Volkswirtschaft.
    10. Frankovic, Ivan & Kuhn, Michael, 2019. "Access to health care, medical progress and the emergence of the longevity gap: A general equilibrium analysis," The Journal of the Economics of Ageing, Elsevier, vol. 14(C).
    11. Barton Hamilton & Andrés Hincapié & Emma C. Kalish & Nicholas W. Papageorge, 2021. "Medical Innovation and Health Disparities," NBER Working Papers 28864, National Bureau of Economic Research, Inc.
    12. Daniel Weiss & Håvard T Rydland & Emil Øversveen & Magnus Rom Jensen & Solvor Solhaug & Steinar Krokstad, 2018. "Innovative technologies and social inequalities in health: A scoping review of the literature," PLOS ONE, Public Library of Science, vol. 13(4), pages 1-20, April.
    13. Rydland, Håvard T., 2020. "Monitoring the social gradient: Inequalities in use of blood pressure monitors in the HUNT study," Technology in Society, Elsevier, vol. 63(C).
    14. McCabe, Katharine, 2016. "Mothercraft: Birth work and the making of neoliberal mothers," Social Science & Medicine, Elsevier, vol. 162(C), pages 177-184.
    15. Pinka Chatterji & Heesoo Joo & Kajal Lahiri, 2010. "Beware of Unawareness: Racial/Ethnic Disparities in Awareness of Chronic Diseases," NBER Working Papers 16578, National Bureau of Economic Research, Inc.
    16. Robert Kaestner & Cuiping Schiman & Jason M. Ward, 2020. "Education and Health Over the Life Cycle," NBER Working Papers 26836, National Bureau of Economic Research, Inc.
    17. Jakub P. Hlávka & Jeffrey C. Yu & Dana P. Goldman & Darius N. Lakdawalla, 2021. "The economics of alternative payment models for pharmaceuticals," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(4), pages 559-569, June.
    18. Raymond N Kuo & Chao-Lun Lai & Yi-Chun Yeh & Mei-Shu Lai, 2017. "Discretionary decisions and disparities in receiving drug-eluting stents under a universal healthcare system: A population-based study," PLOS ONE, Public Library of Science, vol. 12(6), pages 1-13, June.
    19. Pinka Chatterji & Heesoo Joo & Kajal Lahiri, 2012. "Beware Of Being Unaware: Racial/Ethnic Disparities In Chronic Illness In The Usa," Health Economics, John Wiley & Sons, Ltd., vol. 21(9), pages 1040-1060, September.
    20. Lange, Fabian, 2011. "The role of education in complex health decisions: Evidence from cancer screening," Journal of Health Economics, Elsevier, vol. 30(1), pages 43-54, January.

  54. Dana Goldman & James P. Smith, 2005. "Socioeconomic Differences in the Adoption of New Medical Technologies," American Economic Review, American Economic Association, vol. 95(2), pages 234-237, May.
    See citations under working paper version above.
  55. Jay Bhattacharya & Dana Goldman & Neeraj Sood, 2004. "Price Regulation in Secondary Insurance Markets," Journal of Risk & Insurance, The American Risk and Insurance Association, vol. 71(4), pages 643-675, December.

    Cited by:

    1. Carmelo Giaccotto & Joseph Golec & Bryan P. Schmutz, 2017. "Measuring the Performance of the Secondary Market for Life Insurance Policies," Journal of Risk & Insurance, The American Risk and Insurance Association, vol. 84(1), pages 127-151, March.
    2. Nadine Gatzert & Gudrun Hoermann & Hato Schmeiser, 2009. "The Impact of the Secondary Market on Life Insurers’ Surrender Profits," Journal of Risk & Insurance, The American Risk and Insurance Association, vol. 76(4), pages 887-908, December.
    3. Martin Eling & David Pankoke, 2016. "Costs and Benefits of Financial Regulation: An Empirical Assessment for Insurance Companies," The Geneva Papers on Risk and Insurance - Issues and Practice, Palgrave Macmillan;The Geneva Association, vol. 41(4), pages 529-554, October.
    4. Nadine Gatzert, 2010. "The Secondary Market for Life Insurance in the United Kingdom, Germany, and the United States: Comparison and Overview," Risk Management and Insurance Review, American Risk and Insurance Association, vol. 13(2), pages 279-301, September.
    5. Mar Jori & Antonio Alegre & Carmen Ribas, 2011. "Deciding the sale of a life policy in the viatical market: Implications on individual welfare," Working Papers in Economics 256, Universitat de Barcelona. Espai de Recerca en Economia.

  56. Bhattacharya Jayanta & Cutler David M. & Goldman Dana P. & Hurd Michael D. & Joyce Geoffrey F. & Lakdawalla Darius N. & Panis Constantijn W. A. & Shang Baoping, 2004. "Disability Forecasts and Future Medicare Costs," Forum for Health Economics & Policy, De Gruyter, vol. 7(1), pages 1-22, January.

    Cited by:

    1. Niehaus, Frank, 2006. "Alter und steigende Lebenserwartung - Eine Analyse der Auswirkungen auf die Gesundheitsausgaben," WIP-Analysen Dezember 2006, WIP – Wissenschaftliches Institut der PKV.
    2. Niehaus, Frank, 2008. "Prognose des Beitragssatzes in der gesetzlichen Krankenversicherung," WIP-Analysen September 2008, WIP – Wissenschaftliches Institut der PKV.
    3. P.-C. Michaud & D. Goldman & D. Lakdawalla & Y. Zheng & A. Gailey, 2009. "Understanding the Economic Consequences of Shifting Trends in Population Health," Social and Economic Dimensions of an Aging Population Research Papers 255, McMaster University.
    4. Igor Akushevich & Julia S. Kravchenko & Kenneth G. Manton, 2007. "Health‐Based Population Forecasting: Effects of Smoking on Mortality and Fertility," Risk Analysis, John Wiley & Sons, vol. 27(2), pages 467-482, April.
    5. Gregory G. Lubiani & Albert A. Okunade, 2013. "Production Cost Structure In Us Outpatient Physical Therapy Health Care," Health Economics, John Wiley & Sons, Ltd., vol. 22(2), pages 212-223, February.
    6. Niehaus, Frank & Weber, Christian, 2008. "Teilkapitaldeckung als Finanzierungsmodell am Beispiel der Pflegeversicherung," WIP-Analysen Juni 2008, WIP – Wissenschaftliches Institut der PKV.

  57. Bhattacharya, Jayanta & Goldman, Dana & Sood, Neeraj, 2003. "The link between public and private insurance and HIV-related mortality," Journal of Health Economics, Elsevier, vol. 22(6), pages 1105-1122, November.
    See citations under working paper version above.
  58. Goldman Dana P & Joyce Geoffrey F & Malkin Jesse Dylan, 2002. "The Costs of A Medicare Prescription Drug Benefit," The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 2(1), pages 1-18, April.

    Cited by:

    1. Dahlia K. Remler & Joshua Graff Zivin & Sherry A. Glied, 2002. "Modeling Health Insurance Expansions: Effects of Alternate Approaches," NBER Working Papers 9130, National Bureau of Economic Research, Inc.
    2. Melissa Boyle, 2008. "Costs and Benefits of Elderly Prescription Drug Coverage: Evidence from Veterans’ Health Care," Working Papers 0803, College of the Holy Cross, Department of Economics.

  59. Goldman D. P. & Bhattacharya J. & McCaffrey D. F. & Duan N. & Leibowitz A. A. & Joyce G. F. & Morton S. C., 2001. "Effect of Insurance on Mortality in an HIV-Positive Population in Care," Journal of the American Statistical Association, American Statistical Association, vol. 96, pages 883-894, September.

    Cited by:

    1. Santiago Acerenza & Otávio Bartalotti & Désiré Kédagni, 2023. "Testing identifying assumptions in bivariate probit models," Journal of Applied Econometrics, John Wiley & Sons, Ltd., vol. 38(3), pages 407-422, April.
    2. Jaeun Choi & A. James O'Malley, 2017. "Estimating the causal effect of treatment in observational studies with survival time end points and unmeasured confounding," Journal of the Royal Statistical Society Series C, Royal Statistical Society, vol. 66(1), pages 159-185, January.
    3. Jay Bhattacharya & Dana Goldman & Neeraj Sood, 2002. "The Link Between Public and Private Insurance and HIV-Related Mortality," NBER Working Papers 9346, National Bureau of Economic Research, Inc.
    4. Pinka Chatterji & Margarita Alegria & Mingshan Lu & David Takeuchi, 2005. "Psychiatric Disorders and Labor Market Outcomes: Evidence from the National Latino and Asian American Study," NBER Working Papers 11893, National Bureau of Economic Research, Inc.
    5. Appelt, Silvia, 2010. "Authorized Generic Entry prior to Patent Expiry: Reassessing Incentives for Independent Generic Entry," Discussion Papers in Economics 11476, University of Munich, Department of Economics.
    6. Zeng-Hua Lu & Alec Zuo, 2017. "Child disability, welfare payments, marital status and mothers’ labor supply: Evidence from Australia," Cogent Economics & Finance, Taylor & Francis Journals, vol. 5(1), pages 1339769-133, January.
    7. Rashad, Inas & Kaestner, Robert, 2004. "Teenage sex, drugs and alcohol use: problems identifying the cause of risky behaviors," Journal of Health Economics, Elsevier, vol. 23(3), pages 493-503, May.
    8. Marra Giampiero & Radice Rosalba, 2017. "A joint regression modeling framework for analyzing bivariate binary data in R," Dependence Modeling, De Gruyter, vol. 5(1), pages 268-294, December.
    9. Inas Kelly & Dhaval Dave & Jody Sindelar & William Gallo, 2014. "The impact of early occupational choice on health behaviors," Review of Economics of the Household, Springer, vol. 12(4), pages 737-770, December.
    10. Glied, Sherry & Hong, Kai, 2018. "Health care in a multi-payer system: Spillovers of health care service demand among adults under 65 on utilization and outcomes in medicare," Journal of Health Economics, Elsevier, vol. 60(C), pages 165-176.
    11. Datar, Ashlesha, 2006. "Does delaying kindergarten entrance give children a head start?," Economics of Education Review, Elsevier, vol. 25(1), pages 43-62, February.
    12. Dana P. Goldman & Benjamin G. Cohen & Jessica Y. Ho & Daniel L. McFadden & Martha S. Ryan & Bryan Tysinger, 2021. "Improved survival for individuals with common chronic conditions in the Medicare population," Health Economics, John Wiley & Sons, Ltd., vol. 30(S1), pages 80-91, November.
    13. Qin, Xuezheng & Pan, Jay & Liu, Gordon G., 2014. "Does participating in health insurance benefit the migrant workers in China? An empirical investigation," China Economic Review, Elsevier, vol. 30(C), pages 263-278.
    14. Mary Eschelbach Hansen & Paul Jacobs, 2007. "Valuing Substitute Families:Financial Support for Foster and Adoptive Families," Working Papers 2007-04, American University, Department of Economics.
    15. Yingying Meng & Junqiang Han & Siqi Qin, 2018. "The Impact of Health Insurance Policy on the Health of the Senior Floating Population—Evidence from China," IJERPH, MDPI, vol. 15(10), pages 1-17, October.
    16. Steve Bradley & Rob Crouchley, 2020. "The effects of test scores and truancy on youth unemployment and inactivity: a simultaneous equations approach," Empirical Economics, Springer, vol. 59(4), pages 1799-1831, October.
    17. Balsa, Ana I. & Cao, Zhun & McGuire, Thomas G., 2007. "Does managed health care reduce health care disparities between minorities and Whites?," Journal of Health Economics, Elsevier, vol. 26(1), pages 101-121, January.
    18. Chatterji, Pinka & Dave, Daval & Kaestner, Robert & Markowitz, Sara, 2004. "Alcohol abuse and suicide attempts among youth," Economics & Human Biology, Elsevier, vol. 2(2), pages 159-180, June.
    19. Giampiero Marra & Rosalba Radice & Silvia Missiroli, 2014. "Testing the hypothesis of absence of unobserved confounding in semiparametric bivariate probit models," Computational Statistics, Springer, vol. 29(3), pages 715-741, June.
    20. PAN, Jay & QIN, Xuezheng & LIU, Gordon G., 2013. "The impact of body size on urban employment: Evidence from China," China Economic Review, Elsevier, vol. 27(C), pages 249-263.
    21. Appelt, Silvia, 2010. "Authorized Generic Entry prior to Patent Expiry: Reassessing Incentives for Independent Generic Entry," Discussion Paper Series of SFB/TR 15 Governance and the Efficiency of Economic Systems 357, Free University of Berlin, Humboldt University of Berlin, University of Bonn, University of Mannheim, University of Munich.
    22. Likwang Chen & Winnie Yip & Ming‐Cheng Chang & Hui‐Sheng Lin & Shyh‐Dye Lee & Ya‐Ling Chiu & Yu‐Hsuan Lin, 2007. "The effects of Taiwan's National Health Insurance on access and health status of the elderly," Health Economics, John Wiley & Sons, Ltd., vol. 16(3), pages 223-242, March.
    23. Feiyan Yang & Li Wei, 2023. "The impact of tax-subsidized health insurance on health and out-of-pocket burden in China," The Geneva Papers on Risk and Insurance - Issues and Practice, Palgrave Macmillan;The Geneva Association, vol. 48(1), pages 194-246, January.
    24. Han, Sukjin & Vytlacil, Edward J., 2017. "Identification in a generalization of bivariate probit models with dummy endogenous regressors," Journal of Econometrics, Elsevier, vol. 199(1), pages 63-73.

  60. Barton H. Hamilton & Vivian Ho & Dana P. Goldman, 2000. "Queuing for Surgery: Is the U.S. or Canada Worse Off?," The Review of Economics and Statistics, MIT Press, vol. 82(2), pages 297-308, May.

    Cited by:

    1. Moscelli, Giuseppe & Siciliani, Luigi & Tonei, Valentina, 2016. "Do waiting times affect health outcomes? Evidence from coronary bypass," Social Science & Medicine, Elsevier, vol. 161(C), pages 151-159.
    2. Ann P. Bartel & Carri W. Chan & Song-Hee Kim, 2020. "Should Hospitals Keep Their Patients Longer? The Role of Inpatient Care in Reducing Postdischarge Mortality," Management Science, INFORMS, vol. 66(6), pages 2326-2346, June.
    3. Verzulli, R.; & Lippi Bruni, M.;, 2022. "The quicker the better: Fostering timely responses in public hospitals," Health, Econometrics and Data Group (HEDG) Working Papers 22/08, HEDG, c/o Department of Economics, University of York.
    4. Steven Globerman & Luther H. Hodges & Aidan Vining, 2004. "Canadian And Us Health Care Systems Performance And Governance: Elements Of Convergence," Public Economics 0404003, University Library of Munich, Germany.
    5. Bhattacharya, Jay & Shaikh, Azeem M. & Vytlacil, Edward, 2012. "Treatment effect bounds: An application to Swan–Ganz catheterization," Journal of Econometrics, Elsevier, vol. 168(2), pages 223-243.
    6. Daniel Serra & Francisco Silva, 2002. "Locating emergency services with priority rules: The priority queuing covering location problem," Economics Working Papers 642, Department of Economics and Business, Universitat Pompeu Fabra, revised May 2008.
    7. Andrew J. Epstein & Jonathan D. Ketcham & Sean Nicholson, 2010. "Specialization and matching in professional services firms," RAND Journal of Economics, RAND Corporation, vol. 41(4), pages 811-834, December.
    8. Marcelin Joanis & David Boisclair & Claude Montmarquette, 2004. "La santé au Québec : des options pour financer la croissance," CIRANO Project Reports 2004rp-04, CIRANO.

  61. Goldman, Dana P. & Hosek, Susan D. & Dixon, Lloyd S. & Sloss, Elizabeth M., 1995. "The effects of benefit design and managed care on health care costs," Journal of Health Economics, Elsevier, vol. 14(4), pages 401-418, October.

    Cited by:

    1. Cooper, D. & McCausland, W.D. & Theodossiou, I., 2006. "The health hazards of unemployment and poor education: The socioeconomic determinants of health duration in the European Union," Economics & Human Biology, Elsevier, vol. 4(3), pages 273-297, December.
    2. Jerome Dugan, 2015. "Trends in Managed Care Cost Containment: An Analysis of the Managed Care Backlash," Health Economics, John Wiley & Sons, Ltd., vol. 24(12), pages 1604-1618, December.
    3. Munkin M & Trivedi P. K, 2009. "Incentives and Selection Effects of Drug Coverage on Total Drug Expenditure: a Finite Mixture Approach," Health, Econometrics and Data Group (HEDG) Working Papers 09/22, HEDG, c/o Department of Economics, University of York.
    4. Henke, Klaus-Dirk & Rich, Robert F. & Steinbach, Axel & Borchardt, Katja, 2004. "Auf dem Wege zu einer integrierten Versorgung: Neue sozialrechtliche Rahmenbedingungen unter Berücksichtigung der Erfahrungen aus den USA und am Beispiel Berlins," Discussion Papers 2004/12, Technische Universität Berlin, School of Economics and Management.
    5. Partha Deb & Pravin K. Trivedi, 2002. "Specification and Simulated Likelihood Estimation of a Non-normal Outcome Model with Selection: Application to Health Care Utilization," Economics Working Paper Archive at Hunter College 02/5, Hunter College Department of Economics, revised 2004.
    6. Thomas G. McGuire & Jacob Glazer, 2000. "Optimal Risk Adjustment in Markets with Adverse Selection: An Application to Managed Care," American Economic Review, American Economic Association, vol. 90(4), pages 1055-1071, September.

  62. Dana P. Goldman, 1995. "Managed Care as a Public Cost-Containment Mechanism," RAND Journal of Economics, The RAND Corporation, vol. 26(2), pages 277-295, Summer.

    Cited by:

    1. Kim, Kyoo il, 2006. "Sample selection models with a common dummy endogenous regressor in simultaneous equations: A simple two-step estimation," Economics Letters, Elsevier, vol. 91(2), pages 280-286, May.
    2. Allen C. Goodman & Miron Stano, 2000. "Hmos and Health Externalities: A Local Public Good Perspective," Public Finance Review, , vol. 28(3), pages 247-269, May.
    3. Jay Bhattacharya & Dana Goldman & Neeraj Sood, 2002. "The Link Between Public and Private Insurance and HIV-Related Mortality," NBER Working Papers 9346, National Bureau of Economic Research, Inc.
    4. Meyerhoefer, Chad D. & Pylypchuk, Vuriy, 2008. "AJAE Appendix: Does Participation in the Food Stamp Program Increase the Prevalence of Obesity and Health Care Spending?," American Journal of Agricultural Economics APPENDICES, Agricultural and Applied Economics Association, vol. 90(2), pages 1-6.
    5. Michelle M. Mello & Sally C. Stearns & Edward C. Norton, 2002. "Do Medicare HMOs still reduce health services use after controlling for selection bias?," Health Economics, John Wiley & Sons, Ltd., vol. 11(4), pages 323-340, June.
    6. Donna B. Gilleskie & Koleman S. Strumpf, 2005. "The Behavioral Dynamics of Youth Smoking," Journal of Human Resources, University of Wisconsin Press, vol. 40(4), pages 822-866.
    7. Murat K. Munkin & Partha Deb & Pravin K. Trivedi, 2006. "Bayesian analysis of the two-part model with endogeneity: application to health care expenditure," Journal of Applied Econometrics, John Wiley & Sons, Ltd., vol. 21(7), pages 1081-1099.
    8. Holmes, George M., 2005. "Increasing physician supply in medically underserved areas," Labour Economics, Elsevier, vol. 12(5), pages 697-725, October.
    9. Carol Rapaport & Christopher A. Trenholm, 2000. "What do we really know about trends in outpatient medical expenditures for children, 1977-1987?," Staff Reports 97, Federal Reserve Bank of New York.
    10. Yang, Zhou & Bishai, David & Harman, Jeffrey, 2008. "Convergence of body mass with aging: The longitudinal interrelationship of health, weight, and survival," Economics & Human Biology, Elsevier, vol. 6(3), pages 469-481, December.
    11. Zhou Yang & Donna B. Gilleskie & Edward C. Norton, 2004. "Prescription Drugs, Medical Care, and Health Outcomes: A Model of Elderly Health Dynamics," NBER Working Papers 10964, National Bureau of Economic Research, Inc.
    12. Hai Fang & John Rizzo, 2010. "Has the influence of managed care waned? Evidence from the market for physician services," International Journal of Health Economics and Management, Springer, vol. 10(1), pages 85-103, March.
    13. Sebastian Gechert, 2009. "Supplementary Private Health Insurance in Selected Countries: Lessons for EU Governments?," CESifo Working Paper Series 2739, CESifo.
    14. Walter M. Cadette, 1996. "Rethinking Health Care Policy: The Case for Retargeting Tax Subsidies," Economics Working Paper Archive wp_171, Levy Economics Institute.
    15. Chung-Ping Loh, 2009. "Physical inactivity and working hour inflexibility: evidence from a U.S. sample of older men," Review of Economics of the Household, Springer, vol. 7(3), pages 257-281, September.
    16. Thomas J. Miceli & Dennis Heffley, 2002. "Do Hmos Encourage Prevention? An Analysis Of Alternative Health Care Plans," Contemporary Economic Policy, Western Economic Association International, vol. 20(4), pages 429-439, October.
    17. Silvia Balia & Andrew M. Jones, 2011. "Catching the habit: a study of inequality of opportunity in smoking‐related mortality," Journal of the Royal Statistical Society Series A, Royal Statistical Society, vol. 174(1), pages 175-194, January.
    18. Walter M. Cadette, 1999. "Rethinking Health Care Policy: The Case for Retargeting Tax Subsidies," Macroeconomics 9902011, University Library of Munich, Germany.
    19. Munkin, Murat K. & Trivedi, Pravin K., 2003. "Bayesian analysis of a self-selection model with multiple outcomes using simulation-based estimation: an application to the demand for healthcare," Journal of Econometrics, Elsevier, vol. 114(2), pages 197-220, June.
    20. Partha Deb & Pravin K. Trivedi, 2009. "Provider networks and primary‐care signups: do they restrict the use of medical services?," Health Economics, John Wiley & Sons, Ltd., vol. 18(12), pages 1361-1380, December.
    21. Hai Fang & Hong Liu & John Rizzo, 2009. "Has the use of physician gatekeepers declined among HMOs? Evidence from the United States," International Journal of Health Economics and Management, Springer, vol. 9(2), pages 183-195, June.
    22. Silvia Balia & Andrew M. Jones, 2007. "Unravelling the influence of smoking initiation and cessation on premature mortality using a common latent factor model," Health, Econometrics and Data Group (HEDG) Working Papers 07/06, HEDG, c/o Department of Economics, University of York.

Chapters

  1. John A. Romley & Abe Dunn & Dana Goldman & Neeraj Sood, 2020. "Quantifying Productivity Growth in the Delivery of Important Episodes of Care within the Medicare Program Using Insurance Claims and Administrative Data," NBER Chapters, in: Big Data for Twenty-First-Century Economic Statistics, pages 297-338, National Bureau of Economic Research, Inc.
    See citations under working paper version above.
  2. Dana Goldman & Darius Lakdawalla & Yuhui Zheng, 2011. "Food Prices and the Dynamics of Body Weight," NBER Chapters, in: Economic Aspects of Obesity, pages 65-90, National Bureau of Economic Research, Inc.
    See citations under working paper version above.
  3. Goldman, Dana & Lakdawalla, Darius, 2011. "Intellectual Property, Information Technology, Biomedical Research, and Marketing of Patented Products," Handbook of Health Economics, in: Mark V. Pauly & Thomas G. Mcguire & Pedro P. Barros (ed.), Handbook of Health Economics, volume 2, chapter 0, pages 825-872, Elsevier.

    Cited by:

    1. Stern, Ariel Dora, 2017. "Innovation under regulatory uncertainty: Evidence from medical technology," Journal of Public Economics, Elsevier, vol. 145(C), pages 181-200.

  4. Tomas J. Philipson & Eric Sun & Dana Goldman, 2010. "The Effects of Product Liability Exemption in the Presence of the FDA," NBER Chapters, in: Regulation vs. Litigation: Perspectives from Economics and Law, pages 137-163, National Bureau of Economic Research, Inc.
    See citations under working paper version above.
  5. Michael E. Chernew & Dana Goldman & Feng Pan, 2009. "Disability and Spending Growth," NBER Chapters, in: Health at Older Ages: The Causes and Consequences of Declining Disability among the Elderly, pages 237-248, National Bureau of Economic Research, Inc.

    Cited by:

    1. Han, Sae Hwang & Kim, Kyungmin & Burr, Jeffrey A., 2021. "Take a sad song and make it better: Spousal activity limitations, caregiving, and depressive symptoms among couples," Social Science & Medicine, Elsevier, vol. 281(C).

  6. Dana P. Goldman & Geoffrey Joyce & Pinar Karaca-Mandic & Neeraj Sood, 2006. "Adverse Selection in Retiree Prescription Drug Plans," NBER Chapters, in: Frontiers in Health Policy Research, Volume 9, National Bureau of Economic Research, Inc.
    See citations under working paper version above.
  7. Dana P. Goldman & Neeraj Sood & Arleen Leibowitz, 2005. "Wage and Benefit Changes in Response to Rising Health Insurance," NBER Chapters, in: Frontiers in Health Policy Research, Volume 8, National Bureau of Economic Research, Inc.
    See citations under working paper version above.
  8. Jayanta Bhattacharya & David M. Cutler & Dana P. Goldman & Michael D. Hurd & Geoffrey F. Joyce & Darius N. Lakdawalla & Constantijn W. A. Panis, 2004. "Disability Forecasts and Future Medicare Costs," NBER Chapters, in: Frontiers in Health Policy Research, Volume 7, pages 75-94, National Bureau of Economic Research, Inc.
    See citations under working paper version above.

Books

  1. Berndt, Ernst R. & Goldman, Dana P. & Rowe, John (ed.), 2019. "Economic Dimensions of Personalized and Precision Medicine," National Bureau of Economic Research Books, University of Chicago Press, number 9780226611068, September.

    Cited by:

    1. Veenstra David L. & Mandelblatt Jeanne & Neumann Peter & Basu Anirban & Peterson Josh F. & Ramsey Scott D., 2020. "Health Economics Tools and Precision Medicine: Opportunities and Challenges," Forum for Health Economics & Policy, De Gruyter, vol. 23(1), pages 1-14, June.
    2. Manuel Hermosilla, 2021. "Rushed Innovation: Evidence from Drug Licensing," Management Science, INFORMS, vol. 67(1), pages 257-278, January.

  2. Ernst R. Berndt & Dana P. Goldman & John W. Rowe, 2019. "Economic Dimensions of Personalized and Precision Medicine," NBER Books, National Bureau of Economic Research, Inc, number bern-13.

    Cited by:

    1. Veenstra David L. & Mandelblatt Jeanne & Neumann Peter & Basu Anirban & Peterson Josh F. & Ramsey Scott D., 2020. "Health Economics Tools and Precision Medicine: Opportunities and Challenges," Forum for Health Economics & Policy, De Gruyter, vol. 23(1), pages 1-14, June.
    2. Manuel Hermosilla, 2021. "Rushed Innovation: Evidence from Drug Licensing," Management Science, INFORMS, vol. 67(1), pages 257-278, January.

  3. David Cutler & Alan Garber & Dana Goldman, 2007. "Frontiers in Health Policy Research, Volume 10," NBER Books, National Bureau of Economic Research, Inc, number cutl07-1.

    Cited by:

    1. Alessandra Trimarchi & Jan Bavel, 2020. "Partners’ Educational Characteristics and Fertility: Disentangling the Effects of Earning Potential and Unemployment Risk on Second Births," European Journal of Population, Springer;European Association for Population Studies, vol. 36(3), pages 439-464, July.
    2. Andrew James Abbott & Glauco de Vita, 2011. "Testing for long-run convergence across regional house prices in the UK: a pairwise approach," Post-Print hal-00762892, HAL.
    3. Cristiano Codagnone & Fabienne Abadie & Federico Biagi, 2016. "The Future of Work in the ‘Sharing Economy’. Market Efficiency and Equitable Opportunities or Unfair Precarisation?," JRC Research Reports JRC101280, Joint Research Centre.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.